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          Lysosome membrane fusion represents the last step of the endocytic pathway. During 
endocytosis, internalized surface proteins are delivered to endosomes where they are packaged 
into intraluminal vesicles (ILVs). Multiple rounds of ILV formation produce mature 
multivesicular body (MVB) that fuses with lysosomes to expose protein-laden ILVs to lumenal 
acid hydrolases for catabolism. Lysosomes also undergo homotypic membrane fusion for 
remodeling in response to cellular stress, or aging, or for organelle inheritance. A unique feature 
of homotypic lysosome fusion is the formation of IntraLumenal Fragments (ILF), whereby 
portions of the membranes are internalized and degraded upon merging. Although critical for 
homeostasis and remodeling, it is not clear how ILFs are formed during the homotypic lipid 
bilayer fusion reaction, nor is it clear whether similar molecular mechanisms orchestrate MVB-
lysosome fusion. 
         Using Saccharomyces cerevisiae and its vacuolar lysosome as a model, I show that 
coordinated interactions between the fusion protein machinery (Rab-GTPase Ypt7 and its 
effector Vps41), and the protein kinase Yck3, target hemifusion intermediates to control ILF 
formation upon vacuolar lysosome fusion. To do so, I introduced a point mutation in Ypt7 
(D44N) that permits activation but impairs binding to Vps41 causing it to be phosphorylated by 
Yck3. Phosphorylated Vps41 causes the multisubunit tethering complex HOPS to dissociate 
from vacuolar lysosome membranes preventing efficient trans-SNARE pairing required for lipid 
bilayer pore formation. This stall in pore formation allows hemifusion diaphragms to expand 
across docked organelle interfaces causing fewer ILFs to form. Knocking out YCK3 stabilizes 
Vps41 and HOPS on membranes restoring fusion defects and ILF formation.  
          With a better understanding of homotypic vacuolar lysosome fusion and ILF formation, I 
next determined if MVB-vacuolar lysosome fusion relies on a similar mechanism. By developing 
a new luminal β-lactamase complementation assay to measure MVB-vacuolar lysosome fusion 
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in vitro, I show that both fusion events require Ypt7 and HOPS, but heterotypic fusion is distinct 
in that it uses a unique non-canonical Q-SNARE bundle composed of the endosomal Qa-SNARE 
Pep12, Qb-SNARE Vti1, and soluble Qc-SNARE Vam7, that complexes with the lysosomal R-
SNARE Nyv1 to drive lipid bilayer merger. Loss-of-function mutations that impair MVB 






 exchanger NHX1 or components of the ESCRT 
machinery that drive ILV formation blocks heterotypic membrane fusion. Correcting luminal pH 
rescues the fusion impairment caused by deleting NHX1, whereas activating the Rab-GTPase 
Ypt7 rescues fusion defects caused by ESCRT dysfunction.  
          Using new insights from these results, I present refined working models describing the 
molecular underpinnings of homotypic vacuolar lysosome and MVB-vacuolar lysosome fusion. 
Because all of the underlying machinery is conserved in all eukaryotic phyla, I anticipate that 
they will be used to help design strategies to treat human disorders linked to mutations in genes 
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Chapter 1. Introduction 
 
1.1 Lysosomes and their functions         
        Lysosomes are the recycling compartments within eukaryotic cells. Christian de Duve first 
discovered them in 1955 when studying the intracellular distribution of enzymes using 
centrifugal fractionation (de Duve, 2005). Three processes required for lysosomal function are 
membrane fusion, biomaterial catabolism, and nutrient recycling. Membrane fusion mediates the 
delivery of biomaterials to the lumen of the lysosome (Klionsky and Ohsumi, 1999; Teter and 
Klionsky, 2000). Received biomaterials are then broken down by acid hydrolases (proteases and 
lipases) into their constituents (amino acids, lipids, nucleotides; Klionsky et al., 1990). 
Transporter proteins embedded in the lysosome membrane move nutrients from the lumen to the 
cytoplasm where they are reused by the cell (Russnak et al., 2001). 
1.2 Membrane trafficking pathways that feed biomaterials to lysosomes 
          The two major cellular pathways that deliver biomaterials to lysosomes (vacuolar 
lysosomes in Saccharomyces cerevisiae) are autophagy and endocytosis. Autophagy involves the 
encapsulation of intracellular biomaterials (cytoplasmic protein aggregates or damaged 
organelles) to form an autophagosome that fuses with the lysosome exposing their materials to 
hydrolases for recycling (Figure 1; Eskelinen and Saftig, 2009). The second pathway, 
endocytosis, encapsulates extracellular biomaterials or internalizes surface receptors and 
transporters by invagination of the plasma membrane to form early endosomes. Early endosomes 
undergo homotypic fusion to form a late endosome. Here internalized surface proteins are sorted 
and packaged into vesicles (ILVs) by the ESCRT (Endosomal Sorting Complexes Required for 
Transport) machinery. Multiple rounds of ILV formation produce a mature multivesicular body 
(MVB; Huotari and Helenius, 2011; Schmidt and Teis, 2012). The pathway culminates with 
MVB fusion with the lysosome to deliver biomaterials for recycling (Figure 1). 
        In addition to heterotypic (e.g. MVB-lysosome) membrane fusion, lysosomes also undergo 
homotypic (lysosome-lysosome) membrane fusion. Homotypic fusion is essential for lysosomes 
to control their shape, size, and copy number for organelle inheritance for example (Brett and 
Merz, 2008). Homotypic lysosome fusion also mediates the turnover of resident polytopic 
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proteins (Mattie et al., 2017; McNally et al., 2017). In response to substrates, TOR (target of 
rapamycin) signaling or misfolding, transporter proteins are labeled for degradation and sorted 
into an area of membrane called the boundary, encircled by fusogenic proteins and lipids that 
concentrate within a ring that forms at the vertex between adjacent docked lysosome membranes. 
Upon lipid bilayer merger at the vertex ring, the boundary membranes are internalized within the 
lumen of the fusion product as an intraluminal fragment (ILF; Figures 1 and 2). Inside the lumen, 
the ILF is exposed to acid hydrolases to recycle these lysosomal proteins and lipids (Wang et al., 
2002). Thus, homotypic lysosome membrane fusion events are critical for organelle inheritance, 
























Figure 1. Saccharomyces cerevisiae as a model organism to study membrane fusion  
Cartoon model describing the pathways that rely on lysosome membrane fusion for biomaterial 















1.3 Homotypic vacuolar lysosome fusion as model for organelle membrane fusion 
           The mechanisms underlying lysosomal membrane fusion have been best characterized by 
studying the vacuolar lysosome of Saccharomyces cerevisiae as a model (Wickner and Haas, 
2000; Wickner 2010). Yeast vacuolar lysosomes provide numerous advantages for studying 
membrane fusion including; the ease of genetic manipulations and organelle isolation, 
fluorescent microscopy techniques that allow visualization of vacuolar lysosome fusion events in 
live cells and in vitro, and well-established in vitro fusion assays to assess fusion kinetics. In 
brief, the homotypic vacuolar lysosome fusion (HVF) reaction is composed of four subreactions: 
priming, tethering, docking, and fusion (Figure 2). During priming, Sec18 a N-ethylmaleimide-
sensitive factor (NSF) ortholog binds Sec17 (a SNARE chaperone) to disassemble cis-SNARE 
complexes composed of Vam3, Vti1, Vam7, and Nyv1 to reset the fusion machinery for a new 
round of fusion (Mayer et al., 1996). Tethering occurs when opposing vacuolar lysosome 
membranes make first contact. This event is governed by the activation of the Rab-GTPase Ypt7, 
and its effector Vps41 within the multisubunit tethering complex (MTC) called the HOPS 
(HOmotypic fusion and Protein Sorting) holocomplex (Brett et al., 2008). Docking involves 
recruitment of additional fusogenic proteins and lipids to the initial contact site, which 
concentrate at an expanding vertex ring between opposed membranes (Kato and Wickner, 2001). 
Also, SNAREs present on opposing membranes make contact and begin to form a tightly wound 
four-helical bundle called a trans-SNARE complex (Collins and Wickner, 2007). Trans-SNARE 
complex formation triggers the release of Ca
2+ 
from the lumen, which then signals the SNAREs 
to fully zipper (Peters and Mayer, 1998; Merz and Wickner, 2004). Energy from SNARE 
zippering drives the merging of the lipid bilayers to complete fusion (Figure 2; Wiedelhold and 










Figure 2. Homotypic vacuolar lysosome membrane fusion 
Cartoon illustrating the subreactions (or stages) and proteins necessary for driving membrane 





















1. 4 The homotypic vacuolar lysosome fusion machinery  
1.4.1 The Rab-GTPase Ypt7  
          Rab-GTPases are molecular timer switches that toggle from GDP (inactive) to GTP 
(active) bound states. They confer organelle identity and play important roles in protein 
trafficking and membrane fusion (Bourne et al., 1991; Grosshans et al., 2006). GDP-bound Rabs 
require Guanine nucleotide Exchange Factors (or GEFs) to convert them to their active GTP-
bound state, which persists until a GTPase Activating Protein (GAP) initiates GTP hydrolysis 
and converts it back to the inactive GDP-bound state to complete the Rab cycle (Barr and 
Lambright, 2010). Rabs are anchored to membranes of organelles by two isoprenyl lipid 
(geranylgeranyl) moieties that decorate amino acids near their C-termini (Overmeyer and 
Maltese, 1992). Inactive Rabs are extracted from membranes by a GDP dissociation inhibitor 
(GDI), which masks their isoprenyl anchor and keeps them soluble in the cytoplasm (Goody et 
al., 2005). When active, Rab-GTPases interact with their effector proteins to mediate 
downstream events including signaling, transport, and fusion (Grosshans et al., 2006). During 
HVF, Ypt7 activity drives two stages of the reaction: tethering, and docking. It is thought that the 
roles of Ypt7 in both subreactions require binding and stabilizing its cognate effector within the 
multisubunit tethering complex HOPS (Figure 3).  
1.4.2 The multisubunit tethering complex HOPS 
         The HOPS holocomplex contains six subunits: Vps39, which binds Ypt7 independent of its 
nucleotide bound state and facilitates activation by its cognate GEF protein complex Mon1-Ccz1 
(Wang, 2003; Lawrence et al., 2014); Vps41, its cognate effector; and the Vps-C core complex 
composed of the remaining four subunits Vps16, Vps18, Vps11, and Vps33. Vps33 is an SM-
protein that mediates trans-SNARE templating en route to bilayer fusion (Figure 3; Pieren et al., 
2010). In the current model of HOPS driven membrane tethering, active Ypt7 is thought to bind 
Vps39 on one membrane and a second Ypt7-GTP binds Vps41, within the same complex, on the 
opposite membrane (Figures 2 and 3). Through these interactions, a single HOPS complex 
bridges opposed membranes to mediate tethering (Lürick et al., 2016). Vps33 then mediates 
interaction between the R-SNARE Nyv1 on one membrane and the Qa-SNARE Vam3 on the 
opposing membrane to drive trans-SNARE complex formation, a hallmark of the docking 
subreaction (Nichols et al., 1997; Price et al., 2000; Ostrowicz et al., 2010; Bröcker et al., 2012; 
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Pieren et al., 2010; Baker et al., 2015). 
          HOPS function is regulated by the action of the protein kinase Yck3, which 
phosphorylates the amphipathic lipid-packing sensor (ALPS) within Vps41 decreasing its 
affinity for membrane lipids causing it to dissociate from lysosomal membranes (LaGrassa and 
Ungermann, 2005; Brett et al., 2008; Cabrera et al., 2009). Thus when phosphorylated, HOPS is 
dependent on active Ypt7 for its association with the membrane (Hickey et al., 2009).  
1.4.3 SNARE proteins  
          SNARE complex formation ultimately drives endomembrane fusion. Four SNARE 
proteins when assembled in trans mediate HVF (Nyv1, Vam3, Vti1, and Vam7; Collins and 
Wickner, 2007). With the exception of Vam7, these SNARE proteins consist of three domains: a 
C-terminal transmembrane domain, a SNARE domain, and an N-terminal domain. Depending on 
the amino acid residue at the 0 layer which is either a conserved arginine (R) or glutamine (Q) 
within the coiled-coil bundle that forms between their 4 SNARE domains, SNARE proteins are 
classified as R or Q-SNAREs. Each SNARE complex, including the one that drive vacuolar 
lysosome fusion, contain a single R-SNARE (Nyv1) donated by one membrane and three Q-
SNAREs (Qa, Vam3; Qb, Vti1; and Qc, Vam7) that form a bundle donated by the opposing 
membrane (Fasshauer et al., 1998). Vam7, the only soluble SNARE without a transmembrane 
domain, is tethered to membranes by its PX (Phox) domain that binds phosphatidylinositol 3-
phosphate [PI(3)P] (Boeddinghaus et al., 2002; Cheever et al., 2001). After assembly into 
partially wound trans-SNARE complexes during the docking stage of fusion, Ca
2+
 release from 
the lysosomal lumen into the cytoplasm is thought to promote full SNARE complex zippering 
that drives lipid bilayer mixing to complete the fusion reaction (Collins and Wickner, 2007; 
Schwartz and Merz, 2009; Lurick et al., 2015). Following lipid bilayer merging, the still-
assembled four SNARE proteins complex is called a cis-SNARE complex. NSF (Sec18) and its 
chaperone α-SNAP (Sec17) disassemble the cis-SNARE complex for a new round of fusion to 







Figure 3. Model depicting how the fusion machinery assembles at the vertex microdomain 
Within the vertex microdomain, HOPS (Vps39, Vps41, Vps33, Vps18, Vps11) binds Ypt7-GDP 
with its Vps39 subunit to facilitate activation by its GEF Mon1/Ccz1. Active Ypt7 (GTP) then 
binds its cognate effector Vps41 to promote Vps33 mediated trans-SNARE templating between 















1.5 Heterotypic MVB-lysosome membrane fusion 
          Although critical for endocytosis, relatively little is known about the molecular mechanism 
that orchestrates MVB-lysosome fusion. But like other membrane fusion events within the 
endomembrane system (e.g. HVF), MVB-lysosome fusion is thought to require coordinated 
interactions between Rab-GTPases, multisubunit tethering complexes, and SNARE proteins. 
Based on results primarily acquired from genetic studies, the prevailing model of MVB-vacuolar 
lysosome fusion suggests that the same machinery orchestrating HVF is also responsible for 
driving MVB-vacuolar lysosome fusion in S. cerevisiae. For example, both the Rab-GTPase 
Ypt7 and its interacting tethering complex HOPS localize to the MVB and the vacuolar lysosome 
and are required for fusion (reviewed by Luzio et al., 2010; Markgraf et al., 2009; Balderhaar 
and Ungermann, 2013; Spang, 2016). In addition, the same SNARE proteins are implicated in 
this fusion event, as Vti1 also localizes to the MVB and Vam7 can also bind [PI(3)P] on the 
MVB membrane. The remaining two SNAREs required for fusion, Vam3 and Nyv1, are possibly 
donated by the vacuolar lysosome membrane. However, recent evidence suggests that SNARE 
complexes are initially formed through the activity of SM-proteins that promote interactions 
between an R-SNARE from one membrane with the cognate Qa-SNARE from the opposing 
membrane (Baker et al., 2015). As the Qa-SNARE Vam3 and R-SNARE Nyv1 are exclusively 
found on vacuolar lysosomes, it seems unlikely that they both contribute to MVB-vacuolar 
lysosome fusion, suggesting that another SNARE complex mediates this event (Figure 4; Von 
Mollard et al., 1997; Kweon et al., 2003; Furukawa and Mima, 2014). MVBs express their own 
Qa-SNARE (Pep12) and R-SNARE (Snc2) paralogs (Izawa et al., 2012; Furukawa and Mima, 
2014), but neither has been implicated in MVB-vacuolar lysosome fusion.  
          Another distinguishing feature of MVB-vacuolar lysosome fusion is its possible 
dependence on MVB maturation: To ensure efficient degradation, it is assumed that internalized 
surface receptor and transporter proteins must be sorted and packed into ILVs at the MVB prior 
to fusion with vacuolar lysosomes. Although Rab activation has been implicated in sensing MVB 
maturation and triggering this fusion event (Russell et al., 2012), this hypothesis has not been 
formally tested. Thus, there are many open questions that must be answered for a comprehensive 
understanding of this process: which mechanisms are unique to MVB-vacuolar lysosome fusion? 
What triggers this event? Does the MVB need to be properly loaded with ILVs prior to fusion?  
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Figure 4. Cartoon model describing the fusion machineries at the MVB and the vacuolar 
lysosome 
The Rab-GTPase Ypt7, its interacting MTC HOPS, and the Qb-SNARE Vti1 localize to both the 
MVB and the vacuole membranes. The Qa-SNARE Pep12 resides on MVBs, whereas its 




















1.6 The MVB biogenesis machinery 
1.6.1 The ESCRT pathway 
          The formation of MVBs is a crucial stage in the delivery of internalized surface transporter 
and receptor proteins destined for degradation by the lysosome. At the endosome, the ESCRT 
machinery which comprises five distinct complexes (ESCRT-0, I, II, III and Vps4) recognizes, 
binds, and sorts ubiquitylated cargos into ILVs giving rise to a mature MVB (Henne et al., 2011). 
Deleting any of the genes encoding the ESCRT machinery results in accumulation of 
internalized surface proteins in an abnormally enlarged pre-vacuolar compartment often 
containing aberrant stacks of flattened cisternae, which fail to fuse with the lysosome. This 
morphological characteristic is a hallmark of class E mutants, which represent a subset of genetic 
mutations identified in early screens that determined the molecular underpinnings of endocytosis 
and lysosome biogenesis (Rieder et al., 1996; Russell et al., 2012). ESCRTs mutants cause 
hyperactive Vps21 to accumulate on these aberrant compartments at the expense of inactivating 
Ypt7 by preventing recruitment of its cognate GEF complex Mon1-Ccz1 to membranes, 
breaking the Rab cascade that mediates progression of anterograde membrane trafficking to the 
lysosome (Russell et al., 2012). Because active Ypt7 recruits and stabilizes HOPS for SNARE-
mediated fusion (Nordmann et al., 2010; Cabrera et al., 2014), it was proposed that ESCRT- 
mediated Vps21 to Ypt7 conversion may be an important trigger for mature MVB-lysosome 
fusion (Russell et al., 2012). However, the evidence supporting this hypothesis is scant, and it 
has not been formally tested using biochemical approaches due to lack of reliable, robust cell-
free quantitative assays of MVB-vacuolar lysosome fusion.  
1.6.2 The Sodium (Potassium)/Hydrogen exchanger Nhx1   







Nhx1 in yeast, which is orthologous to NHE6 and NHE9 in humans. Loss-of-function mutations 
in NHE6 and NHE9 have been linked to Autism Spectrum Disorders (ASDs; Gilfillan et al., 
2008; Franke et al., 2009; Morrow et al., 2008). In S. cerevisiae, Nhx1 confers tolerance to 
osmotic and pH stress (Nass and Rao, 1998; Brett et al., 2005; Kallay et al., 2011), by 
presumably counteracting the activity of the V-type H
+





influx coupled to H
+
 efflux (Nass and Rao, 1999; Kojima et al., 2012; Brett et al., 2005). 
Electroneutral ion exchange by Nhx1 regulates luminal pH and is required for delivery of 
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internalized surface proteins to the vacuolar lysosome (Bowers et al., 2000). Deleting NHX1 
results in a vps class E phenotype including the appearance of an enlarged pre-vacuolar 
compartment where internalized proteins accumulate and the hyper acidification of the lumen 
(Bowers et al., 2000; Brett et al., 2005). Addition of the weak base chloroquine to nhx1Δ mutants 
alkalizes the compartmental lumen and permits delivery of internalized proteins to vacuolar 
lysosomes in vivo (Brett et al., 2005; Qiu and Fratti, 2010), leading to the hypothesis that the ion 
exchange activity of Nhx1 may regulate MVB-vacuolar lysosome fusion. This hypothesis has 
not been formally tested and would benefit from biochemical approaches (quantitative cell-free 
assays) to develop a comprehensive understanding of this process.   
1.7 Summary 
          Membrane fusion is critical for lysosome function, biogenesis, homeostasis, remodeling 
and inheritance. Disruption of membrane trafficking pathways that culminate with lysosome 
fusion (e.g. autophagy) is thought to underlie many human neurological diseases and cancers 
(Levine and Kroemer, 2008; Kirkegaard and Jäättelä, 2009). Therefore, understanding the 
molecular mechanisms that orchestrate lysosomal fusion events is of great importance for 
understanding the etiology and designing new therapeutic strategies to treat lysosome-associated 
diseases. 
          Herein, I primarily use quantitative cell-free assays to study vacuolar lysosome fusion in 
the model organism Saccharomyces cerevisiae to elucidate the molecular mechanisms that drive 
membrane fusion. My work reveals the role of HOPS in synchronizing the interplay between 
Rab, kinase, and SNAREs cycles during membrane fusion. Specifically, I answer the following 
questions: (1) Is the Ypt7-Vps41 interaction required for vacuolar lysosome membrane 
tethering? (2) Does the protein kinase Yck3 phosphorylate Vps41 to regulate ILF formation 
during homotypic vacuolar lysosome fusion?  (3) What are the unique mechanisms that 
distinguish MVB-vacuolar lysosome fusion from homotypic vacuolar lysosome fusion? 
          In Chapter 2, I characterize a point mutation in Ypt7 (D44N) that disrupts Vps41 binding 
without interfering with other Rab functions. By studying this mutation, I show that the Ypt7-
Vps39 interaction alone is sufficient to drive vacuolar lysosome membrane tethering and 
docking, but trans-SNARE complex stabilization is impaired. Next, I show that Yck3 
phosphorylates Vps41 within the HOPS complex to modulate the kinetics of SNARE-mediated 
pore formation, the rate-limiting step of the lipid bilayer fusion reaction, and control ILF 
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formation to regulate turnover of lysosomal membrane lipids and proteins.  
          In Chapter three, I developed and optimized a new cell-free content mixing assay to 
measure the kinetics of MVB-vacuolar lysosome fusion. Using this assay, I discovered that 
although Ypt7 and HOPS are shared, a non-cognate trans-SNARE complex distinguishes MVB-
vacuole fusion from HVF. I also demonstrate that knocking out genes implicated in MVB 
biogenesis (NHX1 or ESCRTs) impairs heterotypic fusion, and reveal conditions that rescue 
fusion, uncovering possible therapeutic strategies to treat human diseases linked to loss-of-
function mutations in orthologous genes.  
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2.1 Abstract 
          Upon lysosome membrane fusion, a portion of the lipid bilayer is internalized within the 
lumen and degraded by acid hydrolases. Formation of this IntraLumenal Fragment (ILF) is 
important for protein and lipid degradation needed for organelle homeostasis and remodeling. 
But how ILF formation is regulated to optimize membrane turnover is not understood in detail. 
Here we show that interplay between the Rab-GTPase Ypt7, its cognate effector Vps41 (a 
component of the multisubunit tethering complex HOPS) and the casein kinase Yck3 controls 
ILF formation by targeting intermediates of the lipid bilayer fusion reaction. Fewer ILFs formed 
when the interaction between Ypt7 and Vps41 was interrupted. This was due to phosphorylation 
of HOPS by Yck3, preventing stabilization of trans-SNARE complexes needed for lipid bilayer 
pore formation. We propose that HOPS coordinates Rab, kinase and SNARE cycles to optimize 

















2.2 Introduction  
 
          Biomaterials are recycled by lysosomes providing an important source of nutrients for 
eukaryotic cells (Perera and Zoncu, 2016). They require three fundamental processes to perform 
this function: Membrane fusion – to deliver membrane-encapsulated biomaterials (including 
internalized surface receptors, damaged organelles, toxic aggregates or invasive pathogens) to 
the lysosomal lumen (Huber and Teis, 2016); Biomaterial catabolism – within the lumen 
biomaterials encounter acid hydrolases that break them down into their constituents (e.g. lipids, 
amino acids, sugars); and Nutrient transport – nutrient transporter proteins return products of 
catabolism to the cytoplasm for reuse by the cell (Xu and Ren, 2015). Besides being critical for 
lysosome function, membrane fusion is also essential for organelle homeostasis, as it mediates 
delivery of biosynthetic cargoes (e.g. new hydrolase and transporter proteins; Odorizzi et al. 
1998; Luzio et al. 2014), drives organelle inheritance (Weisman, 2003), and controls organelle 
morphology (Brett and Merz, 2008; Klumperman and Raposo, 2014). Thus the molecular 
underpinnings of lysosome membrane fusion have been under intense investigation since the 
discovery of the organelle by Christian de Duve and colleagues over 60 years ago (de Duve, 
2005). The greatest insight into this process has been gleaned from the use of Saccharomyces 
cerevisiae and its vacuolar lysosome (or “vacuole”) as models (Li and Kane, 2009; Nickerson et 
al., 2009; Wickner, 2010), whereby homotypic vacuole membrane fusion requires four 
biochemically distinct, sequential stages: Priming, tethering, docking and fusion. 
          Priming involves the ATP-dependent unraveling of cis-SNARE (Soluble NSF Attachment 
protein REceptor) complexes by the α-SNAP protein Sec17 and NSF ortholog Sec18 (Mayer et 
al., 1996). Tethering is when apposing organelle membranes make first contact. This requires the 
Rab-GTPase Ypt7, a Rab7 ortholog, and its cognate multisubunit tethering complex HOPS 
(HOmotypic vacuole fusion and protein sorting; Mayer and Wickner 1997; Hickey and Wickner 
2010; Orr et al. 2015). HOPS contains six protein subunits, two of which have Ypt7-binding sites 
that mediate intermembrane attachment: Vps39 and Vps41 (Seals et al., 2000b; Brett et al., 2008; 
Nickerson et al., 2009; Bröcker et al., 2012). Vps39 binds Ypt7 independent of its nucleotide-
bound state to accommodate activation by its GEF (Guanine nucleotide Exchange Factor) 
complex composed of Mon1 and Ccz1 (Nordmann et al., 2010). Whereas Vps41 is the cognate 
effector of Ypt7 and thus only binds the Rab when it is active (GTP-bound; Brett et al. 2008) to 
bridge opposed membranes during tethering. Vps41 may also associate with membranes through 
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its amphipathic lipid packing sensor (ALPS) domain (Cabrera et al., 2010), which is also thought 
to contribute to organelle membrane tethering (Ho and Stroupe, 2016).  
          Docking involves the recruitment and enrichment of fusogenic lipids and proteins in a ring 
formed at the vertex between apposed membranes (Wang et al., 2003; Fratti et al., 2004). Here 
Vps33, a SM-protein found within HOPS, mediates trans-SNARE complex formation between 
the R-SNARE Nyv1 on one membrane with the Qa-SNARE Vam3, Qb-SNARE Vti1 and 
soluble Qc-SNARE Vam7 on the opposing membrane (Seals et al., 2000; Lobingier and Merz, 
2012; Baker et al., 2015). Partially zippered SNARE complexes are proofread when bound by 
HOPS (Starai et al., 2008), which also protects them from being disassembled by Sec18 (Xu et 
al., 2010; Lobingier et al., 2014). Orchestration of protein recruitment and assembly is further 
regulated by the casein kinase Yck3 that responds to Ypt7 inactivation to phosphorylate and 
inhibit activities of Vps41 and Vam3 (LaGrassa and Ungermann, 2005; Brett et al., 2008). 
Fusion is bilayer merger accomplished by full zippering of trans-SNARE-complexes to drive 
membranes together and form pores necessary for full lumenal content mixing (Nichols et al., 
1997; Schwartz and Merz, 2009). As the lipid bilayer is severed at the vertex ring where the 
fusion machinery is located, the encircled area of membrane at the interface between apposing 
membranes (called the boundary) is entrapped within the lumen as a membrane fragment (Wang 
et al., 2002; Mattie et al., 2017). This IntraLumenal Fragment (ILF) is then degraded by lumenal 
hydrolases and recycled. Recently, we discovered that vacuolar nutrient transporter proteins are 
selectively sorted into the boundary, internalized and degraded in response to substrate levels, 
protein misfolding or TOR-signaling (McNally et al., 2017). Thus, ILF formation during fusion 
is important for vacuole lipid and protein turnover necessary for organelle homeostasis and 
remodeling. 
          Despite being critical for vacuolar lysosome biology, relatively little is known about how 
formation of ILFs is regulated. However, it is known that ILF formation relies on hemifusion 
intermediate formation during the organelle lipid bilayer fusion reaction (Wang et al., 2002; Jun 
and Wickner, 2007; Mattie et al., 2017). Termed ring fusion-by-hemifusion, vacuole lipid bilayer 
fusion is initiated by stalk formation, whereby lipids within the outer leaflets of opposing 
membranes within close proximity mix causing merger (Reese and Mayer, 2005; Jun and 
Wickner, 2007; Wickner, 2010). This lipid stalk then expands forming a hemifusion diaphragm, 
a lipid bilayer consisting of lumenal facing inner leaflets donated from each apposing membrane 
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(Mattie et al., 2017). Next trans-SNARE-pin zippering drives pore formation, the rate-limiting 
step of the lipid bilayer fusion reaction (Reese et al., 2005), whereby a small rupture is made 
within the hemifusion diaphragm allowing luminal contents to mix (Schwartz and Merz, 2009; 
D’Agostino et al., 2016). This pore then expands to complete full membrane merger resulting in 
a single organelle. The formation of ILFs during vacuole fusion relies on the delay between stalk 
and pore formation (Mattie et al., 2017): If pore formation is delayed, the stalk expands across 
the entire boundary membrane and when a pore forms, no membrane is entrapped during fusion. 
Thus, pore formation must occur rapidly after stalk expansion to form ILFs during vacuole 
fusion.  
          To better understand how these ILFs form (or not) during fusion, we showed that adding 
GTPγS, the non-hydrolyzable ortholog of GTP, to cell-free vacuole fusion reactions causes 
premature stalk formation preventing ILFs from forming (Mattie et al., 2017). Whereas addition 
of purified, recombinant Vam7 protein (the soluble Qc-SNARE) induces premature pore 
formation to enhance ILF formation upon fusion. Although it is apparent that altering the 
activities of GTPases or SNAREs regulates ILF formation during fusion, we were unable to 
demonstrate how the endogenous fusion machinery may perform this function. Because HOPS 
mediates the interplay between the Rab-GTPase Ypt7 and SNAREs (Wickner, 2010), we 
hypothesized that modulating interactions between these proteins may influence ILF formation 
during vacuolar lysosome fusion. Here we test this hypothesis and confirm that functional 
interactions between Ypt7, its effector Vps41 within HOPS and the kinase Yck3 regulate ILF 
formation during vacuolar lysosome fusion.  
 18 
2.3 Results 
2.3.1 Ypt7-D44N slows vacuole fusion and prevents ILF formation in live cells  
         To identify a Ypt7 mutation that may alter ILF formation during vacuole membrane fusion, 
we first examined the vacuole morphology within S. cerevisiae cells expressing different point 
mutations reported to either lock the Rab-GTPase in a GDP-bound (T22N; Liu et al. 2012; 
Lawrence et al. 2014) or GTP-bound state (Q68L and N126I; Brett et al. 2008; Rana et al. 2015), 
reduce its affinity for nucleotides (D129N; Kucharczyk et al. 2001), or disrupt (GTPase 
Activating Protein) GAP induced GTP hydrolysis and possibly effector binding (D44N; Vollmer 
et al., 1999). We expected that mutations of interest would not affect vacuolar morphology, as 
fusion itself should not be abolished, but should affect the production of ILFs (Mattie et al., 
2017). We find that cells expressing Ypt7-T22N or Ypt7-D129N contain fragmented vacuoles 
that resemble those observed in ypt7Δ cells (Figure 5A and B), confirming that Ypt7 nucleotide 
binding and activation is required for homotypic vacuole fusion (Wichmann et al., 1992; Eitzen 
et al., 2000; Balderhaar et al., 2010). Nearly all cells expressing Ypt7-Q68L or Ypt7-N126I 
contained a single large vacuole, confirming that homotypic fusion was enhanced when Ypt7 is 
constitutively active (Rana et al., 2015). However, cells expressing Ypt7-D44N, a mutation that 
also prevents GAP-induced GTP hydrolysis but possibly interferes with effector binding, had 
similar vacuole morphologies as cells expressing wild type Ypt7 (Figure 5A and B). To further 
assess the Ypt7 mutants that permitted fusion, we recorded vacuole fusion events in live cells 
using video microscopy (Figure 5C, Video 1) and made two interesting observations: Vacuoles 
within cells harboring the Ypt7-D44N underwent fewer homotypic fusion events, as compared to 
cells expressing wild type Ypt7 or a GTP-locked mutant of Ypt7 (Q68L; Figure 5D). 
Furthermore, of the vacuole fusion events observed within Ypt7-D44N expressing cells, fewer 
produced visible intralumenal fragments whereas fusion events in Ypt7-Q68L cells produced 
more ILFs as compared to wild type cells (Figure 5E). Together, these preliminary findings 
suggest that introducing mutations that lock Ypt7 in a GTP-bound state (Q68L) or possibly 
disrupt Ypt7 effector binding (D44N) may affect the fusion-by-hemifusion reaction to alter ILF 
formation. We decided to focus our studies on the D44N mutation as it showed the strongest 
phenotype and we reasoned that characterizing a mutation that may disrupt Ypt7-HOPS 
interactions would provide new insights into how the underlying machinery orchestrates vacuole 
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Figure 5. Ypt7-D44N impedes ILF formation during vacuole fusion in vivo 
 
(A) Examples of fluorescence micrographs showing FM4-64 stained vacuoles within live yeast 
cells expressing different Ypt7 mutants. (B) Number of vacuoles per cell was calculated using 
micrographic data shown in A (n ≥ 300). (C) Images from time-lapse videos (Video 1) showing 
examples of FM4-64 stained vacuoles undergoing homotypic fusion within live yeast cells 
expressing either wild type (WT) Ypt7, Ypt7-D44N or Ypt7-Q68L. Numbers represent time in 
seconds. Scale bars, 2 μm. From these videos, (D) percentage of cells that presented vacuole 
fusion events and (E) percentage of vacuole fusion events that failed to form visible ILFs were 







































2.3.2 Ypt7-D44N impairs pore formation during vacuole fusion in vitro  
          To better understand how the D44N mutation in Ypt7 disrupts vacuole fusion, we studied 
the subreactions of the lipid bilayer fusion reaction in vitro. First, we isolated vacuoles from cells 
and measured the kinetics of membrane fusion using lipid or content mixing assays (Haas, 1995; 
Jun and Wickner, 2007). We found that the D44N mutation did not affect vacuole lipid mixing 
(Figure 6A) but severely impaired content mixing (Figure 6B) stimulated by ATP in vitro. To 
confirm that content mixing was indeed blocked, we imaged isolated vacuoles before and 60 
minutes after fusion was stimulated with ATP in vitro (Figure 6C) and calculated vacuole surface 
area (Figure 6D) which increases upon vacuole content mixing. As expected, an increase in 
vacuole surface area was observed over time when vacuoles isolated from wild type cells were 
examined. This was blocked by the addition of the fusion inhibitor rGyp1-46, a purified, 
recombinant protein consisting of only the catalytic domain of the Rab-GAP Gyp1 (Eitzen et al., 
2000; Brett et al., 2008), confirming that fusion (content mixing) was responsible for the 
observed increase in vacuole surface area. Importantly, the surface area of vacuoles isolated from 
cells expressing Ypt7-D44N did not increase over time, consistent with results from the content 
mixing assay. Thus, we are confident to report that the relative amount of lipid mixing to content 
mixing was much greater for the mutant as compared to wild type (Figure 6E) and the delay 
between these events was extended in the mutant (Figure 6F). We also noted that 60 minutes 
after ATP was added to induce fusion fewer ILFs were observed within vacuoles isolated from 
the mutant cells as compared to wild type (Figure 6G) consistent with observations made in vivo 
(Figure 6E). Together, these results indicated that only outer leaflets (not inner leaflets) of lipid 
bilayers have merged and hemifusion diaphragms may be accumulating between docked 
organelles.  
          To test this hypothesis, we first used a polytopic protein exclusion assay to study 
hemifusion diaphragm accumulation during vacuole fusion in vitro by fluorescence microscopy 
(Mattie et al., 2017). If a hemifusion diaphragm forms at the boundary membrane between 
apposing organelles, then polytopic proteins with large cytoplasmic domains such as GFP-tagged 
Vph1, the stalk domain of the V-type H
+
-ATPase, will be excluded from this site because 
biophysical constraints prevent Vph1-GFP from entering a hybrid bilayer composed of lumenal 
facing leaflets on both sides (Nikolaus et al., 2010). Fusion reactions containing vacuoles 
isolated from wild type cells showed uniform distribution of Vph1-GFP on vacuole membranes, 
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i.e. it was present within nearly all boundary membranes observed (Figure 6H and 6I), as 
previously reported (Wang et al., 2002; Mattie et al., 2017; McNally et al., 2017). However, 
many boundary membranes between vacuoles isolated from cells expressing Ypt7-D44N did not 
contain Vph1-GFP, suggesting that hemifusion diaphragms had accumulated during fusion. We 
next imaged these fusion reactions using transmission electron microscopy at magnifications 
sufficient to identify hemifusion intermediates (Mattie et al., 2017). As expected, we found that 
more boundaries did not have a discernable intermembrane space separated apposing vacuole 
membranes when the D44N mutation was introduced into Ypt7 (Figures 6J and K). Although 
individual leaflets were not resolved, the membrane thickness at these boundaries was similar to 
the thickness of a single lipid bilayer, suggesting that these structures were hemifusion 
diaphragms. All things considered, the findings from in vitro experiments suggest that Ypt7-
D44N stalls the bilayer fusion reaction immediately prior to pore formation causing hemifusion 




















Figure 6. Ypt7-D44N impairs pore formation during vacuole fusion in vitro  
Vacuole membrane (A) lipid mixing or (B) content mixing was measured in vitro in the presence 
or absence of ATP to stimulate fusion. Vacuoles were isolated from cells expressing wild type 
(WT) Ypt7 or Ypt7-D44N. Data shown represent mean ± S.E.M (n = 3). (C) Examples of 
fluorescence micrographs showing isolated vacuoles expressing WT Ypt7 or Ypt7-D44N stained 
with FM4-64 in the presence of ATP with or without 3.6 μM rGyp1-46 after incubation for 0 or 
60 minutes. Scale bar, 2 μm. (D) Cumulative probability plot and median values showing surface 
area calculated from micrographic data shown in C. (E) Lipid to content mixing ratio, (F) times 
at half maximal lipid mixing (circles) and content mixing (squares) calculated using data shown 
in A and B. Numbers represent time intervals calculated between lipid and content mixing 
values. (G) Proportion of vacuoles containing visible ILFs calculated from data shown in H. 
Mean ± S.E.M. shown (n ≥ 284). (H) Examples of fluorescence micrographs showing FM4-64 
stained vacuoles isolated from wild type or Ypt7-D44N cells expressing Vph1-GFP acquired at 
60 minutes after fusion was initiated. Interfaces containing (closed) or lacking (open arrowheads) 
GFP fluorescence are indicated. Scale bar, 2 μm. (I) Percentage of vacuolar lysosome boundaries 
that do not contain Vph1-GFP calculated from data shown in H. Mean ± S.E.M. shown (n ≥ 
504). (J) (top, left) Examples of transmission electron micrographs showing vacuoles isolated 
from WT or Ypt7-D44N cells observed under fusogenic conditions at 60 minutes. (bottom, left) 
Higher magnification images of membrane interfaces. Scale bars, 500 nm. (right) Linear density 
plots of areas shown at membrane interfaces. (K) Proportion of total vacuoles observed engaged 

























2.3.3 Ypt7-D44N is active but does not bind and stabilize Vps41 on lysosome membranes  
        Residue D44 is found at the end of the switch I region (RabF1) within the Ypt7 protein that 
changes conformation upon Rab activation to mediate effector binding (Figure 7A; 
Constantinescu et al., 2002). As such, Gallowitz and colleagues originally hypothesized that 
changing this aspartate to an asparagine introduces chemical and electrostatic changes that may 
prevent switch I folding or directly interfere (as the residue is outward-facing) with effector 
binding without disrupting Rab activation (as it does not contribute to the nucleotide binding 
pocket; Vollmer et al., 1999). To test this hypothesis, we immobilized GST-tagged Ypt7 proteins 
on Sepharose beads decorated with glutathione and conducted pull-down assays using wild type 
cell lysate to determine if the D44N mutation disrupts Ypt7 binding to its cognate effector Vps41 
(Seals et al., 2000b; Brett et al., 2008). As predicted, Ypt7-D44N does not bind Vps41 regardless 
of its nucleotide-bound state (Figure 7B). As controls, we confirmed that wild type Ypt7 only 
binds Vps41 when active (bound to GTP or GTPγS) but not inactive (bound to GDP), a hallmark 
of Rab-effector binding (Grosshans et al., 2006), and introducing a Q68L mutation that locks 
Ypt7 in an active state supports Vps41 binding even when the Rab is bound to GDP. Vps41 
contains one of two Ypt7-binding sites in HOPS that orchestrates events downstream of Ypt7 
required for vacuole fusion (Nickerson et al., 2009). The second site is present within Vps39, the 
subunit of HOPS that mediates Ypt7 activation by its GEF Mon1-Ccz1 (Nordmann et al., 2010). 
Unlike Vps41 binding that requires Ypt7 activation, Vps39 interacts with Ypt7 independent of its 
nucleotide-bound state and thus is not classified as an effector (Figure 7B; Brett et al. 2008). 
Importantly, we found that Ypt7-D44N robustly binds Vps39 in a nucleotide-independent 
manner, indicating that the mutant protein folds properly and that binding to its cognate effector 
Vps41 is exclusively impaired.  
          Although it is not implicated in homotypic vacuole fusion, the retromer complex is also 
thought to be an effector for Ypt7 (Liu et al. 2012). Thus, it is possible that the D44N mutation 
could also disrupt this interaction, impairing biosynthetic trafficking pathways that deliver the 
fusion machinery to the vacuole (Seaman et al., 1998) accounting for the observed defect in 
vacuole fusion. However, in our hands, Ypt7 binding to Vps35, a subunit of the retromer 
complex, was independent of its activation state (Figure 7B), suggesting that Vps35 is not a true 
effector of Ypt7. Furthermore, Ypt7-D44N continued to bind Vps35 in a nucleotide-independent 
manner, confirming that the mutation specifically disrupts Vps41 binding and does not affect its 
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interaction with the retromer protein complex.  
         To confirm that the D44N mutation does not interfere with Ypt7 activation, we next 
conducted a Rab-extraction assay using Gdi1, a Rab-chaperone protein that preferentially 
extracts inactive Rab proteins from membranes leaving only active Rab on membranes (Eitzen et 
al., 2000; Brett et al., 2008). Consistent with previous reports, we show that extraction of wild 
type Ypt7-GDP from membranes by purified, recombinant Gdi1 (rGdi1) increases when isolated 
vacuoles are pretreated with rGyp1-46 (a Rab-GAP) to inactivate Ypt7, and decreases when 
pretreated with GTPγS to activate Ypt7 (Figure 7C). However, in striking contrast, extraction of 
Ypt7-D44N by rGdi1 was not observed in the presence or absence of rGyp1-46 or GTPγS, 
suggesting that the entire pool of Ypt7-D44N on the vacuoles was active. This finding is 
consistent with this mutation causing reduced GTPase activity as observed previously by 
Gallowitz and colleagues (Vollmer et al., 1999). We also noted that less Ypt7-D44N co-purified 
with the organelles, which is consistent with reports suggesting that effector binding may 
stabilize Rab-GTPases on membranes by shielding them from Gdi1 (reviewed by Grosshans et 
al. 2006). However, these reports also suggest that interactions with effectors may be needed to 
recruit Rab proteins to the proper membrane locations within the cell (see Cabrera and 
Ungermann 2013). Although the presence of Ypt7-D44N in our organelle preparations implies 
proper localization, we also tagged Ypt7-D44N with GFP and imaged its cellular distribution by 
fluorescence microscopy to confirm that the mutation did not disrupt its cellular distribution 
(Figure 7D). Indeed, we found that GFP-Ypt7-D44N was present exclusively on vacuole 
membranes and intracellular puncta reminiscent of late endosomes, and this distribution was 
similar to wild type GFP-Ypt7 (also see Cabrera et al. 2009). Thus, it seems that Vps39-binding 
and activation of Ypt7-D44N is sufficient to target and stabilize a relatively small (Gdi1-
resistant) pool of Rab on vacuole membranes.  
          Ypt7 activation is thought to be necessary for Vps41 (and HOPS) recruitment and 
stabilization on vacuole membranes (Hickey et al., 2009). Thus, we reasoned that fusion defects 
caused by D44N might be due to dissociation of Vps41 from membranes. To test this hypothesis, 
we sedimented vacuole membranes at different time points after stimulating vacuole fusion in 
vitro with ATP and conducted Western blot analysis to detect Vps41 in the membrane (pellet) 
and soluble (supernatant) fractions (Figure 7E). Consistent with previous reports (Brett et al., 
2008), most Vps41 remains stabilized on membranes during fusion of vacuoles isolated from 
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wild type cells. In contrast, we found that nearly all Vps41 that co-purified with vacuoles 
isolated from cells expressing Ypt7-D44N dissociates from membranes over the course of the 
fusion reaction. The D44N mutation had no effect on Vps39 membrane association, consistent 
with the mutation only disrupting the interaction between Ypt7 and Vps41 but not Vps39. At 
first this result was somewhat perplexing as Vps41 and Vps39 are both subunits that comprise 
stable HOPS holocomplexes (Seals et al., 2000; Plemel et al., 2011; Bröcker et al., 2012). 
However, Vps41 and Vps39 each have moonlighting functions outside of HOPS (Angers and 
Merz, 2009; Hönscher et al., 2014) and HOPS has been proposed to be capable of remodeling 
itself on the fly (Ostrowicz et al., 2010). Thus, to better understand the impact of D44N on 
HOPS complex stabilization on membranes, we also studied Vps33, a SM-protein and subunit of 
the Vps-C core of HOPS, that like the effector Vps41, is thought to function downstream of Ypt7 
activation to mediate trans-SNARE complex formation (Baker et al., 2015) and SNARE- 
mediated pore formation (Pieren et al., 2010; Lobingier and Merz, 2012). Similar to Vps41, we 
found that the D44N mutation caused more Vps33 to dissociate from membranes over the course 
of the vacuole fusion reaction in vitro (Figure 7E). Thus, introducing the D44N mutation into 
Ypt7 prevents stabilization of Vps41 and Vps33 on vacuole membranes during vacuole fusion.  
          In addition to binding active Ypt7, Vps41 is stabilized on membranes by its ALPS domain 
that incorporates itself into the outer leaflet of the vacuole membrane (Cabrera et al., 2010). The 
protein kinase Yck3 regulates Vps41 membrane association by phosphorylating residues S367, 
S368, S371 and S372 within the ALPS domain causing displacement from the outer leaflet 
(LaGrassa and Ungermann, 2005; Cabrera et al., 2010). When Ypt7 is inactivated, it renders 
Vps41 susceptible to phosphorylation by Yck3 causing it to dissociate from membranes (Brett et 
al., 2008; Zick and Wickner, 2012). As Vps41 easily dissociates from membranes harboring 
Ypt7-D44N, we hypothesized that Ypt7-D44N cannot bind and shield Vps41 from 
phosphorylation by Yck3. As Yck3 requires ATP to phosphorylate Vps41 in vitro, we first tested 
this hypothesis by examining Vps41 membrane association in the presence or absence of ATP. 
As previously reported, most Vps41 remains stabilized on membranes 45 minutes after adding 
ATP and this is dependent on the presence of wild type Ypt7, as extracting it from membranes 
with rGdi1 causes Vps41 also to dissociate (Figure 7F). However, nearly all Vps41 that co-
purifies with vacuoles dissociates from membranes expressing Ypt7-D44N 45 minutes after 
adding ATP, in the absence or presence of rGdi1, demonstrating that Ypt7-D44N does not 
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prevent ATP-dependent dissociation of Vps41 from membranes. Importantly, these results 
correlate with Vps41 phosphorylation detected by Western blot (Figure 7G), whereby 
phosphorylated Vps41 migrates slower than the dephosphorylated form of the protein (see Brett 
et al. 2008). Phosphorylated Vps41 only appears in the presence of ATP and addition of GTPγS 
to activate wild type Ypt7 causes less to appear, consistent with active Ypt7 shielding Vps41 
from Yck3. Introducing the D44N mutation into Ypt7 causes most Vps41 to be phosphorylated 
upon ATP addition and adding GTPγS had no effect. Together, these results support the 
hypothesis that Ypt7-D44N does not bind Vps41 making it susceptible to phosphorylation by 
























Figure 7. D44N mutation in Ypt7 uncouples activation from effector binding and prevents 
stabilization of phosphorylated HOPS on membranes  
(A) Structure of Ypt7 in its inactive GDP-bound (left) or active GppNHp-bound state (right; 
Constantinescu et al., 2002). Nucleotides (green), Switch I (blue), switch II (cyan) and D44 (red) 
are indicated. (B) Results of pull-down experiments performed using immobilized GST-Ypt7 
(wild type, WT; D44N; or Q68L) preloaded with GDP (D), GTP (T) or GTPγS (γ) and cell 
lysates from Vps39-GFP cells. Amount of Vps35, Vps41 or Vps39-GFP bound to GST-Ypt7 
resin or found in the lysate (load) were determined by immunoblotting. (C) (top) Cartoon 
illustrating the Rab-GTPase activity assay. (bottom) Vacuoles isolated from wild type (WT) or 
Ypt7-D44N (Δ) cells were incubated with ATP for 40 minutes in the presence or absence of 5 
μM of rGdi1 during the last 10 minutes. Where indicated, reactions were pretreated with either 
3.6 μM rGyp1-46 or 0.2 mM GTPγS. Organelle membranes (pellet, P) were separated from 
soluble factors (supernatant, S) by centrifugation and Ypt7 was detected by immunoblotting. (D) 
Fluorescence micrographs of live cells expressing wild type (WT) or mutant (D44N) GFP-Ypt7. 
Vacuole membranes were stained with FM4-64. Scale bars, 2 μm. (E) At times shown, vacuole 
fusion reactions containing organelles isolated from cells expressing wild type Ypt7 (WT) or 
Ypt-D44N (Δ) were sedimented and the presence of Vps41, Vps33 and Vps39 in membrane 
(pellet, P) and soluble (supernatant, S) fractions was assessed by immunoblotting. (F) As shown 
in C, vacuole fusion reactions containing organelles isolated from wild type (WT) or Ypt-D44N 
(Δ) cells were treated with rGdi1 in the presence or absence of ATP and the membrane 
association of Vps41 or Ypt7 was assessed by immunoblotting. (G) Vacuoles isolated from wild 
type (WT) or Ypt7-D44N cells were incubated in the absence or presence of ATP and/or 0.2 mM 
GTPγS for 60 minutes, and probed for Vps41 by immunoblotting. Slower (*) and faster (°) 
migrating bands representing phosphorylated and dephosphorylated forms of the protein, 




















2.3.4 Ypt7-D44N impairs trans-SNARE complex formation but not membrane tethering 
and docking  
         Ypt7 and HOPS mediate the tethering and docking stages of vacuole membrane fusion, 
leading to trans-SNARE complex zippering that drives pore formation. Specifically, the 
interactions between Ypt7 and its two binding partners within HOPS are thought to mediate 
membrane tethering, whereby HOPS bridges apposing membranes through the Ypt7-Vps41 
interaction on one end of the complex and the Ypt7-Vps39 interaction on the opposing 
membrane at the other end (Bröcker et al., 2012; Lürick et al., 2016). However, disrupting the 
Ypt7-Vps41 interaction in our hands permits lipid mixing which would require tethering as a 
prerequisite. Thus, to confirm that isolated vacuoles expressing Ypt7-D44N continue to undergo 
tethering, we measured the number of vacuoles found in clusters after brief incubation with ATP 
using fluorescence microscopy – a conventional method to assess vacuole or vesicle membrane 
tethering (e.g. Mayer and Wickner 1997). We found that vacuoles expressing Ypt7-D44N 
undergo robust clustering and the extent of tethering was higher compared to vacuoles 
expressing wild type or the GTP-locked mutant (Q68L) Ypt7 (Figure 8A). This result was 
similar to the effect observed when GTPγS was added to wild type vacuoles to activate Ypt7 and 
stimulate tethering, which is consistent with the finding that the Gdi1-resistant pool of Ypt7-
D44N on membranes is hyperactive. We also assessed vacuole membrane docking by measuring 
the boundary length between adjacent docked organelles (Figure 8B) and found that the D44N 
mutation increased boundary length as compared to wild type or Q68L Ypt7, which may be a 
byproduct of blocked content mixing. As a negative control, we also showed that Ypt7 activation 
was required for docking as adding the GAP peptide rGyp1-46 to inactivate wild type Ypt7 
prevented boundary extension, a hallmark of the docking stage of vacuole fusion. Thus, these 
findings confirm that the Ypt7-Vps41 interaction is not required for the tethering and docking 
stages of vacuole membrane fusion.  
         During docking, HOPS plays a critical role in recruiting SNARE proteins to the vertex ring 
where it assembles trans-SNARE complexes and proofreads them prior to SNARE-pin zippering 
that drives pore formation for lipid bilayer merger (Starai et al., 2008; Zick and Wickner, 2013). 
Given that Ypt7-D44N blocks SNARE-mediated pore formation (Figure 6B), we hypothesized 
that perhaps trans-SNARE complex formation is impaired when Ypt7-HOPS binding is 
interrupted by this mutation. To test this hypothesis, we isolated these SNARE-complexes using 
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an approach that ensures that they are formed in trans during the vacuole fusion reaction in vitro 
(see Collins and Wickner 2007; Schwartz and Merz 2009): We isolated complexes from fusion 
reactions containing vacuoles isolated from cells lacking the R-SNARE Nyv1 and expressing the 
Qa-SNARE Vam3 fused to Calmodulin-Binding Protein (CBP-Vam3) mixed with vacuoles that 
express wild type Nyv1, ensuring that CBP-Vam3 can only pair with Nyv1 on opposing 
membranes (Figure 8C). In support of our model, we found that Ypt7-D44N impeded formation 
of stable trans-SNARE complexes under control conditions (ATP-stimulated fusion). Almost no 
Nyv1 co-precipitated with CBP-Vam3 when fusion was blocked on ice, confirming that all 
trans-SNARE complex formation observed occurred in vitro.  
          In response to trans-SNARE complex formation, Ca
2+
 is released from the vacuole lumen 
to promote downstream events required for lipid bilayer fusion (Merz and Wickner, 2004). 
Because Ypt7-D44N partially blocks formation of stable trans-SNARE complexes, we 
hypothesized that it also impairs downstream vacuole Ca
2+
 efflux. To test this hypothesis, we 
measured Ca
2+ 
fluxes during vacuole fusion in vitro using a membrane-impermeant Ca
2+
-sensing 
fluorophore whereby a decrease in fluorescence intensity indicates vacuole Ca
2+ 
uptake and an 
increase indicates lumenal Ca
2+ 
efflux. We found that Ypt7-D44N diminished the amplitude of 
Ca
2+ 
efflux (Figure 8D), which correlated with the observed reduction in stable trans-SNARE 
complexes formed. Ca
2+ 
influx was not affected by the mutation suggesting that all organelles 
were properly loaded with Ca
2+
, and these Ca
2+
 fluxes were not observed in the absence of ATP, 
confirming that they only occur when vacuole fusion is stimulated. Together, these findings 
suggest that blocking the interaction between Ypt7 and Vps41 inhibits formation of stable trans-
SNARE complexes.  
          If our interpretation of these data is correct then promoting formation of stable trans-
SNARE complexes should rescue membrane fusion defects caused by Ypt7-D44N. Adding 
purified recombinant Vam7 (rVam7), a soluble Qc-SNARE protein, to isolated vacuoles drives 
trans-SNARE complex formation and membrane fusion without the requirement for Ypt7 or 
HOPS function (Thorngren et al., 2004). Thus, to test this hypothesis we added rVam7 to 
vacuole fusion reactions (Figure 8E) and found that it indeed rescued defects in vacuole content 
mixing caused by Ypt7-D44N. Fusion was rescued in the absence and presence of ATP, 
confirming that stabilization of Vps41 or HOPS on membranes was not required for rVam7-
mediated fusion. Furthermore, we confirmed that rVam7 also rescued defects in trans-SNARE 
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complex formation caused by Ypt7-D44N (Figure 8C) in support of our hypothesis. Thus, we 
reason that the Ypt7-Vps41 interaction is required for trans-SNARE complex stabilization, a 
prerequisite for SNARE-pin zippering that drives pore formation, the final step of vacuole 





























Figure 8. Ypt7-D44N allows tethering and docking but prevents stabilization of trans-
SNARE complexes  
(A) (top) Examples of fluorescence micrographs showing FM4-64 stained vacuoles isolated from 
cells expressing wild type (WT), D44N or Q68L Ypt7 observed after 10 minutes incubation with 
ATP to stimulate tethering. 0.5 mM GTPγS was added to WT vacuoles where indicated. 
(bottom) Number of vacuoles per cluster was calculated from micrographic data. Means ± 
S.E.M. are shown (n ≥ 177) (B) (top) Examples of fluorescence micrographs showing FM4-64 
stained vacuoles isolated from cells expressing wild type (WT), D44N or Q68L Ypt7 observed 
after 30 minutes incubation with ATP to stimulate docking. 3.6 μM rGyp1-46 was added to WT 
vacuoles where indicated. (bottom) Boundary length was calculated from micrographic data. 
Cumulative probability and mean values ± S.E.M. are plotted (n ≥ 150). (C) (top) Cartoon 
illustrating method to assess trans-SNARE complex formation. (bottom) Example of results 
from trans-SNARE pairing experiments as evaluated by immunoblotting for Nyv1 associated 
with CBP-Vam3 in the presence of ATP (control conditions, CTL) or 100 nM rVam7. Reactions 
conducted under control conditions were placed on ice as a negative control. (middle) Band 
density was calculated from Western blots. Means ± S.E.M. are shown (n = 3). (D) Ca
2+
 fluxes 
during fusion of vacuoles isolated from wild type (WT) cells with or without ATP or Ypt7-D44N 
cells with ATP assessed by monitoring Oregon Green BAPTA-dextran fluorescence over time. 
Influx and efflux amplitudes calculated from these experiments are shown as means ± S.E.M. (n 
= 6). (E) Vacuole content mixing was measured at 90 minutes in the presence or absence of ATP 
or 100 nM rVam7. Vacuoles were isolated from either cells expressing wild type (WT) or D44N 
























2.3.5 Stabilizing Vps41 on membranes by deleting YCK3 overcomes fusion defects caused 
by Ypt7-D44N  
          Based on the data presented, we developed a working model proposing that active Ypt7-
D44N cannot bind Vps41 making its ALPS domain vulnerable to phosphorylation by Yck3, 
which in turn, causes it to dissociate from vacuole membranes. This then prevents HOPS from 
forming stable trans-SNARE complexes required for membrane pore formation to complete 
vacuole fusion. If true then blocking Yck3 activity should prevent Vps41 dissociation from 
membranes and rescue fusion defects caused by Ypt7-D44N. To test this hypothesis, we first 
deleted YCK3 in cells harboring wild type or mutant Ypt7 and assessed vacuole morphology in 
living cells by fluorescence microscopy (Figure 9A). Under standard isotonic conditions, we 
found that deleting YCK3 causes fewer cells to have multilobed vacuoles, an indication that 
vacuole fusion was enhanced, consistent with previous reports (LaGrassa and Ungermann, 2005; 
Brett et al., 2008). Importantly, knocking out YCK3 rescued the vacuole morphology defect 
observed in cells expressing Ypt7-D44N, as the number of cells with multilobed vacuoles was 
similar to wild type cells. Deleting YCK3 also prevents vacuoles from remaining fragmented 
after hypertonic stress (LaGrassa and Ungermann, 2005), presumably because an inhibitory 
circuit that prevents assembly of the fusion machinery is disrupted (Brett et al., 2008). We 
repeated this experiment and found that vacuoles did not remain fragmented after hypertonic 
shock in absence of YCK3 even in cells harboring Ypt7-D44N (Figure 9A), confirming that 
YCK3 contributed to fusion defects caused by this mutation. We next studied vacuole fusion 
events in live cells using video microscopy (Figure 9B, Video 2) and observed a similar number 
of fusion events (Figure 9C) and visible ILFs (Figure 9D) in wild type cells and yck3Δ cells 
expressing Ypt7-D44N. Together, these results suggest that deleting YCK3 rescues fusion 
defects caused by Ypt7-D44N in vivo in support of our model.  
          To confirm that the hypothesized mechanisms underlying this rescue were correct, we next 
measured vacuole content mixing in vitro. As predicted, deleting YCK3 completely rescued the 
defect in content mixing caused by Ypt7-D44N (Figure 9E). This correlated with the 
stabilization of Vps41 and HOPS (Vps33) on membranes over the course of the fusion reaction 
in vitro (Figure 9F). ATP-dependent dissociation of these proteins was no longer observed and 
the slower migrating form of Vps41 did not appear in samples lacking YCK3 (Figure 9G), 
confirming that Vps41 was not phosphorylated and thus was stabilized on membranes, even 
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when binding to active Ypt7 was disrupted by the D44N mutation. As previously reported (Brett 
et al., 2008), extracting wild type Ypt7 did not cause dissociation of Vps41 from membranes 
either, confirming that active Ypt7 is no longer required to stabilize Vps41 on membranes when 
YCK3 is absent. Finally, it is possible that deleting YCK3 may alter the post-translational 
modification profile of Vps41 allowing it to bind Ypt7-D44N, accounting for observed 
alleviation of fusion defects. To eliminate this possibility, we repeated Ypt7 protein pull-down 
experiments presented in Figure 7B with lysate from cells lacking YCK3 (Figure 9H). We found 
that deleting YCK3 was not able to recover the interaction defect, whereby Vps41 did not bind to 
Ypt7-D44N in the absence or presence of YCK3. All together, these findings support our 
working model, which describes how Yck3, Ypt7 and Vps41 work in concert to accommodate 
SNARE-mediated pore formation during homotypic vacuole fusion. Importantly, by exclusively 
targeting this last step of the lipid bilayer fusion reaction, interplay between these proteins 




















Figure 9. Deleting YCK3 suppresses effects of Ypt7-D44N on vacuole fusion  
(A) (left) Examples of fluorescence micrographs showing FM4-64 stained vacuoles within live 
wild type (WT), Ypt7-D44N, yck3Δ, or Ypt7-D44N::yck3Δ cells before (0 min) and 2 min or 30 
min after treatment with 0.4 M NaCl. Dotted lines outline each cell as observed by DIC. (right) 
Proportion of cells with multi-lobed vacuoles calculated using the micrographic dataset (n ≥ 
255). (B) Images from time-lapse videos (Video 2) showing examples of FM4-64 stained 
vacuoles undergoing homotypic fusion within live wild type (WT) Ypt7, Ypt7-D44N, yck3Δ or 
Ypt7-D44N::yck3Δ cells. Numbers represent time in seconds. From these videos, (C) percentage 
of cells that presented vacuole fusion events and (D) percentage of vacuole fusion events that 
failed to form visible ILFs were calculated. Mean ± S.E.M. are shown (n ≥ 200). (E) Vacuoles 
were isolated from wild type (WT), Ypt7-D44N, yck3Δ or Ypt7-D44N::yck3Δ cells and vacuole 
content mixing in the presence of ATP was measured over time. Mean ± S.E.M. are shown (n = 
4). (F) Results from Rab activity assays (see Figure 7C) conducted using vacuoles isolated from 
wild type (WT), Ypt7-D44N, yck3Δ or Ypt7-D44N::yck3Δ cells in the presence or absence of 
ATP. Membrane association of Vps41, Vps33 or Ypt7 was assessed by immunoblotting. 
Membrane (pellet, P) and soluble (supernatant, S) fractions are shown (n = 2). (G) Vacuoles 
isolated from wild type (WT), Ypt7-D44N, yck3Δ, or Ypt7-D44N::yck3Δ cells were incubated 
with ATP for 0 or 30 minutes and membrane association of Vps41 and Vps33 was assessed by 
immunoblot. Membrane (pellet, P) and soluble (supernatant, S) fractions are shown (n = 2). (H) 
Results of pull-down experiments performed using immobilized GST-Ypt7 (WT or D44N) 
preloaded with GDP (D), GTP (T) or GTPγS (γ) and cell lysates from WT or yck3Δ cells. 
Amount of Vps41 bound to GST-Rab resin or found in the lysate (load) was determined by 











2.4 Discussion  
2.4.1 ILF formation is regulated by the Ypt7-Vps41 interaction and HOPS phosphorylation  
        Here we show that uncoupling Ypt7 activation from Vps41 binding (Figure 7B and C) 
interferes with pore formation (Figure 6B) required for vacuole membrane merger. This is 
because Ypt7-GTP no longer shields Vps41 from Yck3 causing its phosphorylation (Figures 7G 
and 9G) and subsequent dissociation of HOPS from membranes (Figures 7E and F, 9F and G). 
Vps33 within HOPS then releases and exposes trans-SNARE complexes to Sec18, which 
unravels them. Thus, because trans-SNARE complexes are not stabilized (Figure 8C), SNARE-
pins cannot efficiently zipper to drive pore formation. Importantly, although pore formation is 
stalled, stalk formation persists in the presence of Ypt7-D44N (Figure 6A) causing a delay 
between stalk and pore formation (Figure 6G) allowing hemifusion diaphragms to expand across 
boundary membranes (Figure 6H-K). So, when fusion events do occur, fewer intralumenal 
membrane fragments are formed (Figures 5F and 6F). Thus, the interplay between Rab-GTPase, 
effector and kinase regulates ILF formation during vacuolar lysosome fusion.  
          Previously we showed that lysosomal polytopic proteins are selectively sorted into the 
boundary and packaged within ILFs for degradation (McNally et al., 2017). Whereas, here we 
show that ILF formation can be regulated to control the amount of membrane lipids and proteins 
internalized. It has been proposed that sorting and packaging of internalized surface transporter 
and receptor proteins into intralumenal vesicles by ESCRTs at the endosome triggers Ypt7 
activation to stimulate multivesicular body fusion with lysosomes (Shideler et al., 2015). As 
Ypt7 has been implicated in sorting and packaging of lysosomal transporter proteins into ILFs 
(McNally et al., 2017), we speculate that a similar signaling mechanism may exist to sense 
lysosomal polytopic protein entry into the boundary and adjust the amount of membrane 
internalized for efficient degradation. Our interpretation of these results also offers an alternative 
function for SNARE complex proofreading by HOPS (Starai et al., 2008), whereby this activity 
seems to be important for adjusting the kinetics of pore formation, the rate limiting step of the 
bilayer fusion reaction (Reese and Mayer, 2005), to regulate production of ILFs during fusion. 
Furthermore, Yck3 is a member of the type I casein kinase family of protein kinases that have 
diverse roles in cell physiology, and are highly integrated into cellular signaling cascades 
(Knippschild et al., 2005), suggesting that it may represent a hub for signal integration to control 
ILF formation and coordinate vacuolar lysosome remodeling as part of global cellular changes 
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induced by aging or replication programs. Thus, it seems that the interplay between Ypt7, Vps41 
and Yck3 does not simply encode an analog switch to control fusion as originally implied (Brett 
et al., 2008). Rather, we propose that it represents a digital modulator that fine-tunes intermediate 
formation during ring fusion-by-hemifusion to adjust ILF formation in response to cellular 
signaling for vacuolar lysosome homeostasis and remodeling.  
2.4.2 Contribution of the Ypt7-Vps41 interaction to lysosome fusion  
          In addition to describing a mechanism that regulates ILF formation, these results provide 
missing evidence needed to advance our understanding of how the protein machinery mediates 
organelle membrane fusion. Recently, multiple groups have published conflicting reports 
concerning the role of the interactions between Ypt7, HOPS and Yck3 in tethering, docking and 
fusion by primarily studying reconstituted, synthetic proteoliposomes (e.g. Hickey et al. 2009; 
Ho and Stroupe 2016; Lürick et al. 2016; Zick and Wickner 2016). Here we took the unique 
approach of modifying Ypt7 to block Vps41 binding and find that tethering (Figure 8A) and 
docking (Figure 8B) of native organelle membranes persists. We are confident that proper 
docking occurs because Ypt7-D44N allows polytopic protein sorting to occur at boundary 
membranes (Figure 6G), the mutation did not affect the prevalence of interactions observed 
between apposing vacuole membranes as visualized by TEM (Figure 6K), and the mutation 
permits trans-SNARE complex formation (Figure 8C) and Ca
2+
-efflux (Figure 8D). Thus, our 
results suggest that the Ypt7-Vps41 interaction is dispensable for membrane tethering and 
docking of organelles. Moreover, we find that blocking the Rab-effector interaction specifically 
abolishes vacuole content mixing (Figure 6B) but permits lipid mixing (Figure 6A). This maps 
the interaction to SNARE-mediated pore formation. Importantly, deleting YCK3 rescues all 
fusion defects caused by this mutation by preventing Vps41 dissociation from membranes 
(Figure 9). Thus, to account for all observations, we propose a new working model of HOPS-
mediated vacuolar lysosome fusion that describes how Rab, kinase and SNAREs cycles may be 
synchronized to regulate ILF formation and to reset the machinery immediately after pore 
formation (Figure 10).  
          Assuming the fusion machinery is reset (inactive and dispersed) after a previous fusion 
event, we propose that most Ypt7 is GDP-bound on the vacuole membrane during the priming 
stage of fusion. Thus, Ypt7 likely stabilizes HOPS on vacuole membranes by exclusively 
binding Vps39 on one end of the complex (Bröcker et al., 2012). To accommodate tethering, we 
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propose that the ALPS domain within Vps41 on the other end of HOPS interacts with acidic 
lipids within the opposing vacuole membrane to initiate contact (Ho and Stroupe, 2016). This 
requires dephosphorylated Vps41, which may be promoted by the protein phosphatase 1 ortholog 
Glc7, as it may contribute to many stages of homotypic vacuole fusion (Peters et al., 1999). Once 
contact is made, we propose that Vps39 within one HOPS complex interacts with the GEF 
Mon1-Ccz1 to activate Ypt7 (Nordmann et al., 2010), which in turn binds Vps41 located nearby 
within a second flipped HOPS complex donated from the opposing membrane (Zick and 
Wickner, 2016). By closing a positive feedback loop (Brett et al., 2008), Rab signaling in trans 
would drive recruitment and stabilization of the fusion protein machinery at the vertex ring only 
between two membranes, preventing abortive assembly on single membranes. As docking 
occurs, membranes are drawn close enough together (~8 nm; Mattie et al. 2017) to encourage 
trans-SNARE templating and partial complex assembly by Vps33 within HOPS (Baker et al., 
2015). Trans-SNARE complex formation correlates with Ca
2+ 
efflux (Merz and Wickner, 2004) 
and is sufficient for stalk formation (Reese and Mayer, 2005; Schwartz and Merz, 2009; Pieren 
et al., 2010). This is when trans-SNARE complex proofreading by HOPS occurs (Starai et al., 
2008), which shields complexes from Sec18 to prevent unraveling (Xu et al., 2010; Lobingier et 
al., 2014), while promoting complete SNARE-pin zippering to drive pore formation (Pieren et 
al., 2010). Pore expansion then completes the fusion reaction, and seems to occur concomitantly 
with dispersal of the vertex ring suggesting that fusion protein machinery is inactivated and 
disassembled (see Videos1 and 2; Wang et al. 2002; Mattie et al. 2017; McNally et al. 2017). 
          Consistent with previous reports (Zick and Wickner 2012; Orr et al. 2015; Ho and Stroupe 
2015; Ho and Stroupe 2016; Lürick et al. 2016; Zick and Wickner 2016), we find that Vps41 
association with the membrane either through binding Ypt7-GTP or insertion of its 
dephosphorylated ALPS domain is sufficient to drive all stages of fusion. However, our findings 
from studying Ypt7-D44N reveal that Yck3 activation may occur after trans-SNARE pairing. 
This introduces a protein kinase cycle during the fusion reaction that defines distinct roles for 
each mechanism: When dephosphorylated, the ALPS-domain of Vps41 stabilizes HOPS on 
membranes to support tethering and docking (Ho and Stroupe, 2016; Zick and Wickner, 2016). 
However, when this domain is phosphorylated after trans-SNARE pairing, the Ypt7-Vps41 
interaction stabilizes HOPS on membranes (Zick and Wickner, 2012; Orr et al., 2015; Ho and 
Stroupe, 2015; Lürick et al., 2016) to ensure trans-SNARE complex proofreading and 
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subsequent zippering to complete fusion. But why would Yck3, an inhibitory kinase, be activated 
during the vacuole fusion reaction?  
          Although we argue that it may control pore formation (the rate-limiting step of the fusion-
by hemifusion reaction) to regulate ILF formation, it may also coordinate completion of Rab and 
SNARE cycles needed to reset the system: Another target of Yck3 is the Qa-SNARE Vam3, 
which is phosphorylated when fusion is blocked, suggesting that this may inhibit its function 
(Brett et al., 2008). Yck3 also phosphorylates Mon1 (a component of the Ypt7 GEF complex) 
causing it to dissociate from the membrane (Lawrence et al., 2014). In Dictyostelium discoideum, 
Ca
2+ 
release during vacuole fusion stimulates GAP activity and inactivates Rab to complete 
vacuole membrane fusion (Parkinson et al., 2014). Thus, we speculate that coordination of Yck3 
activation and Ca
2+
 efflux upon trans-SNARE pairing may promote Ypt7 inactivation by its 
cognate GAP Gyp7 (Brett et al., 2008), which together with Vam3-phosphorylation, may release 
SNAREs from HOPS and synchronize disassembly of the fusion machinery (e.g. cis-SNARE pin 
unraveling by Sec18; Alpadi et al. 2012) immediately upon SNARE-pin zippering to perhaps 
accommodate pore expansion and prevent future rounds of fusion (LaGrassa and Ungermann, 
2005). We speculate that this molecular circuitry acts analogously to a Rab-cascade mechanism 
(Hutagalung and Novick, 2011) to reset the fusion machinery after homotypic fusion, where both 
membranes share identical components.  
         Our findings also provide insight into the potential role for Ca
2+ 
in ring-fusion-by 
hemifusion: During docking, negatively charged, fusogenic lipids concentrate at the vertex ring, 
the site of highest membrane curvature and where membranes are closely apposed (~8 nm apart, 
Figure 2J; Fratti et al. 2004; Wickner 2010; Mattie et al. 2017). Thus, it has been proposed that 
divalent calcium cations released into the intermembrane space may directly drive lipid mixing 
by forming anhydrous trans complexes between negatively charged phospholipids within 
apposing outer leaflets (Wilschut et al., 1980). However, we argue that this is unlikely because 
introducing Ypt7-D44N reduces the amplitude of Ca
2+ 
efflux (Figure 8D) but does not affect 
lipid mixing (Figure 6A). Furthermore, adding GTPγS to fusion reactions does not change Ca2+ 
efflux (data not shown) but enhances lipid mixing (Mattie et al., 2017). Others have reported 
similar findings that show no correlation between Ca
2+ 
efflux and lipid mixing (e.g. Ca
2+ 
signaling is delayed but kinetics of lipid mixing are unaffected by knocking out YBT1; Sasser et 
al. 2012), suggesting that stalk formation is Ca
2+
-independent. Rather, trans-SNARE pairing 
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alone may be sufficient for lipid mixing (Reese and Mayer, 2005; Schwartz and Merz, 2009; 
Pieren et al., 2010) and Ca
2+ 
may exclusively mediate downstream SNARE-pin zippering for 
pore formation (Hofmann et al., 2006; D’Agostino et al., 2016). This is analogous to its role in 
synaptic vesicle fusion to synchronize rapid neurotransmitter release, whereby synaptotagmin 
and complexin mediate Ca
2+
-dependent stalk-to-pore transition at the synapse (Krishnakumar et 
al., 2011). But the contributions of orthologous proteins to vacuolar lysosome fusion are not 
understood in detail and orthologs are not present on vacuolar lysosomes within S. cerevisiae. 
Now that the physiological relevance of ring fusion-by-hemifusion is apparent, we hypothesize 
that Ca
2+
-mediated pore formation may be repurposed to control ILF formation during vacuolar 
lysosome fusion for organelle homeostasis and remodeling, warranting further investigation in 
the near future.  
2.4.3 Physiological relevance of regulating ILF formation by ring fusion-by-hemifusion  
         An intriguing question arises from our findings: Can ILFs form during other membrane 
fusion events within cells? Although we are unaware of any published studies that directly 
address this question, we hypothesis that ILF formation during fusion may be an 
underappreciated and widespread mechanism for cellular membrane remodeling based on the 
following: First, orthologous fusion machinery (Rabs, MTCs, SNAREs) is found on most 
membranes in cells (Nickerson et al., 2009; Kuhlee et al., 2015; Dubuke and Munson, 2016) 
where it mediates fusion events required for exocytosis and endocytosis for example, and this 
machinery is evolutionarily conserved in all eukaryotes (Balderhaar and Ungermann, 2013; 
Spang, 2016). Second, intralumenal membrane vesicles are present within endosomes when 
ESCRTs are impaired (Stuffers et al., 2009; Edgar et al., 2014), suggesting that organelle fusion 
events may instead be responsible for their formation. Finally, reports that imply ILF formation 
during fusion at other membranes are beginning to emerge, e.g. extracellular membrane 
fragments appear during large astrocytic vesicle exocytosis (Peng et al., 2013) and during non-
selective intracellular compartment exocytosis for plasma membrane wound healing (Davenport 
et al., 2016). But why form fragments during these fusion events? We speculate that selective 
protein (and possibly lipid) sorting into these fragments during exocytosis offers the opportunity 
to ensure that newly added membrane from intracellular compartments is devoid of molecules 
that would interfere with plasma membrane identity or function, or to remodel the plasma 
membrane.  
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          However, currently ILF formation has only been convincingly documented during 
homotypic vacuolar lysosome fusion. We argue that this reflects current limitations in light 
microscopy, whereby vacuolar lysosomes and boundaries formed between them during fusion 
are relatively large (~2 μm diameter) facilitating the visualization of protein sorting and 
membrane internalization by HiLo fluorescence microscopy (Tokunaga et al., 2008). But 
visualizing boundary and ILF formation during fusion of smaller organelles (e.g. endosomes, 
~500 nm diameter; mammalian lysosomes, as small as 200 nm; (Klumperman and Raposo, 
2014) are impossible using most optical methods due to the limited diffraction of light that 
prevents resolving two adjacent fluorophores closer than ~250 nm apart. However, new methods 
in super-resolution fluorescence microscopy (e.g. lattice light-sheet microscopy; Chen et al., 
2014) that overcome these technical barriers are beginning to emerge. Thus, we believe that the 
answer to this important question will be revealed soon and predict that regulated ILF formation 
during membrane fusion will have a broad impact on organelle biogenesis, homeostasis and 

















Figure 10. Working model of regulated ILF formation during vacuolar lysosome fusion  
Cartoon showing how Rab-GTPase, protein kinase and SNARE –cycles are coordinated by 
HOPS to regulate intermediates of the ring-fusion-by-hemifusion reaction to control ILF 
formation during homotypic vacuolar lysosome fusion. Disrupting the Ypt7-Vps41 interaction 
by introducing the D44N mutation maps to a late stage of docking when active Ypt7 is required 











































2.5 Materials and Methods  
2.5.1 Yeast strains and reagents   
       All strains and plasmids used in this study are listed in Table 1. For cell-free organelle fusion 
assays (content or lipid mixing), we used the complimentary Saccharomyces cerevisiae strains 
BJ3505 [MATα pep4::HIS3 prbΔ1-1.6R his3–Δ200 lys2–801 trp1-Δ101 (gal3) ura3–52 gal2 
can1] and DKY6281 [MATα leu2-3 leu2-112 ura3-52 his3- Δ200 trpl-Δ901 lys2-801 suc2-Δ9 
pho8::TRP1]. SEY6210 (Vph1-GFP) [MATα, leu1-3, 112 ura3-52 his3-200, trp1-901 lys2-801 
suc2-Δ9, VPH1-GFP::TRP1] was used to assess hemifusion interphases (Mattie et al., 2017). 
DKY6281-CBP::Vam3 nyv1Δ was used to evaluate trans-SNARE complex association (Collins 
and Wickner, 2007). SEY6210 (GFP-Vps39) [MATα, leu1-3, 112 ura3-52 his3-200, trp1-901 
lys2-801 suc2-Δ9, Vam6::His3, pGFP-Vps39] was used to prepare whole cell lysate for protein 
pull-down assays. YPT7 knock out in SEY6210 (Vph1-GFP) or DKY6281-CBP::Vam3 nyv1Δ 
and YCK3 knock out in BJ3505 or DKY6281 cells were performed using the Longtine method 
(Longtine et al., 1998). Plasmids encoding Ypt7-D44N or GFP-Ypt7-D44N under the control of 
the ADH1-promoter were generated by cycle PCR site-directed mutagenesis from pRS405-Ypt7 
or pRS405-GFP-Ypt7 respectively, and inserted into the genome of the strains lacking YPT7. All 
biochemical and yeast growth reagents were purchased from Sigma-Aldrich, Invitrogen or 
BioShop Canada Inc. All restriction enzymes, Ni-Sepharose 6FF, and glutathione Sepharose 4B, 
polymerases, and ligases were purchased from New England Biolabs (County Rd, Ipswich, MA, 
USA). Purified rabbit polyclonal antibody against Ypt7, Vps33, Vps41, and Vps39 were gifts 
from Alexey Merz (University of Washington, Seattle, WA, USA). Recombinant rabbit IgG 
against GFP was purchased from Abcam (Toronto, ON). Proteins used include recombinant Gdi1 
purified from bacterial cells using a calmodulin-binding peptide intein fusion system (Brett et al., 
2008), recombinant Gyp1-46 (the catalytic domain of the Rab-GTPase activating protein Gyp1) 
purified as previously described (Eitzen et al., 2000), and recombinant soluble Qc-SNARE 
Vam7 purified as previously described (Schwartz and Merz, 2009). Reagents used in fusion 
reactions were prepared in 10 mM Pipes-KOH, pH 6.8, and 200 mM sorbitol (Pipes-Sorbitol 
buffer, PS). 
2.5.2 Vacuole isolation and cell-free fusion assays 
       Organelles were isolated from yeast cells by the Ficoll floatation method as previously 
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described (Haas et al., 1994). Lipid mixing assays were assessed according to Jun and Wickner 
(2007) with slight modifications. Vacuoles (300 μg) isolated from BJ3505 or BJ3505 (Ypt7-
D44N) were incubated with 150 μM octadecyl rhodamine B (R18) in a total volume of 400 μl PS 
buffer for 10 minutes at 4°C. Stained vacuoles were then mixed gently with 600 μl 15% (wt/vol) 
Ficoll and transferred to a thin wall polypropylene tube (13 x 51 mm, Beckman), overlaid with 1 
ml 8% (wt/vol) Ficoll, 1 ml 4% (wt/vol) Ficoll, and 1 ml of PS buffer without ficoll, and 
centrifuged for 30 minutes (105000 g, 4°C) in an SW 55 Ti rotor (Beckman). To evaluate 
vacuole lipid bilayer mixing, 6X reactions (180 μl) containing 4 μg of R18-labeled vacuoles and 
32 μg of unlabeled vacuoles from DKY6281 or DKY6281 (Ypt7-D44N) were mixed under 
fusion conditions (125 mM KCl, 5 mM MgCl2, 1 mM ATP, 40 mM creatine phosphate, 0.5 
mg/ml creatine kinase, 10 μM CoA) in PS buffer. Reactions were transferred to a black, half-
volume 96-well flat-bottom microtiter plates and rhodamine fluorescence (λex= 544 nm; λem= 
590 nm) was measured using a BioTek Synergy H1 plate reading fluorometer. Readings were 
taken every two minutes for 60 minutes at 27°C. Data shown were normalized to values obtained 
at 60 minutes under standard fusion conditions. Content mixing assays were conducted as 
described previously (Haas et al., 1994). Briefly, 30 μl reactions containing 3 μg of vacuoles 
lacking the protease Pep4 (BJ3505), and 3 μg of vacuoles from cells without Pho8 (DKY6281) 
in fusion reaction buffer were incubated at 27°C for 120 minutes, and then assayed for ALP 
maturation. Data shown were normalized to values obtained at 120 minutes under standard 
fusion conditions. 
2.5.3 Ypt7 extraction assay 
       The Rab-GTPase extraction assay was performed as previously described (Brett et al., 
2008). Briefly, 5X reactions (150 μl) containing 30 μg organelles from DKY6281 (wild type or 
Ypt7-D44N) cells were incubated under fusion condition for 30 minutes at 27°C. rGdi1 (5 μM) 
was added, and the reactions were further incubated for 10 more minutes. Samples were placed 
on ice for 2 minutes and protease inhibitors were added (0.46 μg/ml leupeptin, 3.5 μg/ml 
pepstatin, 2.4 μg/ml pefabloc, 1 mM PMSF). Samples were immediately centrifuged (5000 g, 5 
minutes, 4°C) to separate membrane-bound proteins from those in the supernatant. The 
supernatant (100 μl) was transferred into fresh tubes and mixed with 25 μl 5X Laemmli SDS 
sample buffer while the pellets were resuspended in 100 μl 1X of the same sample buffer and 
boiled at 95°C for 10 minutes. One tenth of the total isolated supernatant or pellet was analyzed 
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by Western blot.  
2.5.4 Rab-GTPase pull-down assay  
       pGST-Ypt7 (D44N) was generated from pGST-Parallel-1 Ypt7 (Brett et al., 2008) by cycle 
PCR site directed mutagenesis. The resulting plasmid was expressed in E. coli BL21-pRIL cells. 
GST-tagged proteins (Ypt7-WT, D44N, or Q68L) were bound to glutathione–Sepharose 4B resin 
(GE Healthcare) as described previously (Brett et al., 2008). Rab proteins were loaded with 
GDP, GTP, or GTPγS by incubating Rab-bound resin in nucleotide loading buffer (50 mM Tris-
Cl, pH 8.5, 100 mM NaCl, 0.01% 2-mercaptoethanol, 5 mM MgCl2, and 500 μM guanine 
nucleotide) for 1 hour. The resin was washed 3 times with 500 μl pull-down buffer (50 mM 
Hepes-KOH, pH 7.8, 100 mM NaCl, 5 mM MgCl2, and 5 mM 2-mercaptoethanol). Nucleotide-
loaded GST-Rab resin (50 μl) was then incubated with 150 μg of whole cell lysates for two hours 
at 4°C. The resin was then washed 3 times with 500 μl lysis buffer (20 mM Hepes-KOH, pH 7.4, 
50 mM potassium acetate, 200 mM sorbitol, 0.01% 2-mercaptoethanol, 5 mM MgCl2, 0.7 μg/ml 
leupeptin, 0.5 μg/ml pepstatin, and 1 mM PMSF). GST-Rabs and their bound proteins were 
eluted by boiling samples in 1X Laemmli SB (95°C, 10 minutes). To prepare whole cell lysates, 
1 L of cells expressing Vps39-GFP or cells from DKY6281 missing the YCK3 gene were grown 
to an OD600= 1. The cell wall was digested with zymolyase (30°C, 30 minutes) and the resulting 
spheroplasts were resuspended in lysis buffer and Dounce homogenized (30 strokes) on ice. The 
lysate was solubilized with 1% Triton X-100 and clarified by centrifugation (20000 g, 15 min).  
2.5.5 Tethering and docking assays  
       To evaluate vacuole clustering, 1X reactions (30 μl) containing 6 μg of vacuoles from 
DKY6281-WT, Ypt7-D44N, or Ypt7-Q68L were incubated in fusion reaction buffer (10 mM 
Pipes/KOH, pH 6.8, 200 mM sorbitol, 125 mM KCl, 5 mM MgCl2, 1 mM ATP, 40 mM creatine 
phosphate, 0.5 mg/ml creatine kinase, 10 μM CoA) and supplemented with 3 μM FM4-64 for 10 
minutes at 27°C. Samples were then chilled on ice, and 10 μl aliquots were transferred to pre-
chilled slides and imaged by fluorescence microscopy. The docking assay was as described 
(Wang et al., 2002) with minor modifications. Vacuoles (6 μg) from DKY6281-WT, Ypt7-
D44N, or Ypt7-Q68L were preincubated with 3 μM FM4-64 for 10 minutes. Stained vacuoles 
were brought to 30 μl total volume with fusion reaction buffer, incubated for 30 minutes at 27°C, 
and then placed immediately on ice. Aliquots (10 μl) were transferred to pre-chilled slides and 
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imaged by fluorescence microscopy.  
2.5.6 Trans-SNARE paring assay  
       Analysis of trans-SNARE complex formation was assayed as described (Jun and Wickner, 
2007), whereby the levels of Nyv1 that co-immunoprecipitate with CBP::Vam3 was determined. 
Briefly, 45 μg of vacuoles each from DKY6281-CBP::Vam3 nyv1Δ and BJ3505 or DKY6281 
(Ypt7-D44N, CBP::Vam3 nyv1Δ) and BJ3505 (Ypt7-D44N) were incubated under fusion 
conditions for 45 minutes. Reactions were then placed on ice for 5 minutes, and samples were 
centrifuged (11000 g, 15 minutes, 4°C). Supernatants were decanted, and membrane fractions 
were resuspended in 180 μl solubilization buffer (20 mM Tris-Cl pH 7.5, 150 mM NaCl, 1 mM 
MgCl2, 0.5% Nonidet P alternative, 10% glycerol) with protease inhibitors (0.46 μg/ml 
leupeptin, 3.5 μg/ml pepstatin, 2.4 μg/ml pefabloc, 1 mM PMSF). Reactions were topped up to a 
final volume of 560 μl and nutated for 20 minutes at 4°C. Reactions were centrifuged again 
(16,000 g, 20 minutes, 4°C) and supernatants collected. Ten percent of the extracts were 
collected as input samples, and the remaining extracts were brought to 2 mM CaCl2. The 
CBP::Vam3/Nyv1 complexes were recovered with calmodulin Sepharose beads 4B (GE 
Healthcare) by nutating overnight at 4°C, collected by brief centrifugation (4,000 g, 2 minutes, 
4°C), washed five times with sample buffer, and followed by bead sedimentation. Bound 
proteins were eluted by boiling beads (95°C, 10 minutes) in SDS sample buffer containing 5 mM 
EGTA for SDS-PAGE analysis and immunoblotting.  
2.5.7 HiLo Fluorescence microscopy   
       Live yeast cells stained with FM4-64 to label vacuole membranes were prepared for imaging 
using a pulse-chase method as previously described (Brett et al., 2008). For in vitro imaging, 
vacuolar lysosomes isolated from DKY6281-WT, Ypt7-D44N, Ypt7-Q68L or strains expressing 
Vph1-GFP (WT or Ypt7-D44N) were stained with FM4-64 by treating organelles with 3 μM 
FM4-64 for 10 minutes at 27°C before addition to fusion reaction buffer. Reactions were then 
incubated at 27°C for 60 minutes and placed on ice prior to visualization using a Nikon Eclipse 
TiE inverted microscope equipped with a motorized laser TIRF illumination unit, Photometrics 
Evolve 512 EM-CCD camera, an ApoTIRF 1.49 NA 100x objective lens, and bright (50 mW) 
blue and green solid-state lasers operated with Nikon Elements software (housed in the Centre 
for Microscopy and Cellular Imaging at Concordia University). Micrographs were processed 
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using ImageJ software (National Institutes of Health) and Adobe Photoshop CC. Images shown 
were adjusted for brightness and contrast, inverted and sharpened with an unsharp masking filter.  
2.5.8 Transmission electron microscopy  
        As previously described (Mattie et al., 2017), fusion reactions were incubated at 27°C for 
30 minutes, vacuoles were gently pelleted (5000 g for 5 minutes) at 4°C and immediately fixed 
with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) overnight at 4°C. Vacuole pellets 
were washed with 0.1 M sodium cacodylate (3 times, 10 minutes) and then fixed with 1% 
osmium tetroxide for two hours at 4°C. Pellets were washed with water (3 times, 5 minutes) 
followed by gradual dehydration in ethanol (30-100%) and 100% propylene oxide. Pellets were 
infiltrated with epon:propylene oxide for 1 hour and then embedded in pure epon by 
polymerization (48 hour at 57°C). Samples were cut into 100 nm thick sections using an ultra-
diamond knife and Reichert Ultracut II microtome, loaded onto 200-mesh copper grids, and 
stained with uranyl acetate (8 minutes) and Reynold's lead (5 minutes). Sections were imaged at 
120 kV using a FEI Tecnai TEM outfitted with a Gatan Bioscan digital camera (1k × 1k pixels) 
housed in the Facility for Electron Microscopy Research (FEMR) at McGill University. For each 
condition, images were obtained from at least three separate vacuole fusion reactions. 
Micrographs shown were adjusted for brightness and contrast and sharpened with an unsharp 
masking filter using Adobe Photoshop CC software.   
2.5.9 Western blot analysis  
         Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
using a Bio-Rad mini protein system (Bio-Rad Laboratories, Hercules, CA, USA). After 
separation, proteins were transferred onto a nitrocellulose membrane by wet transfer method at 
12 V for 8 hours using a Royal Genie Blotter apparatus (Idea Scientific, Minneapolis, MN, 
USA). Membranes were blocked with 3% BSA in PBST buffer (137 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4, 2 mM KH2PO4, 0.1% Tween-20) and then washed twice with PBST and 
incubated with primary antibody diluted to 1:1000 in PBST for 1 hour at room temperature. 
Membranes were washed with PBST five times, and then incubated with HRP-labeled goat anti-
rabbit IgG diluted 1:10000 in PBST for 1 hour at room temperature. After an additional 5 washes 
with PBST, the membranes were probed to detect bound secondary antibody using GE 
Amersham Imager 600 (GE Healthcare, Piscataway, NJ, USA).   
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2.5.10 Data analysis and presentation  
         To calculate vacuoles surface area, we took two measurements for the diameter across from 
each other (assuming that vacuoles were spherical) and averaged them. Boundary lengths of 
vacuole interfaces were calculated as a percentage of the vacuole circumference (calculated 
using diameter measurements) represented by the interface between two vacuole membranes 
(measured as the distance along apposed flattened membranes). All quantitative data were 
processed using Microsoft Excel v.14.0.2 software (Microsoft Cooperation, Redmond, WA, 
USA), including calculation of mean and S.E.M. Comparisons were calculated using Student 
two-tailed t-test, P values < 0.05 indicate significant differences. Data were plotted using Kaleida 
Graph v.4.0 software (Synergy Software, Reading, PA, USA). All figures were prepared using 
Adobe Illustrator CC software (Adobe Systems, San Jose, CA, USA). 
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Table 1: Yeast strains and plasmids used in this study. 
 
Strain  Genotype Source 
BJ3505 
 
MATα pep4::HIS3 prb1-∆1.6R his3–200 lys2–801 
trp1∆101 (gal3) ura3–52 gal2 can1 




MATα leu2-3 leu2-112 ura3-52 his3- Δ200 trpl-Δ901 lys2-
801 suc2-Δ9 pho8::TRP1 




MATα pep4::HIS3 prb1-∆1.6R his3–200 lys2–801 





MATα leu2-3 leu2-112 ura3-52 his3- Δ200 trpl-Δ901 lys2-





MATα, leu1-3, 112 ura3-52 his3-200, trp1-901 lys2-801 
suc2-Δ9, Vam6::His3, pGFP-Vps39 




MATα, leu1-3, 112 ura3-52 his3-200, trp1-901 lys2-801 
suc2-Δ9, VPH1-GFP::TRP1 










MATα leu2-3 leu2-112 ura3-52 his3- Δ200 trpl-Δ901 lys2-
801 suc2-Δ9 pho8::TRP1 ypt7∆::YPT7(Q68L) 




MATα leu2-3 leu2-112 ura3-52 his3- Δ200 trpl-Δ901 lys2-
801 suc2-Δ9 pho8::TRP1 ypt7∆::YPT7(T22N) 




MATα leu2-3 leu2-112 ura3-52 his3- Δ200 trpl-Δ901 lys2-
801 suc2-Δ9 pho8::TRP1 ypt7∆::YPT7(N126I) 




MATα leu2-3 leu2-112 ura3-52 his3- Δ200 trpl-Δ901 lys2-
801 suc2-Δ9 pho8::TRP1 ypt7∆::YPT7(D129N) 
Kucharczyk 
et al., 2001 
CBY063 DKY6281; ypt7∆::KANMX This study 
CBY069 
 




CBY074 BJ3505; yck3∆::KANMX  This study 
CBY075 DKY6281; yck3∆::KANMX This study 
CBY076 BJ3505; YPT7(D44N)::NATMX yck3∆::KANMX This study 














Plasmid Description  Source 
pGST-Ypt7 
 
pEX-GST AMP; LacOpr-Ypt7 
 




pEX-GST AMP; LacOpr-Ypt7(Q68L) 
 
Brett et al., 
2008 
pCB033 pEX-GST AMP; LacOpr-Ypt7(D44N) This study 
pCB037 pRS405 LEU; ADHIpr-YPT7 This study 
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pCB038 pRS405 LEU; ADHIpr-YPT7(D44N) This study 
pCB042 pRS405 LEU; ADHIpr-GFP-YPT7 This study 







Chapter 3. Characteristics of Multivesicular Body-Lysosome Membrane Fusion Revealed 
by A New Cell-Free Assay 




         Endocytosis controls expression of surface polytopic proteins for cellular housekeeping, 
signaling and survival. Internalized proteins marked for degradation are delivered to endosomes 
and packaged into intraluminal vesicles by the ESCRT machinery to form a multivesicular body 
(MVB). When mature, the MVB fuses with lysosomes exposing proteins to lumenal hydrolases 
for catabolism. To better understand this last step of endocytosis, we developed a luminal β-
lactamase complementation assay to measure membrane fusion between MVBs and vacuolar 
lysosomes isolated from Saccharomyces cerevisiae. We show that MVB- vacuolar lysosome 
fusion is driven by the Rab-GTPase Ypt7, multisubunit tethering complex HOPS, and the 
endosomal syntaxin ortholog Pep12 in complex with the lysosomal SNAREs Nyv1, Vti1 and 
Vam7, but does not require Ca
2+






 exchanger NHX1 or the 
ESCRT machinery impairs MVB-vacuolar lysosome fusion. These defects are overcome by 
chloroquine or Ypt7 activation, respectively; offering strategies to treat human disorders linked 















          Endocytosis is critical for regulating surface expression levels of polytopic proteins such 
as transporters and receptors for cellular signaling and survival in all eukaryotic organisms. 
Proteins destined for degradation are labeled with ubiquitin and cleared from the surface by 
invagination of the plasma membrane to form early endosomes. Through membrane fusion 
events, early endosomes deliver cargo proteins to an endosomal compartment where they 
encounter the ESCRT (Endosomal Sorting Complexes Required for Transport) machinery that 
sorts them into intraluminal vesicles (ILVs). Many rounds of ILV formation produce a 
multivesicular body (MVB; Huotari and Helenius 2011; Schmidt and Teis 2012), that when 
mature, fuses with the vacuolar lysosome to expose the ILVs to lumenal hydrolases for 
catabolism (Luzio et al., 2003; Piper and Katzmann, 2007). Although critical for surface protein 
degradation, we still do not understand many aspects of this terminal step of the endocytic 
pathway in molecular detail.  
          However, based on results primarily acquired using genetic approaches and microscopy, a 
model has emerged describing the mechanisms underlying MVB-vacuolar lysosome fusion that 
are thought to be conserved in all eukaryotic species (reviewed by Luzio et al. 2010; Markgraf et 
al. 2009; Balderhaar and Ungermann 2013; Spang 2016). Most evidence supporting this model 
comes from studies employing the genetically tractable model organism Saccharomyces 
cerevisiae (see Balderhaar and Ungermann 2013; Spang 2016). From these studies, it is apparent 
that MVBs contain two paralogs of almost every component of the fusion machinery (Lachmann 
et al., 2011; Furukawa and Mima, 2014). Presumably, one set is required for endosome 
membrane fusion events responsible for anterograde membrane trafficking to the MVB (for 
surface protein delivery and organelle biogenesis), and the other set is proposed to mediate 
MVB-vacuolar lysosome fusion. Most reports suggest that the machinery underlying the latter 
fusion event is redundant with mechanisms that drive homotypic vacuolar lysosome fusion, as 
components of this machinery are found on MVB and vacuolar lysosome membranes (Numrich 
and Ungermann, 2014; Spang, 2016). As such, inferences have been drawn from detailed 
knowledge of the homotypic vacuolar lysosome membrane fusion reaction generated from the 
use of cell-free membrane fusion assays (Balch et al., 1984; Conradt et al., 1994; Jun and 
Wickner, 2007). This powerful biochemical approach has permitted dissection of this process in 
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molecular detail revealing four distinct subreactions required for organelle membrane fusion and 
the critical players for each that presumably mediate MVB-vacuolar lysosome fusion as well (see 
Figure 12A):   
          “Priming”, the first subreaction, requires Sec17, an α-SNAP [soluble NSF (N- 
ethylmalemide-sensitive factor) attachment protein] ortholog and SNARE chaperone, and Sec18, 
an NSF ortholog and homohexameric ATPase, to unravel cis-SNARE complexes from previous 
fusion events to free up individual SNARE proteins for future rounds of membrane fusion 
(Mayer et al., 1996; Ungermann et al., 1998). As the only α-SNAP and NSF orthologs in S. 
cerevisiae Sec17 and Sec18 are thought to mediate all SNARE-mediated membrane fusion 
events in the cell, but their roles in MVB-vacuolar lysosome fusion have not been investigated. 
Afterwards (or possibly concomitantly), organelle membranes undergo “tethering”, the second 
subreaction, whereby apposing membranes make first contact. This requires activation of the 
Rab-GTPase Ypt7 and interaction with its cognate multisubunit tethering complex (MTC) called 
HOPS (homotypic fusion and vacuole protein sorting complex; Seals et al. 2000; Wurmser et al. 
2000; Hickey and Wickner 2010). Next, fusogenic proteins (e.g. Ypt7, HOPS and SNAREs) and 
lipids are recruited to the initial contact site where they assemble into an expanding ring at the 
vertex between adjacent organelles (Wang et al., 2003; Fratti et al., 2004). Called “docking”, this 
subreaction also includes the formation of trans-SNARE protein complexes mediated by HOPS 
(Collins and Wickner, 2007; Starai et al., 2008; Baker et al., 2015). Like homotypic vacuolar 
lysosome fusion, Ypt7 and HOPS are also implicated in MVB-vacuolar lysosome fusion where 
they presumably contribute to tethering and docking (Balderhaar et al., 2010; Peterson and Emr, 
2001; Bugnicourt et al., 2004). During the last subreaction called “fusion”, trans-SNARE 
complexes fully zipper driving lipid bilayer merger (Schwartz and Merz, 2009). Only one of four 
SNAREs (Vam3, Vti1, Vam7 and Nyv1) within the complex that mediates homotypic vacuolar 
lysosome fusion is also found on MVB membranes (Vti1; Gossing et al. 2013; Jun et al. 2007) 
and the SNAREs donated by each organelle to the complex that drives MVB-vacuolar lysosome 
fusion are unknown.  
         Recognizing the impact of this approach on our understanding of homotypic vacuolar 
lysosome fusion, we developed a similar cell-free assay to measure MVB-vacuolar lysosome 
membrane fusion and use it to study the mechanisms underlying this heterotypic fusion event. 
We also sought to understand how specificity is conferred in this system by identifying features 
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of this process that differ from homotypic vacuolar lysosome fusion. In addition to the fusion 
protein machinery, we examine other factors that contribute to the membrane fusion process, 
including Ca
2+
 signaling (Merz and Wickner, 2004), pH (although this is contentious; Coonrod et 
al., 2013; Desfougères et al., 2016) and monovalent cations (e.g. K
+
; Starai et al., 2005; Cang et 







that resides on MVB membranes (Nass and Rao, 1998). Deleting NHX1 causes endocytic 
defects that implicate a role in MVB-vacuolar lysosome fusion (Bowers et al., 2000; Brett et al., 
2005; Kallay et al., 2011). Herein we use this assay to test this hypothesis and understand how 
Nhx1 activity may regulate the fusion machinery. We also use it to address how MVBs delay 
fusion with vacuolar lysosomes until they fill with ILVs by testing the hypothesis that, after ILV 
formation, the ESCRT machinery stimulates a Rab-cascade mechanism to activate Ypt7, which 
in turn stimulates MVB-vacuolar lysosome fusion (Russell et al., 2012; Shideler et al., 2015). 
From these results, we propose a refined model describing the mechanisms that mediate or 
regulate MVB-vacuolar lysosome membrane fusion, and use it to identify strategies to overcome 
fusion defects caused by deleting components of the ESCRT machinery or NHX1, as analogous 
mutations in orthologous genes are linked to human neurological diseases and cancers (Saksena 




3.3 Results  
3.3.1 A new cell-free assay to measure MVB-vacuole membrane fusion  
          The prevailing model of MVB-vacuolar lysosome fusion is almost exclusively supported 
by evidence derived from genetic approaches that often inadvertently prevent delivery of 
fusogenic proteins to vacuolar lysosome membranes. Thus, to better understand the molecular 
underpinnings of this event, we took an alternative biochemical approach by developing a new 
cell-free MVB-vacuole membrane fusion assay based on a strategy used by Jun and Wickner 
(2007) that relies on the reconstitution of β-lactamase upon luminal content mixing (Figure 
11A): To target the first fusion probe to the MVB lumen, we fused the C-terminus of the 
endosomal Qa-SNARE Pep12 to the proto-oncogene product c-Fos followed by the ω-subunit of 
β-lactamase (Pep12-Fos-Gs-ω). To target our second fusion probe to the vacuolar lysosome 
lumen, we fused the targeting sequence of lysosomal protease carboxypeptidase Y (CPY; first 50 
amino acids) to Jun, a cognate binding partner of c-Fos, followed by the α-subunit of β-lactamase 
(CPY50-Jun-Gs-α). Upon MVB-vacuole lipid bilayer merger, organellar lumenal contents 
containing the probes mix allowing Jun and c-Fos to interact driving the complementary halves 
of β-lactamase together to reconstitute enzyme activity. Reconstituted β-lactamase activity is 
then measured by monitoring nitrocefin hydrolysis (by recording absorbance at 492 nm over 
time) to quantify MVB-vacuolar lysosome fusion.  
          To confirm that the fusion probes were properly localized within cells, we created yeast 
strains expressing versions of the probes tagged with GFP at their C-termini, stained them with 
FM4-64 to label vacuole membranes and imaged them using fluorescence confocal microscopy 
(Figure 11B). The Pep12-GFP fusion protein appeared on puncta consistent with MVB 
localization as reported previously (Becherer et al., 1996), whereas the CPY50-GFP fusion 
protein was found within the vacuole lumen. Next, we fractionated cellular membranes by 
sucrose gradient (Figure 11C) and used Western blot analysis to confirm that Pep12-Fos-Gs-ω is 
found in similar fractions (9-12) as Vps10, a resident protein on MVBs (Marcusson et al., 1994), 
as well as endogenous Pep12. CPY50-Jun-Gs-α is not found in fractions containing the MVB 
fusion probe, but rather in fractions (3-4) containing Nyv1, a R-SNARE that is exclusively found 
on vacuolar lysosome membranes (Wen et al., 2006), and endogenous CPY a vacuole resident 
protein. Notably, the two Rab-GTPases thought to mediate MVB fusion, the endosomal Rab 
Vps21 and the vacuolar Rab Ypt7, as well as components of the HOPS complex (Vps41 and 
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Vps33) and the Qa-SNARE Vam3 were found in the same fractions as both fusion probes. We 
then collected the fractions containing MVB membranes (9-12) from Pep12-Fos-Gs-ω 
expressing cells or vacuole membranes (3-4) from CPY50-Jun-Gs-α expressing cells and mixed 
them together under conditions that promote the homotypic vacuole membrane fusion reaction in 
vitro (see Jun and Wickner 2007). Unfortunately, these preparations were fusion incompetent, as 
we did not observe β-lactamase activity in reactions containing either MVB and vacuole 
membranes or vacuole membranes alone containing vacuole localized fusion probes (i.e. 
CPY50-Fos-Gs-ω and CPY50-Jun-Gs-α; Figure 11D). Thus, we sought an alternative method to 
isolate the organelles to optimize our cell-free fusion assay.  
          Based on a method to isolate intact, fusogenic vacuolar lysosomes from yeast cells (see 
Conradt et al. 1992), we decided to use a 4-step Ficoll gradient to isolate both MVBs and 
vacuoles in the same preparations. Although vacuoles are known to accumulate at the 0-4% 
Ficoll interface, it is not clear whether MVBs also migrate to this layer during centrifugation. 
Thus, we performed Ficoll based fractionation experiments using cells expressing GFP-tagged 
versions of the fusion probes, collected organelles that accumulated at the 0-4% Ficoll interface, 
stained their membranes with FM4-64 and imaged them by confocal fluorescence microscopy 
(Figure 11E). Pep12-GFP is present in the preparation and localizes to small puncta adjacent to 
vacuole membranes reminiscent of MVB structures, whereas CPY50-GFP is found within the 
lumen of isolated vacuolar lysosomes, consistent with our observations of living cells shown in 
Figure 11B. We also observed the presence of our fusion probes (Pep12-Fos-Gs-ω or CPY50-
Jun-Gs-α) in this fraction by Western blot analysis (Figure 11F). Other markers of both MVBs 
(Vps10, endogenous Pep12) and vacuolar lysosomes (Nyv1, endogenous CPY) were also present 
confirming that both organelles can be found in this preparation. The presence of MVBs and 
vacuoles was also confirmed by visualization of the samples by transmission electron 
microscopy (Figure 11G). We observed structures reminiscent of MVBs based on size and 
morphology (e.g. a round organelle of 500 nm diameter containing numerous circular ILVs of 
20-80 nm diameter; (Friend, 1969; Russell et al., 2012) immediately adjacent to larger (> 1 μm 
radius) single membrane encased organelles containing lipophilic materials characteristic of 
vacuolar lysosomes (Mattie et al., 2017). We next mixed equal proportions of organelles isolated 
from cells only expressing the MVB fusion probe and organelles isolated from cells exclusively 
expressing the vacuole fusion probe with 125 mM KCl, 5 mM MgCl2 and 1 mM ATP and 
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incubated the reactions at 27°C for up to 90 minutes to promote MVB-vacuolar lysosome fusion 
in vitro. Upon measuring reconstituted β-lactamase activity (Figure 11H), we observed robust 
heterotypic fusion showing a signal up to 10 times greater than background (i.e., reactions run 
without ATP or left on ice during the duration of the reaction). Although the extent of fusion was 
less, rates of heterotypic fusion were comparable to those observed for homotypic vacuole fusion 
suggesting that the kinetics of the membrane fusion subreactions may be similar. This new assay 
offers us a method to study MVB-vacuolar lysosome fusion using similar biochemical 
approaches that have been applied to successfully characterize homotypic vacuole fusion with 
molecular precision (see Wickner 2010). Herein, we use it to better understand the molecular 
underpinnings of this organelle fusion event, and to determine how MVB maturation triggers 






Figure 11. A cell-free assay to measure MVB-lysosome membrane fusion  
(A) Cartoon illustrating the approach used to develop a new cell-free assay to quantify MVB-
vacuole fusion. One fusion probe contains c-Fos and the ω-fragment of β-lactamase fused to the 
C-terminus of Pep12 to target it to the MVB lumen. The complementary fusion probe contains 
Jun and the α-fragment of β-lactamase fused to the C-terminus of a peptide encoding the first 50 
amino acid of CPY to target it to the vacuolar lysosome lumen. Fluorescence micrographs of (B) 
live cells or (E) isolated organelles (using the Ficoll method) expressing Pep12-GFP or CPY50-
GFP. Vacuole membranes were stained with FM4-64. Dotted lines outline the yeast cell as 
observed by DIC. Scale bars, 2 μm. (C) Western blots of yeast membranes fractionated by 
sucrose gradient. (D) Membrane fusion values obtained from reactions containing organelles 
isolated by the sucrose fractionation method. (F) Western blot analysis of organelles isolated 
using the Ficoll floatation method. (G) Transmission electron micrographs of a fusion reaction 
containing MVBs and vacuolar lysosomes imaged at 30 minutes in the presence of ATP. Panels 
below show higher magnification images of boxed regions illustrating docking sites between 
apposing organelles. V, vacuolar lysosomes. Scale bar, 500 nm. (H) Membrane fusion values 
obtained from reactions containing organelles isolated using the Ficoll floatation method. 
Reactions were conducted in the presence or absence of ATP for 90 minutes at 27°C. Mean ± 
S.E.M. values are plotted and at least 3 experiments were performed for each condition shown. 



















3.3.2 Protein machinery required for MVB-vacuole membrane fusion  
        Homotypic vacuole membrane fusion requires the coordination of fusogenic proteins and 
lipids with ion fluxes to orchestrate four progressive subreactions (priming, tethering, docking 
and fusion) culminating with lipid bilayer merger (Wickner, 2010). Based on genetic studies and 
the analysis of endocytic trafficking in vivo, it is thought that many of these mechanisms also 
mediate MVB-vacuolar lysosome fusion, as both events involve the lysosomal membrane 
(Balderhaar et al., 2010; Bröcker et al., 2012; Balderhaar and Ungermann, 2013), lending to the 
prevailing model of MVB-vacuolar lysosome fusion shown in Figure 12A. To test this model, 
we first studied the proteins required for the priming subreaction by targeting Sec17, an α-SNAP 
ortholog that functions as a SNARE chaperone required for unraveling vacuolar cis-SNARE 
complexes from previous fusion events to permit future ones (Figure 12B). Consistent with 
Sec17 being the only α-SNAP ortholog encoded in the S. cerevisiae genome that contributes to 
membrane fusion at many sites within the cell (Griff et al., 1992; Mayer et al., 1996), we found 
that addition of anti-Sec17 antibody to block Sec17 activity impairs heterotypic fusion, like 
homotypic fusion, suggesting that it also mediates the priming subreaction of MVB-vacuolar 
lysosome fusion. 
         The subsequent stage of the organelle membrane fusion reaction is tethering, which is 
operationally defined as when apposing membranes make first contact. Afterwards, fusogenic 
proteins and lipids are recruited to and assemble at this site to stabilize the interaction between 
membranes in preparation for lipid bilayer merger, a hallmark of the docking subreaction (Wang 
et al., 2003; Fratti et al., 2004). Both tethering and docking are thought to be driven by activation 
of Rab-GTPases (Eitzen et al., 2000; Ostrowicz et al., 2010; Balderhaar et al., 2010, 2013). Thus, 
we predict that the addition of Rab inhibitors such as recombinant Gdi1 protein (rGdi1), a Rab-
GTPase chaperone that extracts inactive Rab proteins from membranes (Garrett et al., 1994), or 
purified Gyp1-46, the active domain of the Rab-GAP protein Gyp1 that inactivates Rabs (Will 
and Gallwitz, 2001), will block heterotypic fusion. As predicted, heterotypic fusion, like 
homotypic fusion, is blocked by Rab inhibitors suggesting a role for Rab-GTPase activation in 
MVB-vacuolar lysosome fusion (Figure 12B). Two Rab proteins are present on these organelles, 
the endosomal Rab Vps21 and the vacuolar Rab Ypt7. To determine which Rab contributes to 
MVB-vacuolar lysosome fusion, we added purified antibodies raised against either Rab protein 
to fusion reactions to impair Rab activity and examined the effects on fusion (Figure 12B). Like 
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homotypic vacuole fusion (Eitzen et al., 2000), we find that heterotypic fusion requires Ypt7 and 
not Vps21, confirming reports by other groups (Balderhaar et al., 2010). 
         To mediate tethering and docking, active Rab-GTPases must interact with cognate effector 
proteins found within a multisubunit tethering complex (Price et al., 2000). Two MTCs could 
mediate the MVB-vacuolar lysosome fusion reaction: CORVET (class C core vacuole/endosome 
tethering complex) found on MVBs or HOPS found on vacuoles and MVBs (Peplowska et al., 
2007; Nickerson et al., 2009; Balderhaar and Ungermann, 2013). Both complexes are composed 
of 6 subunits, but share 4 of them including Vps33, a SM-protein ortholog important for trans-
SNARE complex assembly (Subramanian, 2004; Brett et al., 2008; Baker et al., 2015). Thus, to 
first determine if either MTC contributes to MVB-vacuolar lysosome fusion, we added affinity-
purified anti-Vps33 antibody to fusion reactions to block Vps33 activity within the CORVET 
and HOPS complexes (Figure 12B). As predicted, anti-Vps33 antibody blocks both heterotypic 
and homotypic fusion confirming the involvement of MTCs in this process. To determine which 
MTC is involved in MVB-vacuolar lysosome fusion, we targeted unique subunits found in each 
complex: Vps41, an effector protein that binds to active Ypt7, that is only found in HOPS and its 
ortholog Vps8, a Vps21 effector protein, that is exclusively found in CORVET (Peplowska et al., 
2007; Markgraf et al., 2009; Price et al., 2000; Ostrowicz et al., 2010). First, we added a purified 
antibody raised against Vps41 to fusion reactions to block Vps41 activity. Like homotypic fusion 
which requires Vps41 function, heterotypic fusion was impaired suggesting that Vps41 and 
HOPS mediate this event. Next, because we did not have access to a reliable antibody raised 
against Vps8, we took a genetic approach to block Vps8 activity by knocking out the VPS8 gene 
in yeast strains harboring the fusion probes. After determining that the probes were properly 
localized in the vps8Δ mutant cells (Figure 12C), we found that knocking out VPS8 had no effect 
on homotypic vacuole fusion (Figure 12D), which was expected given that Vps8 is not found on 
vacuole membranes and CORVET does not mediate this fusion event. However, we find that the 
deleting the VPS8 gene enhances MVB-vacuolar lysosome fusion (Figure 12D). Although 
unexpected, this result confirms our hypothesis that VPS8 is not required for MVB-vacuolar 
lysosome fusion and offers insight into how Vps-C complex numbers are balanced on MVB 
membranes, whereby loss of one complex (CORVET) may free up shared subunits needed to 
increase the abundance of the other complex (HOPS). In any case, together these results support 
the prevailing model of MVB-vacuolar lysosome fusion by confirming the involvement of Ypt7 
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and HOPS in the tethering and docking stages of the reaction.  
        The final stage of the organelle fusion reaction is lipid bilayer merger driven by SNARE-pin 
formation (Nichols et al., 1997). For homotypic vacuole fusion, trans-SNARE complexes are 
minimally composed of the three Q-SNAREs – the syntaxin ortholog Vam3 (Qa), Vti1 (Qb) and 
the SNAP25 ortholog Vam7 (Qc) and the R-SNARE Nyv1, a synaptobrevin ortholog 
(Ungermann and Wickner, 1998; Ungermann et al., 1998) whereby Vam7, a soluble protein, 
complexes with Vam3 and Vti1 on one membrane and Nyv1 on the opposing membrane 
(Schwartz and Merz, 2009; Baker et al., 2015). Of these 4 SNAREs, only the Qb-SNARE Vti1 is 
expressed on MVBs (Furukawa and Mima, 2014). Otherwise MVBs express orthologous Qa- 
(Pep12), Qc- (Tlg1) and R- (Snc2) SNAREs (Becherer et al., 1996; Von Mollard et al., 1997), 
but it is not clear which ortholog contributes to the trans-SNARE complex that drives MVB-
vacuolar lysosome fusion. Elegant work by Joji Mima’s group revealed that reconstituted Pep12 
protein is capable of forming stable, fusogenic complexes with the vacuolar SNARE proteins in 
place of Vam3 (Furukawa and Mima, 2014). Thus, we hypothesized that a trans-SNARE 
complex composed of Pep12, Vti1, Vam7 and Nyv1 may drive MVB-vacuole membrane fusion. 
To test this hypothesis, we added purified antibodies against Pep12 or Vam3 to fusion reactions 
to specifically block the activity of each Qa-SNARE protein (Figure 12B). As predicted, anti-
Vam3 antibody blocked homotypic, but had a lesser effect on heterotypic fusion, whereas anti-
Pep12 antibody completely blocked heterotypic but had no effect on homotypic fusion, 
suggesting that Pep12 is the Qa-SNARE necessary for MVB-vacuolar lysosome fusion. To 
demonstrate that Vam7 is also in the SNARE complex that drives MVB-vacuolar lysosome 
membrane fusion, we added recombinant Vam7 protein (rVam7) to isolated organelles in the 
absence of ATP. Because it is sufficient to drive homotypic vacuole fusion in vitro (Thorngren et 
al., 2004), we reasoned that it could also stimulate MVB-vacuolar lysosome fusion if our model 
is accurate. As expected, rVam7 is sufficient to drive heterotypic fusion (Figure 12E), and like 
homotypic fusion, it further stimulates fusion when organelles are pretreated with anti-Sec17 
antibody to prevent unraveling of newly formed SNARE complexes (see Stroupe et al. 2006). To 
demonstrate that the R-SNARE Nyv1 mediates MVB-vacuolar lysosome membrane fusion, we 
deleted the NYV1 gene from yeast strains containing fusion probes. After confirming the probes 
were properly localized (Figure 12C), we measured organelle fusion and found that neither 
heterotypic or homotypic fusion occurred when NYV1 was absent (Figure 12D), suggesting that 
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Nyv1 is necessary for MVB-vacuolar lysosome fusion.  
        Having shown that SNARE complexes containing Pep12, Vam7 and Nyv1 are necessary 
and sufficient for MVB-vacuolar lysosome fusion, we next sought to isolate these complexes 
using an approach that ensures that they are formed in trans during the membrane fusion reaction 
in vitro (see Collins and Wickner 2007; Schwartz and Merz 2009): We isolated organelles from 
cells that are missing the NVY1 gene and expressing Pep12 fused to Calmodulin-Binding 
Protein (CBP::Pep12) and mixed them with organelles isolated from cells missing the gene 
encoding Pep12 (Figure 12F). We then incubated the organelle fusion reactions for 60 minutes, 
sufficient time to allow trans-SNARE pairing, melted membranes using a non-ionic detergent, 
performed a pull-down assay for CBP::Pep12 using calmodulin Sepharose resin and used 
Western blotting to detect co-precipitation of Nyv1 with CBP::Pep12. In support of our model, 
we found that Nyv1 and Vti1 co-purify with CBP::Pep12 but only under fusion conditions 
(Figure 12G). Addition of rVam7 was sufficient to drive complex formation, consistent with it 
driving MVB-vacuolar lysosome fusion. We used CBP::Vam3 in place of CBP::Pep12 as a 
positive control, and demonstrated that trans-SNARE complexes required for homotypic fusion 
formed in vitro, as reported previously (Figure 12H; Schwartz and Merz 2009). Importantly, 
Pep12 does not co-purify with CBP::Vam3 and Vam3 does not co-purify with CBP::Pep12 








Figure 12. Characterization of the protein machinery underlying MVB-vacuole fusion  
(A) Cartoon illustrating the subreactions and proteins proposed to mediate MVB-vacuolar 
lysosome fusion. (B) Homotypic and heterotypic membrane fusion measured in the presence or 
absence of affinity purified antibodies against Sec17 (1.8 μM), Ypt7 (1.8 μM), Vps21 (1.2 μM), 
Vps33 (1.8 μM), Vps41 (1.8 μM), Pep12 (1.2 μM), Vam3 (2.6 μM), or purified recombinant 
Gdi1 (4 μM) or Gyp1-46 (5 μM) proteins. (C) Micrographs of live wild type (WT), vps8Δ or 
nyv1Δ cells expressing Pep12-GFP or CPY50-GFP. Vacuole membranes were stained with FM4-
64. Scale bars, 2 μm. (D) Membrane fusion values from reactions containing organelles isolated 
from cells with or without VPS8 or NYV1. (E) Membrane fusion values from reactions 
conducted with or without ATP or rVam7 (100 nM) to stimulate fusion. Fusion reactions were 
also pre-treated with 1.8 μM anti-Sec17 for 10 minutes to reveal more SNARE proteins 
(Thorngren et al., 2004). (F) Cartoon illustrating method used to isolate trans-SNARE 
complexes from in vitro organelle fusion reactions. (G, H) Western blots showing results from 
pull-down experiments used to study trans-SNARE complexes containing CBP::Pep12 (G) or 
CBP::Vam3 (H) that form in vitro 60 minutes after addition of ATP (Std) or 100 nM rVam7 to 
stimulate organelle fusion. Reactions were kept on ice to prevent fusion as negative control. 
Mean ± S.E.M. values are plotted and n ≥ 2 for all conditions shown. (Note that panels B and E 

























 levels block MVB-lysosome fusion  
          Lumenal calcium efflux is required for homotypic vacuolar lysosome fusion: trans-
SNARE complex formation drives Ca
2+
 release, which in turn promotes full SNARE zippering 
for lipid bilayer merger (Merz and Wickner, 2004). As such, adding Ca
2+ 
chelators to in vitro 
reactions blocks membrane fusion (Peters and Mayer, 1998; Starai et al., 2005). On the other 
hand, adding CaCl2 to mimic release has no effect, as the amount of Ca
2+
 normally released is 
sufficient for fusion and the earlier stages of fusion are Ca
2+
-independent (Figure 13A). 
However, in contrast, we found that adding CaCl2 blocked heterotypic fusion (Figure 13A). In 
accord, we found that adding low concentrations (< 0.5 mM) of the rapid divalent cation chelator 
BAPTA (Figure 13B; Ricci et al. 1998) stimulated MVB-vacuolar lysosome fusion. Higher 
concentrations of BAPTA block both homotypic and heterotypic fusion, consistent with previous 
reports that suggest that it alters ionic strength causing the Q-SNARE Vam7 and the HOPS 
complex to dissociate from vacuole membranes (Starai et al., 2005; Pryor et al., 2000). 
Regardless, these observations suggest that although heterotypic and homotypic fusion events 
share underlying machinery, Ca
2+
-dependence is a distinct feature of homotypic fusion. 
Furthermore, heterotypic fusion seems to be inhibited by cytoplasmic Ca
2+
, suggesting that 
luminal Ca
2+
 release may act as a switch mechanism to direct membrane trafficking by stalling 













Figure 13. Effect of Ca
2+
 on MVB-vacuole fusion  
Organelle membrane fusion was measured in the absence or presence of increasing 
concentrations of CaCl2 (A) or the rapid divalent metal chelator BAPTA (B). All fusion reactions 
were incubated for 90 minutes at 27°C in the presence of ATP. Mean ± S.E.M. values are plotted 





















3.3.4 Ionic requirements for MVB-vacuole fusion 
        Ionic and osmotic gradients regulate endocytosis and membrane fusion (Heuser, 1989; 
Starai et al., 2005). MVBs and vacuoles have distinct luminal environments controlled by unique 
sets of resident transporters. For example, MVBs are more alkaline than vacuoles due to the 






 exchanger Nhx1 that opposes the activity of the V-ATPase (Nass and 
Rao, 1998, 1999; Huotari and Helenius, 2011), and they are thought to lack channels and 
transporters responsible for Ca
2+
 signaling. On the other hand, vacuolar lysosomes are important 
contributors to cellular pH and Ca
2+
 homeostasis and signaling (Denis and Cyert, 2002), and act 
as cellular stores for ions, metals, polyphosphates and other biomolecules, which are sequestered 
and released by unique resident transporters (Luzio et al., 2003) that may contribute to 
homotypic membrane fusion (Sasser and Fratti, 2014). Thus, we hypothesized that homotypic 
and heterotypic fusion have different ionic requirements. To test this hypothesis, we first 
changed the pH of the reaction buffer to mimic changes in cytoplasmic [H
+
] and examined the 
effect on organelle fusion in vitro (Figure 14A). 
          Compared to homotypic fusion, heterotypic fusion was less tolerant to changes in pH 
although the peak fusion signal was near resting cytoplasmic pH (6.80) for both events. In 
mammalian cells, alkalinization of the MVB lumen promotes fusion with lysosomes (Cao et al., 
2015). Thus, to determine if changing lumenal pH also affects MVB-vacuolar lysosome fusion in 
our system, we treated isolated organelles with chloroquine, a weak base that accumulates within 
MVBs and vacuoles and raises lumenal pH (Pearce et al. 1999; Qiu and Fratti 2010; Figure 14B). 
We found that both homotypic and heterotypic fusion were enhanced by chloroquine, however it 
had a greater effect on MVB-vacuolar lysosome fusion. Together, these results confirm that 
MVB-vacuolar lysosome fusion responds to changes in cytoplasmic and lumenal pH, and reveals 
that this response is different than homotypic lysosome fusion, suggesting that these events may 
be differentially regulated by cellular signaling events mediated by pH transients, e.g., budding 
(Henderson et al., 2014), or that involve changes in MVB function in response to changes in 
environmental pH, e.g. Rim20-Rim101 pathway (Xu et al., 2004; Boysen and Mitchell, 2006). 
Specific monovalent cations and osmotic balance are required for homotypic lysosome fusion 
(Starai et al., 2005; Brett and Merz, 2008). Thus, we next studied the effect of increasing [KCl], 
an important cytoplasmic osmolyte, on MVB-lysosome fusion (Figure 14C). Heterotypic fusion 
is less tolerant to shifts of [KCl] than homotypic fusion, which may reflect how the organelles 
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regulate their volume using different mechanisms. We then tested the dependence of fusion on 
K
+





 had no effect on either fusion event, whereas replacing it with NH4
+
 
diminished both fusion events. However, one distinguishing feature of MVB-vacuolar lysosome 




. Nhx1, which is exclusively found on MVBs, can 
transport Rb
+




 (Brett et al., 2005) and is needed to deliver surface proteins 
to vacuolar lysosomes for degradation (Bowers et al., 2000; Brett et al., 2005). Thus, this unique 
monovalent cationic profile may reflect a function for Nhx1 in MVB-vacuolar lysosome fusion, 





















Figure 14. Ionic requirements for MVB-vacuole fusion  
Organelle membrane fusion was measured in the presence of increasing pH (A), [chloroquine] 
(B) or [KCl] (C), or when KCl was replaced with other salts (125 mM; D). All fusion reactions 
were incubated for 90 minutes at 27°C in the presence of ATP. Mean ± S.E.M. values are plotted 
and n ≥ 3 for all conditions shown. Note that panels A, C, and D also appeared in the M.Sc. 









3.3.5 Nhx1 activity contributes to MVB-lysosome fusion  
        Deleting NHX1 causes aberrant accumulation of internalized surface proteins within 
enlarged MVBs (Bowers et al., 2000; Brett et al., 2005). Similar phenotypes are observed when 
knocking out genes encoding the ESCRT machinery responsible for protein sorting and 
intralumenal vesicle formation, two processes required for MVB maturation (Henne et al., 2011). 
However, a unique feature of abnormal MVBs within nhx1Δ cells is the presence of intralumenal 
vesicles (Kallay et al., 2011), suggesting that deleting NHX1 blocks delivery of proteins to 
vacuolar lysosomes after ESCRT function. The only known requirement for protein delivery to 
the vacuolar lysosome for degradation after ESCRT function is MVB-vacuolar lysosome fusion. 
Thus, to test the hypothesis that Nhx1 contributes to MVB-vacuole fusion, we knocked out 
NHX1 in yeast strains harboring fusion probes, isolated their organelles, and confirmed that the 
fusion probes properly localized to the MVB and vacuolar lysosome lumen (Figure 15A and B). 
We also isolated organelles from cells expressing Nhx1 tagged with GFP and examined them by 
fluorescence microscopy to demonstrate that Nhx1-positive MVBs were found in our isolated 
organelle preparations (Figure 15C). Examination of these preparations under conditions that 
promote fusion revealed the accumulation of Nhx1-GFP on vacuole membranes over time 
(Figure 15C), suggesting that Nhx1-GFP positive MVBs were fusing with vacuolar lysosomes in 
vitro. Next, we measured fusion between MVBs and vacuolar lysosomes isolated from either 
wild type or nhx1Δ cells and found that knocking out NHX1 impaired heterotypic fusion (Figure 
15D). Deleting NHX1 has been shown to block delivery of some biosynthetic cargo to the 
vacuolar lysosome (Bowers et al., 2000; Brett et al., 2005). Thus, it is possible that impaired 
fusion may be a consequence of improper delivery of the fusion machinery to vacuolar 
lysosomes in nhx1Δ cells. To eliminate this possibility, we mixed organelles isolated from either 
wild type or nhx1Δ cells expressing complementary fusion probes and measured membrane 
fusion in vitro (Figure 15E). Reactions containing nhx1Δ vacuolar lysosomes and wild type 
MVBs showed similar fusion values as reactions containing wild type organelles, confirming 
that the fusion machinery was properly delivered to vacuolar lysosomes in nhx1Δ cells. 
Furthermore, fusion between wild type vacuolar lysosomes and nhx1Δ MVBs showed 
impairment similar to fusion between only nhx1Δ organelles, confirming that underlying defect 
is inherent to MVB, not vacuolar lysosome, dysfunction. 
        It has been proposed that cation-proton exchange by Nhx1 underlies its function in 
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endocytosis, as deleting NHX1 hyper-acidifies the lumen of the vacuole and treating live cells 
with a weak base that accumulates in acidic compartments rescues associated endocytic defects 
in the absence of the transporter (Ali et al., 2004; Brett et al., 2005; Kojima et al., 2012). 
However Nhx1 is predominantly found on MVBs (Nass and Rao 1998; Bowers et al. 2000; Brett 
et al. 2005; Figure 15C). Thus, we reasoned that lumenal pH of the MVB would also be 
abnormally acidic when NHX1 is deleted if it acts as a proton leak mechanism as proposed (Nass 
and Rao, 1998; Brett et al., 2005). To test this hypothesis, we measured lumenal MVB pH using 
a ratiometric fluorescence method that includes tagging the lumenal face of Pep12 with a pH-
sensitive variant of GFP, called pHluorin, fused to mCherry, a relatively pH-insensitive 
fluorescent protein with different spectral properties. After demonstrating that the probe was 
properly localized to MVBs (Figure 15F) and responsive to pH in our preparations (Figure 15G), 
we determined that enlarged MVBs isolated from nhx1Δ cells were indeed hyperacidic as 
compared to those isolated from wild type cells (Figure 15H). Adding a weak base to correct pH 
defects overcomes endocytic impairments caused by knocking out NHX1 in living cells (Brett et 
al., 2005). To determine if restoration of MVB-vacuolar lysosome fusion underlies this 
observation, we next added the weak base chloroquine to fusion reactions and found that it 
rescued MVB-vacuolar lysosome fusion defects caused by knocking out NHX1 (Figure 15I). 
Together, these results suggest that proton transport by Nhx1 is important for the MVB-vacuolar 
lysosome fusion stage of endocytosis. 
        As lumenal proton export by Nhx1 is coupled to monovalent cation import (Nass and Rao, 
1998; Brett et al., 2005), we next examined if monovalent cation transport by Nhx1 is also 
critical for MVB-vacuolar lysosome fusion. When characterizing the ionic requirements for 





 (Figure 14D) and hypothesized that perhaps Nhx1 activity accounts for this observation, as 
it is the only known mechanism on MVBs that transports Rb
+




 (Brett et al., 
2005). To test this hypothesis, we measured MVB-vacuolar lysosome fusion in the presence of 
RbCl and found that it is entirely abolished when NHX1 is deleted (Figure 15J), suggesting that 
Rb
+
 transport by Nhx1 is required for MVB-vacuolar lysosome fusion under these conditions. 
This effect is specific for Rb
+







. Together, these findings confirm that cation-proton exchange by 
Nhx1 mediates its role in MVB-vacuolar lysosome fusion.  
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Figure 15. Loss of Nhx1 activity impairs MVB-vacuole fusion  
Fluorescence micrographs of live cells (A) or isolated organelles (B) with (WT) or without 
(nhx1Δ) NHX1 expressing Pep12-GFP or CPY50-GFP. (C) Fluorescence micrographs of fusion 
reactions containing organelles isolated from WT cells expressing Nhx1-GFP acquired at time 
points after addition of ATP to stimulate fusion. Vacuole membranes were stained with FM4-64. 
(D) MVB-vacuolar lysosome fusion values acquired over time after adding ATP to reactions 
containing organelles isolated from WT or nhx1Δ cells. (E) MVB-vacuolar lysosome fusion 
values acquired 90 minutes after addition of ATP to reactions containing organelles mixed from 
WT and nhx1Δ cells. (F) Fluorescence micrographs of live WT or nhx1Δ cells expressing the 
MVB lumenal pH probe Pep12-pHluorin-mCherry. (G) Lumenal pH calibration curves for 
MVBs isolated from WT and nhx1Δ cells expressing Pep12-pHluorin-mCherry. (H) Lumenal 
MVB pH values for organelles isolated from WT or nhx1Δ cells expressing Pep12-pHluorin-
mCherry in the absence or presence of ATP. (I, J) MVB-vacuole fusion values acquired 90 
minutes after addition of ATP to reactions containing organelles mixed from WT and nhx1Δ 
strains in the presence or absence of 4 mM chloroquine (I), or when KCl was replaced with 
different salts (125 mM; J). All fusion values shown are means ± S.E.M. normalized to standard 
fusion conditions (wild type organelles, 90 minutes after adding ATP). n ≥ 3 for all conditions 
shown. All scale bars, 2 μm. Note that panels D and J also appeared in the M.Sc. thesis of 























3.3.6 Nhx1 targets SNAREs, not Ypt7 activity to regulate organelle fusion  
          How does ion transport by Nhx1 affect the machinery underlying the membrane fusion 
reaction? It was previously shown that Nhx1 binds Gyp6, a Rab GTPase Activating Protein 
(Rab-GAP) that inactivates the Rab-GTPase Ypt6, and to a lesser extent Ypt7, which are 
implicated in MVB fusion with the trans-Golgi network and vacuolar lysosome, respectively 
(Ali et al., 2004; Brett et al., 2008; Vollmer et al., 1999; Will and Gallwitz, 2001), and knocking 
out GYP6 partially suppresses endocytic defects observed in nhx1Δ cells (Ali et al., 2004). Given 
that Rab conversion at the MVB is required to activate Ypt7, and Ypt7 activation is needed for 
MVB-vacuolar lysosome fusion, we hypothesized that Nhx1 may target Rab activity to regulate 
MVB-vacuolar lysosome fusion, whereby loss of NHX1 may cause inactivation of Ypt7 which 
accounts for the observed impairment in organelle fusion. To test this hypothesis, we employed 
an assay to assess the proportion of active Ypt7 protein present on isolated organelles: We added 
rGdi1, a Rab-chaperone protein, that selectively binds and extracts inactive Rab from isolated 
membranes and separated the pool of soluble rGdi1-bound inactive Ypt7 (supernatant) from 
membrane bound (presumably active) Ypt7 (pellet) by differential centrifugation (Brett et al., 
2008). Compared to organelles isolated from wild type cells, MVBs and vacuolar lysosomes 
from nhx1Δ cells contained similar amounts of active Ypt7 on membranes, and this pool of Ypt7 
was equally susceptible to inactivation by GAP activity (by addition of rGyp1-46 protein) or 
activation by addition of GTPγS a non-hydrolyzible analog of GTP (Figure 16A and B), 
suggesting that deleting NHX1 has no effect on Ypt7 activity. To further test this hypothesis, we 
treated isolated organelles from WT or nhx1Δ cells with GTPγS to activate Ypt7 and measured 
MVB-vacuole fusion (Figure 16C). We found that GTPγS treatment was unable to rescue the 
MVB-vacuole fusion defect caused by nhx1Δ. Finally, disrupting Rab-activation has been shown 
to affect targeting of Ypt7 to MVB and vacuolar lysosome membranes (Cabrera and Ungermann, 
2013). Thus, we also assessed the effect of knocking out NHX1 on the distribution of Ypt7-GFP 
within cells using fluorescent microscopy. Consistent with our other findings, deleting NHX1 
had no discernable effect on Ypt7-GFP targeting to MVBs and vacuolar lysosome membranes 
within live cells (Figure 16D). Together, these results suggest that Nhx1 does not target Ypt7 
function to regulate organelle fusion.  
          Given that loss of NHX1 activity does not target Ypt7, we next performed a preliminary 
screen to determine if deleting NHX1 affected the cellular distribution of other GFP-tagged 
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proteins responsible for MVB-vacuolar lysosome fusion to better understand how Nhx1 
contributes to the MVB-vacuolar lysosome fusion reaction. However, no discernable differences 
in cellular targeting of GFP-tagged components of the HOPS complex (Vps41) or other proteins 
implicated in membrane fusion were observed (data not shown). However, when studying GFP-
tagged Vph1 (the stalk domain of the V-type H
+
-ATPase complex that is exclusively found on 
vacuolar lysosome membranes in wild type cells), we found that Vph1-GFP abnormally 
accumulated on enlarged MVBs in nhx1Δ cells (Figure 16D). This observation made two 
important implications: (1) it is consistent with the hyper-acidification of the MVB lumen in 
nhx1Δ cells and may account for this observation, and (2) it suggests that deleting NHX1 may 
target a stage of the membrane fusion reaction proposed to be dependent on Vph1, which is after 
Ypt7 and HOPS function, but prior to complete bilayer merger by trans-SNARE complex 
zippering (Strasser et al., 2011). To test the latter hypothesis, we stimulated fusion in vitro with 
the soluble Qc-SNARE rVam7 in place of ATP, which would bypass any affects nhx1Δ may 
have on trans-SNARE complex assembly (Figure 16E). Indeed, rVam7 rescued fusion of 
organelles isolated from nhx1Δ cells to levels similar to wild type fusion under standard 
conditions. Pretreating reactions with anti-Sec17 antibody to promote entry of rVam7 into 
SNARE complexes further improved fusion, confirming that the SNARE machinery was intact 
on organelles isolated from nhx1Δ cells. Together, these results suggest that Nhx1 activity targets 
a component of the fusion machinery that functions upstream of trans-SNARE pairing and 










Figure 16. Loss of Nhx1 activity does not affect Ypt7 signaling 
 (A) Rab-GTPase activity assessed using membrane extraction by rGdi1. Organelles isolated 
from wild type (WT) or nhx1Δ cells were incubated with ATP for 40 minutes in the presence or 
absence of 5 μM rGdi1 or 3.6 μM rGyp1-46 during the last 10 minutes of incubation. As a 
control, reactions indicated were pretreated with 0.2 mM GTPγS to prevent membrane extraction 
of Ypt7 by rGdi1. Organelle membranes (pellet, P) were separated from soluble factors 
(supernatant, S) by centrifugation and Ypt7 was detected in both fractions by immunoblotting. 
(B) Evaluation of Ypt7 extraction by densitometric analysis of Western blots shown in A. (C) 
MVB-vacuole fusion values acquired 90 minutes after addition of ATP to reactions containing 
organelles isolated from WT or nhx1Δ cells that were pretreated with increasing concentrations 
of GTPγS for 10 minutes. (D) Fluorescence micrographs of live WT or nhx1Δ cells expressing 
either Vph1-GFP or Ypt7-GFP. Vacuole membranes and aberrant MVBs were stained with 
FM4-64. Scale bar, 2 μm. (E) Membrane fusion values from reactions containing organelles 
isolated from WT or nhx1Δ cells incubated for 90 minutes in the presence or absence of ATP or 
rVam7 (100 nM) to stimulate fusion. Fusion reactions indicated were pre-treated with 1.8 μM 
anti-Sec17 for 10 minutes to reveal more SNARE proteins (Thorngren et al., 2004). Mean ± 
S.E.M. values are plotted and n ≥ 3 for each experiment shown. Note that panel A and E also 



































3.3.7 The ESCRT machinery activates Ypt7 to promote MVB-lysosome fusion  
        The ESCRT machinery mediates sorting and packaging of internalized surface proteins into 
intralumenal vesicles at the MVB (Henne et al., 2011). Many rounds of intralumenal vesicle 
formation occur to form a mature MVB that then fuses with the vacuolar lysosome to expose 
proteins to lumenal hydrolases for degradation. Deleting components of the ESCRT machinery 
causes internalized surface proteins to accumulate on enlarged endocytic compartments devoid 
of intralumenal vesicles within cells (Odorizzi et al., 1998a; Katzmann et al., 2001). Based on 
these observations, it has been hypothesized that proper protein sorting and intralumenal vesicle 
formation are needed to trigger the terminal step of this pathway, MVB-vacuolar lysosome 
fusion (Russell et al., 2012). To test this hypothesis, we used our new cell-free MVB-vacuolar 
lysosome fusion assay whereby we isolated organelles containing only the MVB fusion probe 
(Pep12-Fos-Gs-ω) from cells devoid of either VPS23, VPS36 or SNF7 (components of the 
ESCRT-I, ESCRT-II or ESCRT-III, respectively) and mixed them with organelles expressing 
only the lysosomal fusion probe (CPY50-Jun-Gs-α) isolated from wild type cells (Figure 17A). 
This approach ensures that the fusion machinery is properly delivered to vacuolar lysosome 
membranes, as knocking out components of the ESCRT machinery is known to block the CPY 
and CPS biosynthetic pathways to the vacuolar lysosome (Odorizzi et al., 1998a; Katzmann et 
al., 2001). Furthermore, ESCRTs only function on MVB membranes, not vacuolar lysosomes, so 
we reasoned that any defects in ESCRT-mediated signaling required to trigger MVB-vacuolar 
lysosome fusion should occur on MVBs isolated from cells devoid of ESCRT components. 
Using fluorescence microscopy, we first confirmed that the targeting domain of the MVB fusion 
probe (Pep12-GFP) was properly localized to aberrant, enlarged MVBs proximal to vacuolar 
lysosomes within mutant cells (Figure 17B; see Coonrod and Stevens 2010; Russell et al. 2012). 
Next, we measured mutant MVB fusion with wild type vacuolar lysosomes in vitro and found 
that deleting components of the ESCRT machinery blocked heterotypic fusion (Figure 17C), 
suggesting that ESCRT function is needed to trigger MVB-vacuolar lysosome fusion.  
          So how does the ESCRT machinery signal the fusion machinery to trigger mature MVB 
vacuolar lysosome fusion? According to a recent report by Odorizzi and colleagues, deletion of 
VPS4, a AAA-ATPase that catalyzes disassembly of ESCRT-III, prevents Rab-GTPase 
conversion at the MVB membrane whereby inactivation of Vps21 after an endosome-MVB 
fusion event for protein delivery triggers activation of Ypt7 to initiate the next trafficking step, 
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MVB-vacuolar lysosome fusion en route to the lysosome (Russell et al., 2012). Deleting VPS4 
causes active Vps21 to accumulate on enlarged MVBs devoid of intralumenal vesicles, which 
disrupts Ypt7 activation, and presumably blocks MVB-vacuolar lysosome fusion. To validate 
this model, we treated isolated organelles with 0.2 mM GTPγS to constitutively activate 
GTPases including Ypt7 on membranes and measured heterotypic fusion to determine if it 
rescued MVB-vacuolar lysosome fusion defects caused by knocking out ESCRT subunits. As 
predicted, GTPγS treatment partially restores fusion defects caused by deleting ESCRT (Figure 
17C). In addition, stimulating fusion with rVam7 instead of ATP to bypass the Ypt7 function 
also rescued fusion defects caused by deleting ESCRT components (Figure 17C). This result 
confirms that the SNAREs are functional on MVB membranes, and confirms that ESCRT 
function ultimately targets Rab-GTPase activation to trigger MVB-vacuolar lysosome fusion. To 
confirm that Ypt7 is the target of signaling triggered by ESCRT function, we introduced a Q68L 
mutation into Ypt7 to render it constitutively active (see Brett et al., 2008) in cells lacking 
VPS23, a subunit of the ESCRT-I complex, to overcome the MVB-vacuolar lysosome fusion 
defects caused by this mutation. After confirming that the targeting domain of the MVB fusion 
probe was properly localized in vps23Δ cells expressing Ypt7 Q68L (Figure 17D), we measured 
fusion between mutant MVBs and wild type vacuolar lysosomes in vitro and found that 
introduction of Ypt7 Q68L completely suppressed the defect in heterotypic fusion caused by 
deleting VPS23 (Figure 17E). Unlike fusion between wild type organelles, addition of GTPγS 
had no effect on heterotypic fusion in the presence of Ypt7 Q68L, suggesting that Ypt7 Q68L 
was indeed constitutively active and conferred sensitivity to GTPγS in our organelle fusion 
reactions. In all, these findings offer critical evidence in support of the hypothesis that the 
ESCRT machinery triggers MVB-vacuolar lysosome fusion by activation of Ypt7 through a Rab 
cascade mechanism.  
3.3.8 Nhx1 and the ESCRT machinery use independent mechanisms to trigger heterotypic 
fusion  
         Although their contributions to MVB maturation are unique, knocking out either ESCRT 
subunits or Nhx1 disrupt MVB-vacuolar lysosome fusion. Unlike ESCRTs, Nhx1 does not target 
Ypt7 activity. However fusion defects caused by all knockout mutations can be rescued by 
addition of rVam7. Furthermore, intralumenal vesicles form in nhx1Δ cells suggesting that Nhx1 
may function downstream of ESCRTs. Thus, it is possible that that ESCRT function may 
 87 
stimulate Nhx1 to promote fusion. If so, given that chloroquine rescues MVB-vacuolar lysosome 
fusion when NHX1 is absent, we hypothesized that chloroquine should also rescue heterotypic 
fusion defects caused by deleting ESCRT subunits. Upon measuring MVB-vacuolar lysosome 
fusion in vitro, we found that chloroquine did not rescue defects caused by these mutations 
(Figure 17F), eliminating this possibility and suggesting that ESCRTs and Nhx1 use independent 






















Figure 17. Deletion of ESCRT components prevents Ypt7 activation necessary for MVB-
vacuole fusion  
(A) Cartoon illustrating the method used to study effects of deleting components of the ESCRT 
machinery on MVB-vacuolar lysosome fusion. Organelles isolated from wild type (WT) or 
mutant cells expressing the MVB fusion probe were mixed with organelles isolated from WT 
cells expressing the lysosomal fusion probe. (B) Micrographs of live WT, vps23Δ, vps36Δ or 
snf7Δ cells expressing Pep12-GFP. Vacuoles membranes were stained with FM4-64. (C, F) 
MVB-vacuole fusion values from reactions containing organelles isolated from WT, vps23Δ, 
vps36Δ or snf7Δ cells. Reactions were conducted in the absence or presence of ATP, 0.2 mM 
GTPγS, or 100 nM rVam7 (C) or in the presence of increasing concentrations of chloroquine (F). 
(D) Micrographs of live WT or vps23Δ, or vps23Δ Ypt7-Q68L cells expressing Pep12-GFP. 
Vacuoles membranes were stained with FM4-64. (E) MVB-vacuole fusion values from reactions 
containing organelles isolated from WT, vps23Δ or vps23Δ Ypt7-Q68L cells in the absence or 
presence of ATP or 0.2 mM GTPγS. All fusion reactions were incubated for 90 min at 27°C. 
Fusion values shown are means ± S.E.M. normalized to fusion values from reactions containing 
































3.4.1 A new cell-free assay for MVB-lysosome fusion  
          Here we describe a new cell-free assay to measure MVB-vacuolar lysosome membrane 
fusion based on reconstitution of lumenal β-lactamase (Figure 11). Two additional lines of 
evidence confirmed that MVB-vacuolar lysosome fusion occurred within our fusion reaction in 
vitro: (1) We observed the accumulation of Nhx1-GFP, a polytopic protein that resides on the 
MVB, on vacuole membranes within the heterotypic fusion reaction over time, which is a 
predicted outcome of MVB-vacuolar lysosome fusion (Figure 15C), and (2) flattened organelle 
membrane interfaces reminiscent of docking sites that occur during other organelle fusion events 
were observed between MVBs and vacuolar lysosomes by TEM at 30 minutes into the reaction 
when the docking subreaction was predicted to occur (Figure 11G). The method of organelle 
isolation was crucial for success, and although MVBs are not separated from vacuolar lysosomes 
in these preparations, targeting the fusion probes to each organelle in separate yeast strains and 
mixing them later ensures that reconstituted β-lactamase activity represents only fusion that 
occurs in vitro under controlled conditions. We show that this new assay offers many 
experimental advantages that facilitate study of the MVB-vacuolar lysosome membrane fusion 
reaction in detail: (1) It is quantitative, and with maximum values observed at 10 times over 
background, this assay offers a robust, colorimetric alternative to fluorescence based techniques 
that rely on fluorescence colocalization (3X over background; Cao et al. 2015) or radiolabeled 
techniques that rely on interactions between Avidin-asialofetuin and I
125
-labeled biotinylated 
polymeric IgA (4X over background; Pryor et al. 2000). (2) By mixing MVBs expressing one 
fusion probe isolated from mutant cells with vacuolar lysosomes containing the complementary 
fusion probe from wild type cells (or vice versa), it allowed us to identify the organelle with 
defective fusion machinery and eliminate possible effects of impaired delivery of biosynthetic 
cargo (such as fusogenic proteins) to vacuole membranes caused by deleting ESCRT or NHX1 
genes (Robinson et al., 1988; Raymond et al., 1992; Bowers et al., 2000). (3) It permits kinetic 
analysis of the heterotypic membrane fusion reaction, as it can be initiated in vitro with the 
addition of either ATP or rVam7 protein. (4) It offers the convenience of using protein reagents 
to study subreactions of the process, or of changing the reaction buffer conditions to simulate 
changes in the “cytoplasm” to better understand how heterotypic fusion is regulated. Herein, we 
demonstrate the utility of this assay by characterizing the molecular mechanisms that contribute 
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to this process and reveal how it may be triggered after MVB maturation. Thus, we speculate that 
this powerful experimental tool will be of great utility to others interested in further studying 
mechanisms that contribute to this important step in endocytosis.  
          One noteworthy aspect of our design, however, is the over-expression the Qa-SNARE 
Pep12, which is used to target the fusion probe to MVBs, raising concerns of whether increased 
Pep12 levels could affect the fusion reaction. We believe that it has minimal effects on 
heterotypic fusion because (1) endosomal morphology looks normal in micrographs of cells 
expressing the probe, and (2) many groups have shown that over-expression of all SNAREs 
within the complex (three Q-SNAREs and an R-SNARE) is required to alter fusion of organelles 
(sometimes leading to lysis; e.g. Starai et al. 2007) or synthetic liposomes (e.g. Mima et al. 
2008). It is also worth noting that we used the same probes and assay to measure MVB-MVB 
fusion in vitro without success (data not shown). We suspect that this outcome is likely a result 
of co-purification with vacuolar lysosomes, whereby MVBs seem to be more likely to encounter 
a vacuolar lysosome than a MVB in vitro (micrographs presented offer examples), decreasing the 
relative number of possible MVB-MVB fusion events that occur in the reaction. However, in 
theory, the same approach can be used to study other organelle membrane fusion events by 
swapping the targeting sequence and purifying the organelles using a method that ensures 
sufficient purification has occurred to permit organelle interactions in vitro, that isolates 
organelles in buffer that permits fusion (e.g. low osmolarity; Brett and Merz 2008), and that does 
not damage membranes (e.g. isolation by floatation; Conradt et al. 1992). 
3.4.2 Unique features of the MVB-lysosome fusion reaction  
         Using this new cell-free assay, we generated evidence (see Figure 12) that complements 
results from studies relying on genetic approaches, trafficking assays and microscopy (e.g. Arlt 
et al. 2015) to validate the prevailing model of MVB-vacuolar lysosome membrane fusion 
(Bröcker et al. 2010; Epp et al. 2011; see figure 8). Specifically, we demonstrated that: (1) 
Heterotypic fusion does not require cytosolic components and is activated by addition of ATP to 
fusion reactions, suggesting ATP hydrolysis is necessary for membrane fusion. (2) Sec17, a 
SNARE chaperone and the only α-SNAP ortholog in S. cerevisiae, is required for heterotypic 
fusion, and likely functions during the priming stage of the reaction as it does for membrane 
fusion at other sites within cells (Clary et al., 1990; Mayer et al., 1996). (3) The Rab-GTPase 
Ypt7, not Vps21, is required for this fusion event. (4) The Ypt7-effector complex HOPS, and not 
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CORVET (the other MTC found on MVBs important for homotypic endosome fusion; 
Balderhaar and Ungermann 2013) is required for MVB-vacuolar lysosome fusion in vitro. We 
hypothesize that both Ypt7 and HOPS mediate the tethering and docking stages of this reaction, 
as they are critical for these stages of the homotypic vacuole fusion reaction (Ungermann et al., 
2000; Price et al., 2000). (5) Pep12, the resident Qa-SNARE on MVBs, replaces Vam3, the 
vacuolar Qa-SNARE, in trans-SNARE complexes responsible for heterotypic lipid bilayer 
merger, the last stage of the reaction. Thus, it seems that the composition of the SNARE protein 
complex, rather than Rab-GTPases or MTCs, encode specificity between two distinct membrane 
fusion events. Because Q-SNAREs are thought to preassemble on a single membrane (Schwartz 
and Merz, 2009) and Vti1 is found on MVBs as well as vacuolar lysosomes (Gossing et al., 
2013), we propose that MVB membranes donate Pep12 and Vti1 to the complex that assembles 
with the soluble Qc SANRE Vam7 and Nyv1 donated from vacuolar lysosome membranes. This 
finding is consistent with results from synthetic systems showing that recombinant Pep12, Nyv1, 
Vti1 and Vam7 protein complexes form, are stable and drive liposome fusion (Furukawa and 
Mima, 2014). Overexpression of VAM3 suppresses cellular trafficking defects in pep12Δ cells 
(Götte and Gallwitz, 1997), suggesting that they can replace each other in SNARE complexes as 
has been reported in other organisms (e.g. Arabidopsis thaliana; Uemura et al. 2010). 
Furthermore, Vps33, the Sec1/Munc18 family-protein within the HOPS complex responsible for 
trans-SNARE templating required for homotypic vacuole fusion (Baker et al., 2015), can 
substitute Vam3 with Pep12 with equal affinity (Lobingier and Merz, 2012), suggesting that 
there is a conserved mechanism of how trans-SNARE complexes form and zipper to mediate 
lipid bilayer merger in response to upstream signaling by active Ypt7 and HOPS.  
          During homotypic vacuolar lysosome fusion, Ypt7, HOPS and SNAREs assemble as a 
ring at the vertex between apposed membranes, creating a flat circular boundary area at the site 
of contact between organelles (Wang et al., 2003; Mattie et al., 2017; McNally et al., 2017). We 
observed similar flattened interfaces between MVBs and vacuoles by TEM (Figure 11G), 
suggesting that this machinery creates the same topological arrangement to mediate MVB-
vacuolar lysosome fusion. Paralogs of these fusion proteins are found on all endocytic organelles 
within S. cerevisiae cells (Nickerson et al., 2009; Kümmel and Ungermann, 2014; Numrich and 
Ungermann, 2014). Thus we speculate that the vertex ring may be a topological requirement for 
these families of proteins to function in assemblies necessary for organelle membrane fusion in 
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the endocytic pathway. It is also noteworthy that the boundary membrane is internalized within 
the lumen as a byproduct of lipid bilayer merger at the vertex ring (Wang et al., 2002). Recently, 
we demonstrated that lysosomal polytopic proteins are selectively sorted into this boundary and 
upon membrane fusion are internalized and degraded by lumenal hydrolases (Mattie et al., 2017). 
Called the intralumenal fragment pathway, this process is important for lysosomal protein quality 
control, and is thought to remodel vacuolar lysosome membranes in response to cellular cues. 
Importantly, Ypt7 and possibly HOPS, but not ESCRTs, contribute to protein sorting in this 
pathway. Given that a similar boundary membrane forms during MVB vacuolar lysosome fusion 
and that Ypt7 and HOPS contribute to this event, it is tempting to speculate a similar mechanism 
may be used to degrade polytopic proteins on MVB membranes, or to remodel the membrane of 
the MVB-vacuolar lysosome fusion product to control organelle identity. Furthermore, it would 
explain the presence of large ILVs within MVBs that form in the absence of the ESCRT 
machinery (Stuffers et al., 2009).  
          At multiple sites within cells, Ca
2+
 fluxes are known to promote SNARE-zippering 
required for lipid bilayer merger (Pang and Südhof, 2010). Although we planned to use 
published methods to measure Ca
2+
 transients during MVB-vacuolar lysosome fusion events in 
vitro (e.g. Merz and Wickner 2004; Sasser et al. 2012), Ca
2+
 indicators (e.g. aequorin, Fluo-4) 
added to our cell-free heterotypic fusion reactions would not distinguish between Ca
2+
 released 
during homotypic fusion events or heterotypic events, as both occur in our samples. Instead we 
resorted to adding calcium chloride or divalent metal chelators to fusion reactions and found that 
the presence of cytoplasmic Ca
2+
 inhibits MVB-vacuolar lysosome fusion (Figure 13). This 
finding is in contrast to similar studies conducted using organelles isolated from mammalian 
cells whereby lumenal Ca
2+
 release by a purine receptor-type channel P2X4 is required for fusion 
(Cao et al., 2015). However, late endosomes (MVBs) were not distinguished from vacuolar 
lysosomes in these studies, making it difficult to compare results, and the S. cerevisiae genome 
does not include orthologous genes encoding purine receptor channel genes or other Ca
2+
 
channels implicated in endosome-lysosome fusion (e.g. two pore channels; Tian et al., 2015), 
which may explain why our findings are different. Homotypic vacuolar lysosome fusion, on the 
other hand, requires lumenal Ca
2+
 efflux (although the channel responsible remains unknown; 
Merz and Wickner 2004). Thus, we speculate that Ca
2+
 release from vacuolar lysosomes may act 




into the cytoplasm promotes homotypic fusion events whilst preventing heterotypic events, and 
vice versa.  
3.4.3 ESCRT function triggers MVB-lysosome fusion by promoting Rab conversion      
          Prior to our study, correlational evidence was presented suggesting that ESCRTs 
contribute to MVB-vacuolar lysosome fusion (see Metcalf and Isaacs, 2010; Russell et al., 2012; 
Shideler et al., 2015). Herein, we show that knocking out a single component in any of the 
ESCRT complexes prevents MVB-vacuolar lysosome fusion in vitro (Figure 17C). Because 
these results were gleaned from reactions containing vacuolar lysosomes isolated from wild type 
cells mixed with aberrant MVBs from mutant cells, we are confident that the fusion defect is due 
to a defect present on the MVB, and eliminates the possibility that impaired delivery of 
biosynthetic cargo to vacuoles observed in mutant cells underlies observed heterotypic fusion 
defects (Robinson et al., 1988; Raymond et al., 1992). Because all mutations resulted in the same 
phenotype, we reason that the triggering mechanism for fusion must occur downstream from the 
component that functions latest in the pathway, Snf7 (ESCRT-III), consistent with it being 
activated after ILV formation has occurred (Russell et al., 2012). Although the precise molecular 
mechanism remains unknown, previous work suggested that blocking ESCRT function prevents 
activation of Ypt7 through disruption of a Rab-conversion mechanism through the accumulation 
of active Vps21 on aberrant MVB membranes (Russell et al., 2012; Shideler et al., 2015). Using 
our new cell-free assay, we were able to partially rescue defects in heterotypic fusion caused by 
ESCRT mutations by adding GTPγS to activate Ypt7, supporting this hypothesis (Figure 17C). 
We reason that partial recovery may result from GTPγS also activating Vps21, which would 
exacerbate the blockade in Rab conversion, thus counteracting the effect of GTPγS on Ypt7 
activation (Shideler et al., 2015). Thus, as an alternative approach, we replaced wild type YPT7 
with a constitutively active mutant (Ypt7-Q68L) to target only this Rab-GTPase and not Vps21. 
When expressed in cells lacking VPS23, a component of ESCRT-I, Ypt7-Q68L completely 
rescued heterotypic fusion in vitro (Figure 17E). Thus, we reason that ESCRT function during 
MVB maturation is required for activation of Ypt7 to trigger MVB-vacuolar lysosome fusion 
(Figure 18). Although the mechanism that couples ESCRT function with Ypt7 activation remains 
elusive, it likely involves stimulation of the GEF (guanine exchange factor) protein complex 
Mon1-Ccz1 responsible for Ypt7 activation (Nordmann et al., 2010) and the Rab-GAP Msb3 that 
inactivates Vps21 (Lachmann et al., 2012), possibly through coordination with the Rab-effectors 
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HOPS and BLOC 1 (Rana et al., 2015) on MVB membranes.  
3.4.4 Nhx1 activity controls SNARE-mediated MVB-lysosome membrane fusion  
        Using our new cell-free heterotypic fusion assay, we were able to directly test the existing 
model of Nhx1 function and provide direct evidence for key aspects that were previously only 
implied: (1) We demonstrate that deleting NHX1 impairs MVB-vacuole fusion (Figure 15D) 
accounting for impaired delivery of internalized surface polytopic proteins to the vacuolar lumen 
for degradation (Bowers et al., 2000; Brett et al., 2005). (2) Although Nhx1 has not been 
reported to be present on vacuolar lysosome membranes in vivo, we demonstrate that Nhx1 can 
accumulate on these compartments after heterotypic fusion in vitro (Figure 15C). This finding 
offers an explanation for the observed presence of Nhx1 on these isolated organelles reported by 
Fratti and colleagues (Qiu and Fratti, 2010), and offers an explanation as to why the vacuole 
lumen is hyperacidic in nhx1Δ cells in support of Nhx1 functioning as a H+-leak pathway on both 
compartments (Nass and Rao, 1998; Ali et al., 2004). Although we did not pursue the basis of 
the discrepancy between observations made in vitro and in vivo, it is possible that Nhx1 proteins 
are recovered to the MVB after heterotypic fusion by the retromer pathway (Balderhaar et al., 
2010; Arlt et al., 2015) and this mechanism is either impaired in vitro or occurs at a rate that was 
not accommodated by the 90 minute reaction. (3) We also demonstrate that MVBs, where Nhx1 
is predominantly localized, are also hyperacidic within nhx1Δ cells (Figure 15H). We found that 
Vph1, the stalk domain of the vacuolar V-ATPase assembly, abnormally accumulated on MVBs 
within cells lacking NHX1 (Figure 16D). Given that MVB hyper-acidification in vitro requires 
ATP (Figure 15H), we hypothesize that Vph1 mislocalization to MVBs may underlie the 
phenotype; it could replace Stv1 in existing V-ATPase complexes or recruit more V-ATPase 
complexes to this compartment to increase H
+
-pumping capacity (Kawasaki-Nishi et al., 2001). 
(4) Although the weak base chloroquine facilitated recovery of heterotypic fusion between 
organelles isolated from nhx1Δ cells, both homotypic and heterotypic fusion events were 
stimulated by chloroquine in the presence of NHX1, consistent with a recent report suggesting 
that luminal alkalinization promotes homotypic vacuolar lysosome membrane fusion 
(Desfougères et al., 2016). This result is consistent with the prevailing model of Nhx1 function 
whereby lumenal exchange activity drives MVB-vacuolar lysosome fusion. However, lumen-to-
cytoplasm H
+
 translocation by Nhx1 requires cytoplasm-to-lumen counter-transport of a 
monovalent cation, such as K
+
 (Nass and Rao, 1998; Brett et al., 2005). In support of the model, 
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we found that cell-free heterotypic fusion is supported by Rb
+
 in place of K
+
 but only in the 
presence of NHX1 (Figure 15J). Nhx1 is the only known transporter on the MVB to accept Rb
+
 
as a substrate (Brett et al., 2005), albeit at a lower affinity than K
+
, which possibly reflects the 
observed reduction in heterotypic fusion in the presence of NHX1 (Figure 15J). Furthermore, 
Nhx1 on MVBs may underlie the different pH and monovalent cationic profiles observed for 
MVB-vacuolar lysosome fusion as compared to vacuolar homotypic lysosome fusion (Figure 
14). Thus, our results provide invaluable evidence to the prevailing model of Nhx1 function 
whereby lumenal H
+
 export (resulting in alkalinization) coupled to monovalent cation import 
drives MVB-vacuolar lysosome fusion for degradation of internalized surface polytopic proteins.  
          But how does Nhx1 activity regulate heterotypic membrane fusion? Firstly, we confirmed 
that the defect is present on MVB membranes, as in vitro heterotypic fusion between nhx1Δ 
MVBs and wild type vacuoles was impaired whereas wild type MVB- nhx1Δ vacuole fusion was 
tolerated (Figure 15E). We originally hypothesized that Nhx1 activity alters the charge on MVB 
membranes by reducing protonation of negatively charged lipids on the outer leaflet promoting 
membrane association of cytoplasmic fusion proteins (e.g. HOPS; Stroupe et al., 2006b). 
However, we did not observe changes in the cellular distribution of GFP-tagged components of 
HOPS or Ypt7 within nhx1Δ cells (e.g. Figure 16D; data not shown). This result is consistent 
with a report demonstrating that fusion machinery proteins continue to co-purify with MVBs and 
vacuoles isolated from nhx1Δ cells at levels similar to wild type organelles (Qiu and Fratti, 
2010), suggesting that deleting NHX1 does not affect the membrane association of soluble 
fusogenic proteins on MVBs or vacuolar lysosomes. Because the Rab-GAP Gyp6 was shown to 
bind and inhibit Nhx1 (Ali et al., 2004), we hypothesized that loss of NHX1 may inactivate Ypt7 
accounting for impaired fusion. But deleting NHX1 had no effect on Ypt7 activation (Figure 
16A and B), and addition of GTPγS to activate Ypt7 did not overcome fusion defects (Figure 
16C), eliminating this possibility and suggesting that Nhx1 and ESCRT machinery target 
different components of the machinery underlying MVB-vacuolar lysosome fusion. Rather, 
heterotypic fusion defects caused by deleting NHX1 were overcome by adding rVam7 (Figure 
16E), a soluble SNARE protein known to drive vacuole membrane fusion without a requirement 
for Ypt7 or HOPS (Thorngren et al., 2004). Thus, because MVBs within nhx1Δ cells contain 






 exchange by Nhx1 is activated 
downstream of ESCRTs to promote MVB-vacuole fusion after maturation whereby lumenal 
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alkalinization by Nhx1 triggers an unknown target upstream of trans-SNARE complex formation 
independent of Ypt7 activation or HOPS function (Figure 18).  
         Orthologous machinery in metazoans has been implicated in both MVB maturation and 
MVB-vacuolar lysosome membrane fusion (e.g. Solinger and Spang, 2013; Pols et al., 2013; 
Wartosch et al., 2015) and this machinery is thought to drive these processes using mechanisms 
similar to those observed in S. cerevisiae (Luzio et al., 2010). Mutations in components of the 
ESCRT machinery are linked to human disorders including cancers and neurodegenerative 
disorders, whereby defects in endocytosis are observed (Saksena and Emr, 2009). Similarly, loss-
of-function mutations in NHE6, a human ortholog of NHX1, are linked to Christianson 
syndrome, a devastating neurodevelopmental disorder (Gilfillan et al., 2008). Compelling work 
by the Morrow, Walkley and Strømme groups demonstrates a strikingly similar role for NHE6 in 
endocytosis within neurons where, for example, it is important for TrkB/Brain Derived 
Neurotropic Factor signaling for proper development of neural circuitry (Strømme et al., 2011; 
Ouyang et al., 2013). Mutations in NHE6 or its paralog NHE9 are also thought to impair 
endocytosis in astrocytes possibly underlying cellular defects that contribute to Alzheimer’s 
disease (Prasad and Rao, 2015) or glioblastoma (Kondapalli et al., 2015). Regardless, our final 
model describing the molecular basis of MVB-vacuolar lysosome membrane fusion could 
explain observed cellular defects that underlie these diverse human diseases and offers strategies 













Figure 18. Working model of MVB-vacuole membrane fusion 
Cartoon illustrating the fusion protein machinery underlying MVB-vacuolar lysosome membrane 
















3.5 Materials and Methods  
3.5.1 Yeast strains and reagents  
       All strains and plasmids used in this study are listed in Table 2. For cell-free organelle fusion 
assays, we used the Saccharomyces cerevisiae strain BJ3505 [MATα pep4::HIS3 prbΔ1-1.6R 
his3–Δ200 lys2-801 trp1-Δ101 (gal3) ura3–52 gal2 can1] because it is devoid of vacuolar 
lumenal proteases that would otherwise degrade lumenal fusion probes. For MVB-vacuolar 
lysosome fusion, BJ3505 cells were transformed with complementary fusion probes: pCB002 
(pRS406-Pep12-Fos-Gs-ω) and pCB003 (pRS404-Pep12-Fos-Gs-ω) to target the MVB lumen or 
pYJ406-Jun (pRS406-CPY50-Jun-Gs-α) and pCB011 (pRS404-CPY50-Jun-Gs-α) to target the 
vacuolar lysosome lumen. For homotypic vacuolar lysosome fusion, BJ3505 cells were 
transformed with complementary fusion probes targeting the vacuolar lysosome lumen: pYJ406-
Fos (pRS406-CPY50-Fos-Gs-ω) and pCB008 (pRS404-CPY50-Fos-Gs-ω) or pYJ406-Jun 
(pRS406-CPY50-Jun-Gs-α) and pCB011 (pRS404-CPY50-Jun-Gs-α). NHX1::GFP was knocked 
in or NHX1, VPS23, VPS36, and SNF7 were knocked out of BJ3505 cells using the Longtine 
method (Longtine et al., 1998). To assess localization of fusion probes, we transformed wild type 
or mutant BJ3505 cells with pCB035 (pRS406-Pep12-GFP) to target the MVB lumen or pCB044 
(pRS406-CPY50-GFP) to target the vacuole lumen, and imaged live cells by fluorescence 
microscopy. All biochemical and yeast growth reagents were purchased from Sigma-Aldrich, 
Invitrogen or BioShop Canada Inc. All restriction enzymes, Ni-Sepharose 6FF, and glutathione 
Sepharose 4B, polymerases, and ligases were purchased from New England Biolabs (County Rd, 
Ipswich, MA, USA). Purified rabbit polyclonal antibody against Sec17 was a gift from William 
Wickner (Dartmouth College Hanover, NH, USA), whereas those against Vam3, Ypt7, Vps21, 
Vps33, Vps41, Vps10 and CPY were gifts from Alexey Merz (University of Washington, 
Seattle, WA, USA). Recombinant mouse antibody against Pep12 was purchased from Invitrogen 
(Mainway, Burlington, ON). Recombinant rabbit IgG against GFP was purchased from Abcam 
(Toronto, ON). Proteins used include recombinant Gdi1 purified from bacterial cells using a 
calmodulin-binding peptide intein fusion system (Brett et al., 2008), recombinant Gyp1-46 (the 
catalytic domain of the Rab-GTPase activating protein Gyp1) purified as previously described 
(Eitzen et al., 2000), and recombinant soluble Qc-SNARE Vam7 purified as previously 
described (Schwartz and Merz, 2009). Reagents used in fusion reactions were prepared in 10 
mM Pipes-KOH, pH 6.8, and 200 mM sorbitol (Pipes-sorbitol buffer, PS).  
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3.5.2 Membrane fractionation by sucrose gradient  
       Yeast cells were grown in YPD overnight to OD600nm= 1.6/ml, harvested, and spheroplasted 
with lyticase for 30 minutes at 30
o
C. Spheroplasts then were sedimented and resuspended in 10 
ml of TEA buffer (10 mM triethanolamine, pH 7.5, 100 mg/ml phenylmethylsulfonyl fluoride, 
10 mM NaF, 10 mM NaN3, 1 mM EDTA, and 0.8 M sorbitol) and homogenized on ice by 
Dounce homogenization (20 strokes). Cell lysates were centrifuged at 15000 g for 20 minutes, 
and the resulting supernatant then was centrifuged at 100000 g for 12 hours to sediment cellular 
membranes. Pellets were resuspended in 1 ml of TEA buffer and loaded onto a stepwise (20–
70%) sucrose density gradient, and then centrifuged at 100000 g for 16 hours at 4°C to separate 
different cellular membranes by density. Samples were collected from the top, and each fraction 
was precipitated using 10% trichloroacetic acid, washed and resuspended in 100 μl of SDS-
PAGE buffer. Fractions then were loaded into SDS-polyacrylamide gels and subjected to 
electrophoresis to separate proteins by size. Western blot analysis was performed to determine 
fractions that contain proteins of interest.  
3.5.3 Organelle isolation and cell-free fusion assay  
       Organelles were isolated from yeast cells by a Ficoll floatation method as previously 
described (Haas et al., 1994). Organelle membrane fusion was assessed using a modified version 
of a published assay that relies on split β-lactamase complementation upon content mixing (Jun 
and Wickner, 2007). In brief, organelles were isolated from two separate strains that each 
express a single complementary fusion probe, and 6 μg of organelles from each strain were 
added to 60 μl fusion reactions in standard fusion buffer supplemented with 11 μM recombinant 
GST-Fos protein to reduce background caused by lysis. Reactions were incubated up to 90 
minutes at 27°C and then stopped by placing them on ice. Content mixing was quantified by 
measuring the rate of nitrocefin hydrolysis by reconstituted β-lactamase. Then, 58 μl of the 
fusion reactions were transferred into a clear-bottom 96-well plate and mixed with 142 μl of 
nitrocefin developing buffer (100 mM NaPi pH 7.0, 150 μM nitrocefin, 0.2% Triton X-100). To 
measure nitrocefin hydrolysis, absorbance at 492 nm was monitored at 15 seconds intervals for 
15 minutes at 30°C with a Synergy H1 multimode plate reading spectrophotometer (Biotek, 
Winooski, VT, USA). Slopes were calculated and one fusion unit is defined as 1 nmol of 
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hydrolyzed nitrocefin per minute from 12 μg of organelle proteins. Standard fusion buffer 
contains 125 mM KCl, 5 mM MgCl2, ATP regenerating system (1 mM ATP, 40 mM creatine 
phosphate, 0.5 mg/ml creatine kinase), and 10 μM CoA in PS buffer. To block fusion, either 
antibodies raised against Sec17, Ypt7, Vps21, Vps33, Vps41, Vam3, Pep12, or purified 
recombinant Gdi1 (4 μM) or Gyp1-46 (5 μM) proteins were added to fusion reactions. Where 
indicated, vacuoles were pretreated with 0.2 mM GTPγS for 10 minutes at 27°C prior to addition 
to fusion reactions, or reactions were supplemented with 100 nM rVam7 and 10 μg/ml bovine 
serum albumin.  
3.5.4 Trans-SNARE paring assay  
       Analysis of trans-SNARE complex formation was assayed as described (Jun and Wickner, 
2007), whereby the levels of Nyv1 that co-immunoprecipitate with CBP::Pep12 or CBP::Vam3 
were determined. Briefly, 45 μg of organelles each from CBY224 or DKY6281-CBP::Vam3 
nyv1Δ and BJ3505 were incubated under fusion conditions for 60 minutes. Reactions were then 
placed on ice for 5 minutes, and samples were centrifuged (11000 g, 15 minutes, 4°C). 
Supernatants were decanted, and membrane fractions were resuspended in 180 μl solubilization 
buffer (20 mM Tris-Cl pH 7.5, 150 mM NaCl, 1 mM MgCl2, 0.5% Nonidet P-40 alternative, 
10% glycerol) with protease inhibitors (0.46 μg/ml leupeptin, 3.5 μg/ml pepstatin, 2.4 μg/ml 
pefabloc, 1 mM PMSF). Reactions were topped up to a final volume of 560 μl and nutated for 20 
minutes at 4°C. Reactions were centrifuged again (16000 g, 20 minutes, 4°C) and supernatants 
collected. Next, 10% of the extracts were collected as input samples, and the remaining extracts 
were brought to 2 mM CaCl2. The CBP::Pep12/Nyv1 or CBP::Vam3/Nyv1 complexes were 
recovered with calmodulin Sepharose beads 4B (GE Healthcare) by nutating overnight at 4°C, 
collected by brief centrifugation (4000 g, 2 minutes, 4°C), washed five times with sample buffer, 
and followed by bead sedimentation. Bound proteins were eluted by boiling beads (95°C, 10 
minutes) in SDS sample buffer containing 5 mM EGTA for SDS-PAGE analysis and 
immunoblotting.  
3.5.5 Ypt7 extraction assay  
       The Rab-GTPase extraction assay was performed as previously described (Brett et al., 
2008). Briefly, 5X reactions containing 30 μg organelles from wild type or nhx1Δ BJ3505 cells 
were incubated under fusion condition for 30 minutes at 27°C. Then, 5 μM of rGdi1 was added, 
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and the reactions were further incubated for 10 more minutes. Samples (then immediately) were 
centrifuged (5000 g, 5 minutes, 4°C) to separate membrane bound proteins from those in the 
supernatant. Supernatant (100 μl) was transferred into fresh tubes and mixed with 25 μl 5X 
Laemmli SDS sample buffer while the pellets were resuspended in 100 μl 1X of the same sample 
buffer and boiled at 95°C for 10 minutes. One tenth of the total isolated supernatant or pellet was 
analyzed by Western blot.  
3.5.6 Measurement of MVB lumenal pH  
       Wild type or nhx1Δ BJ3505 cells were transformed with pCB046 to express pHluorin (pH 
sensitive) fused to mCherry (pH-insensitive) at the C-terminus of Pep12. Organelles were 
isolated as previously described (Haas et al., 1994). Reactions (60 μl) containing 12 μg of 
isolated organelles were incubated at 27°C for 10 minutes with 50 μM nigericin in PS buffer 
titrated to pH values between 5.80 and 7.80. Fluorescence intensities for pHluorin (excitation at 
485 nm, emission at 520 nm) and mCherry (excitation at 584 nm, emission at 610 nm) were then 
measured with a Synergy H1 multimode plate reading fluorometer (Bioteck, Winooski, VT, 
USA). A blank reference well containing 60 μl PS buffer was used to detect background 
fluorescence. Background subtracted pHluorin:mCherry ratio values were then plotted against 
pH values to generate a calibration curve. Sample fluorescence was then compared to the 
calibration curve to calculate MVB lumenal pH. 
3.5.7 Western blot analysis  
       Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
using a Bio-Rad mini protein system (Bio-Rad Laboratories, Hercules, CA, USA). After 
separation, proteins were transferred onto a nitrocellulose membrane by the wet transfer method 
at 12 V for 8 hours using a Royal Genie Blotter apparatus (Idea Scientific, Minneapolis, MN, 
USA). Membranes were blocked with 3% BSA in PBST buffer (137 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4, 2 mM KH2PO4, 0.1% Tween-20) and then washed twice with PBST and 
incubated with primary antibody diluted to 1:1000 in PBST for 1 hour at room temperature. 
Membranes were washed with PBST five times, and then incubated with HRP or FITC labeled 
goat anti-rabbit IgG diluted 1:10000 in PBST for 1 hour at room temperature. After an additional 
5 washes with PBST, the membranes were probed to detect bound secondary antibody using GE 
Amersham Imager 600 for chemiluminescence or a Typhoon scanner for fluorescence (GE 
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Healthcare, Piscataway, NJ, USA).  
3.5.8 Fluorescence microscopy  
       Live yeast cells stained with FM4-64 to label vacuole membranes were prepared for imaging 
using a pulse-chase method as previously described (Brett et al., 2008). For in vitro imaging, 
organelles isolated from strains expressing Nhx1-GFP, Pep12-GFP, or CPY50-GFP were stained 
with FM4-64 by treating organelles with 3 μM FM4-64 for 10 minutes at 27°C. Standard fusion 
reaction buffer was then added and organelles were incubated up to 90 minutes at 27°C and 
placed on ice prior to visualization. We used a Nikon Eclipse TiE inverted microscope equipped 
with a motorized laser TIRF illumination unit, Photometrics Evolve 512 EM-CCD camera, an 
ApoTIRF 1.49 NA 100x objective lens, and bright (50 mW) blue and green solid-state lasers 
operated with Nikon Elements software (housed in the Centre for Microscopy and Cellular 
Imaging at Concordia University). Micrographs were processed using ImageJ software (National 
Institutes of Health) and Adobe Photoshop CC. Images shown were adjusted for brightness and 
contrast, inverted and sharpened with an unsharp masking filter.  
3.5.9 Transmission Electron Microscopy  
       Isolated organelles were processed for transmission electron microscopy (TEM) using a 
custom protocol (Mattie et al., 2017). Fusion reactions were centrifuged at 4
o
C for 5 minutes, the 
supernatant was removed, 0.5 ml fixative (2.5% glutaraldehyde) was added to pellets and they 
were incubated overnight at 4
o
C. Pellets then were washed with washing buffer (0.1M sodium 
cacodylate) three times for 10 minutes and incubated in 0.5 ml freshly prepared osmium 
tetroxide solution (1% OsO4 in 1.5% KFeCN) for two hours at 4
o
C. Pellets were then washed 
with water three times for 5 minutes prior to dehydration by adding increasing concentration of 
ethanol (30%, 50%, 70%, 80%, 90%, for 10 minutes each, and then in 100% ethanol, 3 times for 
10 min) and treatment with 100% propylene oxide twice for 5 minutes. For sample infiltration, 
pellets were incubated in 1:1 volume ratio of propylene oxide:Epon for 1 hour at room 
temperature. The supernatant then was replaced with 100% Epon, and samples were placed 
under vacuum for 1 hour to remove bubbles and remaining traces of propylene oxide. The 
samples were incubated overnight at room temperature followed by the addition of 0.5 ml fresh 
100% Epon for polymerization by incubation at 4
o
C for 48 hours. Epon-embedded samples were 
cut into 90-100 nm sections using a Ultracut microtome and DiATOME Ultra diamond knife, 
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and each section then was placed on a copper mesh grid. Sections on grids were stained with 4% 
uranyl acetate for 8 min, then with 6% lead for 5 min, and followed by three washes with water. 
The final samples were imaged using FEI Tecnai 120 kV electron microscope outfitted with an 
AMT XR80C CCD camera system at the Facility for Electron Microscopy Research (McGill 
University, Montreal, QC). Digital images were processed using Adobe Photoshop CC software 
(Adobe Systems, San Jose, CA, USA). Brightness and contrast levels were adjusted and 
unsharpened filter was applied to images shown.  
3.5.10 Data analysis and presentation  
       All quantitative data were processed using Microsoft Excel v.14.0.2 software (Microsoft 
Cooperation, Redmond, WA, USA), including calculation of mean and S.E.M. Data were plotted 
using Kaleida Graph v.4.0 software (Synergy Software, Reading, PA, USA). All figures were 
prepared using Adobe Illustrator CC software (Adobe Systems, San Jose, CA, USA). References 




Table 2: Yeast strains and plasmids used in this study. 
 
Strain  Genotype Source 
BJ3505 
 
MATα pep4::HIS3 prb1-∆1.6R his3–200 lys2–801 
trp1∆101 (gal3) ura3–52 gal2 can1 
Jones et al., 
1982 



















CBY049 CBY044; nhx1∆::KANMX  This study 
CBY050 CBY046; nhx1∆::KANMX  This study 
CBY051 CBY048; nhx1∆::KANMX  This study 
CBY058 BJ3505; pCB035.ADHIpr-PEP12-GFP This study 
CBY060 BJ3505; pCB046.ADHIpr-PEP12-pHluorin-mCherry This study 
CBY067 CBY058; nhx1∆::KANMX  This study 
CBY117 BJ3505; pCB044.ADHIpr-CPY50-GFP This study 
CBY118 CBY117; nhx1∆::KANMX  This study 
CBY130 CBY044; nyv1∆::KANMX  This study 
CBY131 CBY046; nyv1∆::KANMX  This study 
CBY132 CBY048; nyv1∆::KANMX  This study 
CBY134 CBY044; vps8∆::KANMX  This study 
CBY135 CBY046; vps8∆::KANMX  This study 
CBY136 CBY048; vps8∆::KANMX  This study 
CBY137 CBY058; vps8∆::KANMX  This study 
CBY138 CBY117; vps8∆::KANMX  This study 
CBY155 CBY058; nyv1∆::KANMX  This study 
CBY156 CBY117; nyv1∆::KANMX  This study 
CBY179 CBY058; snf7∆::KANMX  This study 
CBY199 CBY058; vps23∆::KANMX  This study 
CBY217 CBY058; vps36∆::KANMX  This study 
CBY196 CBY044; vps23∆::KANMX  This study 
CBY222 CBY044; vps36∆::KANMX  This study 
CBY223 CBY044; snf7∆::KANMX  This study 
CBY224 BJ3505 nyv1∆::TRP1; pCB045.ADHIpr-CBP-PEP12  This study 
CBY232 CBY044 YPT7-Q68L::NATMX; vps23∆::KANMX  This study 
CBY236 CBY058 YPT7-Q68L::NATMX; vps23∆::KANMX  This study 
Plasmid Description  Source 
pCB002 pRS406 URA3; ADHIpr-PEP12-FOS-GS-ω This study 








pCB008 pRS404 TRP1; ADHIpr-CPY50-FOS-GS-ω This study 
pYJ406-Jun-
α 




pCB011 pRS404 TRP1; ADHIpr-CPY50-JUN-GS-α This study 
pCB035 pRS406 URA3; ADHIpr-PEP12-GFP This study 
pCB044 pRS406 URA3; ADHIpr-CPY50-GFP This study 
pCB045 pRS406 URA3; ADHIpr-CBP-PEP12 This study 





Chapter 4. Conclusions and future directions 
 
4.1 Overview 
          Lysosomes are the recycling compartments of all eukaryotic cells. They receive 
biomaterials through both homotypic (lysosome-lysosome) and heterotypic (MVB- or 
autophagosome-lysosome) fusion events, which exposes them to the degradative environment of 
the lumen where they are broken down by acid hydrolases into small building blocks and 
returned to the cytoplasm by nutrient transporters for reuse (Russnak et al. 2001; Luzio et al. 
2007; Li and Kane 2009). Thus, lysosomal function is crucial for cellular metabolism and 
clearance of toxic biomaterials that would otherwise cause cell death. Disruption of this function 
by targeting the molecular mechanisms underlying fusion, degradation, or recycling contributes 
to diverse human disorders, including lysosomal storage disorders, neurodegenerative disorders, 
and cancers (Parkinson-Lawrence et al. 2010; Ballabio and Gieselmann 2009; Lutgens et al. 
2007). 
          Although critical for lysosome function, biogenesis, inheritance, homeostasis and 
remodeling, many mechanistic details underlying lysosomal membrane fusion are still unclear. 
In this thesis, I elucidated a role for HOPS in coordinating the interplay between Rab, protein 
kinase, and SNARE cycles to orchestrate homotypic lysosome fusion and regulate the amount of 
lysosome membrane internalized and degraded upon fusion. I also show that HOPS recognizes 
two distinct trans-SNARE complexes: One composed of exclusively lysosomal Q-SNAREs 
Vam3, Vti1 and Vam7, and the R-SNARE Nyv1 for homotypic fusion, and another composed of 
a non-cognate endosomal Q-SNARE bundle including Pep12, Vti1 and Vam7, and the lysosomal 
R-SNARE Nyv1, required for heterotypic MVB-vacuole membrane fusion. Therefore, my work 
fine-tunes our understanding of the molecular mechanisms underlying membrane fusion events 
at the lysosome membrane. 
4.2 Rab-Kinase-SNARE cycles are regulated by HOPS to orchestrate vacuolar lysosome 
fusion and control ILF formation 
          In Chapter 2, I described a point mutation in Ypt7 (D44N) that uncouples Rab activation 
from effector (Vps41) binding (Figure 7B and C). I found that Ypt7-D44N impairs pore 
formation (inner leaflet merger), but has no effect on lipid mixing (outer leaflet merger; Figure 
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6A and B), causing fewer ILFs to form during fusion events in live cells and in vitro (Figures 5C 
and 6G; video 1). The abnormally high lipid to content mixing ratio (Figure 6E), suggests that 
the transition from lipid stalk to pore formation is stalled and causes hemifusion diaphragms to 
accumulate (Figure 6F, H, I, J, K). Although it cannot bind Vps41, Ypt7-D44N continues to 
support tethering and docking (Figure 8A and B) but HOPS is not stabilized on membranes 
(Figure 7E and F), compromising the formation and stability of trans-SNARE complexes (Figure 
8C and D). These observations suggest that the Ypt7-Vps41 interaction is dispensable for 
membrane tethering and docking during HVF but is required for trans-SNARE complex 
zippering that mediates pore formation. The addition of exogenous rVam7 to drive trans-
SNARE complex assembly and promote stability rescued fusion defects caused by Ypt7-D44N 
(Figure 8E), confirming that the Ypt7-Vps41 interaction likely contributes to SNARE complex 
proofreading and protection by HOPS required for full SNARE-pin zippering (Starai et al. 2008; 
Lobingier et al. 2014).  
          Importantly, the D44N mutation in Ypt7 did not interfere with its cellular distribution or 
the ability to activate the Rab. In fact, the entire pool of Ypt7-D44N that co-purified with 
isolated organelles was GDI resistant (Figure 7C and D) and caused extensive vacuolar lysosome 
tethering, similar to the addition of GTPγS to organelles harboring the wild type Ypt7 (Figure 
8A), suggesting that Ypt7-D44N was hyperactive, consistent with it being resistant to 
inactivation by GAPs (Vollmer et al., 1999). As previously reported, active Ypt7 binds Vps41 to 
shield it from Yck3 (Hickey et al., 2009), which otherwise phosphorylates Vps41 causing it to 
dissociate from membranes (Brett et al., 2008). Consistent with these reports, Ypt7-D44N causes 
hyper-phosphorylation of Vps41 (Figure 7G) and its dissociation from membranes during the 
fusion reaction (Figure 7E). Stabilizing HOPS on membranes by deleting YCK3 overcomes 
fusion defects caused by Ypt7-D44N and restores ILF formation (Figure 9). Thus, I conclude 
that phosphorylation of Vps41 by Yck3 targets pore formation to reduce ILF production (Figure 
10). 
          Altogether, these results further refine our knowledge of how multisubunit tethering 
complexs like HOPS coordinate the functions of Rabs (Ypt7), protein kinases (Yck3), and 
SNAREs to drive membrane fusion and fine-tune ILF formation: (1) Ypt7-Vps39 and the ALPS 
motif within Vps41 play a direct role in membrane tethering, while Ypt7-effector interaction is 
exclusively needed for trans-SNARE complex stabilization by HOPS, and (2) phosphorylation 
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of HOPS by Yck3 targets and stalls pore formation, causing expansion of hemifusion 
diaphragms to reduce ILF production.  
          Several MTCs have been identified in eukaryotes and are categorized into two groups: (1) 
the CATCHR (complex associated with tethering containing helical rods) family of MTCs 
functioning in the secretory pathway like Golgi-associated retrograde protein (GARP) complex 
required for transport between the endosome and the trans-Golgi network, the dependence on 
SLY1–20 (Dsl) complex required for transport from Golgi to endoplasmic reticulum, the 
conserved oligomeric Golgi (COG) complex required for intra-Golgi trafficking, and the 
exocyst, which drives tethering of post-Golgi vesicles to the plasma membrane (Yu and 
Hughson, 2010), and (2) MTCs that act in the endolysosomal pathway HOPS and CORVET 
(Solinger and Spang, 2013). The fact that all MTCs bind small GTPases, most commonly Rabs, 
and interact with SNARE proteins to recognize, tether, and orchestrate SNARE mediated 
membrane fusion (Solinger and Spang, 2013; Kuhlee et al., 2015; Spang, 2016) suggests that 
MTCs function in similar ways and raises the following question. Do all multisubunit tethering 
complexes-mediated fusion events produce ILFs? Based on my results with HVF, I speculate 
that ILF formation is a conserved feature of all membrane fusion events that are driven by 
coordinated interactions between GTPases, MTCs, and SNARE proteins, and soon new 
technologies in super-resolution fluorescence microscopy (e.g., lattice light-sheet microscopy; 
Chen et al., 2014) will reveal the answer to this question. 
4.3 Ypt7, HOPS and a non-cognate SNARE complex underlie MVB-vacuolar lysosome 
fusion 
           In Chapter 3, I developed a new cell-free content mixing assay to measure MVB-vacuole 
fusion kinetics. It is based on the reconstitution of β-lactamase activity from its two subunits (ω 
and α) that I initially targeted to the MVB and the vacuolar lysosome, respectively. Expressing 
the fusion probes in separate yeast strain and then mixing the isolated organelles ensured that the 
fusion reaction is controlled and the resulting β-lactamase activity is indicative of authentic 
MVB-vacuole fusion events (Figure 11A). Using this assay, I was able to confirm previous 
reports, mainly by the Ungermann group, suggesting that Ypt7 and its cognate tethering complex 
HOPS are required for both HVF and heterotypic MVB-vacuole fusion (Figure 12A and B). 
Consistent with it being the only α-SNAP in S. cerevisiae, I found that Sec17, which is required 
for cis-SNARE complex disassembly during the priming stage of HVF is also needed for MVB-
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vacuole fusion (Figure 12B). In addition to that, I was able to dissect the trans-SNARE complex 
required to drive MVB-vacuole fusion, and found that it is composed of the endosomal SNAREs 
Pep12 (Qa) and Vti1 (Qb) in complex with the vacuolar R-SNARE Nyv1 and the soluble Qc-
SNARE Vam7. This unique trans-SNARE complex is what ensures specificity between HVF 
(Vam3, Vti1, Vam7, and Nyv1) and MVB-vacuole fusion as the remaining machinery is shared 
by both fusion events (Figure 12B, D, E, F, and G).  
          But how could homotypic and heterotypic fusion events be balanced? Yck3 
phosphorylates Vam3 when the HVF reaction is blocked (Brett et al., 2008). However, it is not 
yet known whether Yck3 or any other kinase phosphorylates its ortholog Pep12 on endosomes. 
Hence, I speculate that Vam3 phosphorylation by Yck3 could function as a switch mechanism to 
free the vacuolar R-SNARE Nyv1 and the Qc-SNARE Vam7 for endosomal Pep12 and Vti1 
SNAREs to engage in this non-cognate complex unique to MVB-vacuolar lysosome fusion. It is 
noteworthy that at the site of contact between the MVB and the vacuole a flat circular boundary 
area similar to that observed at contact sites between docked vacuolar membranes is observed. 
This boundary membrane is internalized within the lumen as a byproduct of lipid bilayer merger 
at the vertex ring during HVF to recycle vacuolar lysosome polytopic proteins (Wang et al., 
2002; Mattie et al., 2017; McNally et al., 2017). Therefore, based on the similarity in the 
underlying fusion machinery and the shared topological arrangement between docked vacuolar 
membranes and MVB-vacuole membranes, I speculate that the same mechanism also exists to 
recycle MVB polytopic proteins. Thus, I propose that Yck3 phosphorylates the vacuolar Qa-
SNARE Vam3 to balance homotypic and heterotypic fusion events and regulate the endocytic 
and ILF degradation pathways important for lysosomal and MVB membrane remodeling and 
biogenesis. 
4.4 MVB maturation triggers fusion with vacuolar lysosomes 
          ESCRT proteins are crucial for MVB maturation and biogenesis. In Chapter 3, I also show 
that deleting any of the components of the ESCRT machinery blocks MVB-vacuole fusion in 
vitro (Figure 7C). Elegant work by the Odorizzi group revealed that when ESCRT protein Vps4 
was inactivated, MVBs accumulated hyperactive Vps21 and inactive Ypt7, suggesting that the 
Vps21 to Ypt7 Rab conversion cascade was impaired. After establishing that heterotypic fusion 
in vitro requires active Ypt7 (Figure 12B), I introduced a point mutation into Ypt7 (Q68L) to 
render it constitutively active (Brett et al. 2008). As expected, Ypt7-Q68L rescued MVB-
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vacuolar lysosome fusion in the absence of VPS23 (a component of ESCRT-I; Figure 17C and 
E). Thus, my results provide direct evidence in support of the hypothesis that ESCRT-mediated 
MVB maturation activates Ypt7 to trigger fusion with vacuolar lysosomes.  
          Nhx1 is an MVB resident protein (Nass and Rao 1998). Herein, we show that Nhx1-GFP 
decorates the limiting membranes of vacuolar lysosomes upon MVB-vacuole fusion (Figure 
15C). Nhx1 ion exchange activity is what contributes to the distinct ionic profile of MVB-
vacuole fusion. It can tolerate K
+
 replacement with Rb
+
 and regulates luminal pH of MVBs 
(Figure 15F, G, H, I, and J). Deleting NHX1 impairs MVB-vacuole fusion (Figure 15D and C) 
and impairs the cellular distribution of the proton pump (Vph1) from the vacuole to the MVB 
membrane (Figure 16D), which would count for the hyper-acidification of the MVB lumen in the 
absence of NHX1. I also show that Nhx1 does not regulate Ypt7 activity through its interaction 
with Gyp6, a Rab GAP protein (Ali et al. 2004; Figure 16A, B, and C). However, addition of 
rVam7 rescued fusion defects observed in nhx1Δ (Figure 16E) suggesting that trans-SNARE 
assembly is intact and functions downstream of Nhx1 activity, hence I hypothesize that ion 
exchange activity after ESCRT mediated MVB maturation targets an unknown factor upstream 
the trans-SNARE complex to mediate MVB-vacuole membrane fusion (Figure 18).  
          Although both ESCRTs and Nhx1 functions are required for MVB biogenesis and fusion 
with the vacuolar lysosome, the mechanisms by which they contribute to MVB-vacuolar 
lysosome fusion are different. Nhx1 ion exchange activity seems to target trans-SNARE 
complexes, whereas ESCRTs appear to be required for Ypt7 activation. But what is the link 
between ESCRT function and Ypt7 activation? When ESCRTs function is impaired, 
ubiquitylated cargoes destined for degradation at the vacuolar lysosome accumulate at the 
limiting membrane of the late endosome and cannot be sorted into ILVs (Rieder et al., 1996; 
Russell et al., 2012). I speculate that this defect in membrane remodeling, causes an increase in 
surface tension at the endosome membrane, and in response, endosomes tend to flatten their 
membranes to diffuse this tension by forming aberrant stacks of flattened cisternae, which could 
interfere with Mon1-Ccz1 (Ypt7-GEF) recruitment to membranes and ultimately disrupts Ypt7 
activation. Unlike Mon1-Ccz1, Vps9 (Vps21-GEF) possess a CUE domain capable of 
recognizing ubiquitylated cargos at the endosome (Prag et al., 2003; Shideler et al., 2015), hence 
Vps9 is enriched at these aberrant structures in response to ESCRT dysfunction causing Vps21 to 
become hyperactive (see Russell et al., 2012). This is consistent with the proposed Rab 
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conversion cascade theory, which states that activation of a Rab recruits the GAP for the 
proceeding Rab. Mon1-Ccz1 is not recruited to the membranes upon ESCRT dysfunction, and 
hence it cannot recruit Msb3 (Vps21-cognate GAP) to inactivate Vps21 (Rana et al., 2015).  
 
4.5 Future directions  
4.5.1 Yck3 activation coordinates completion of Rab cycle 
          My working model of HVF shown in Figure 10 of Chapter 2, suggests that Yck3 
activation might occur after trans-SNARE pairing whereby it phosphorylates Mon1 (a 
component of the Ypt7 GEF complex) causing it to dissociate from organelle membranes 
(Lawrence et al., 2014). Thus, I speculate that Yck3 activation may promote Ypt7 inactivation by 
its cognate GAP protein (Gyp7; Brett et al., 2008), which together with Vam3-phosphorylation, 
may release SNAREs from HOPS and synchronize disassembly of the fusion machinery (Alpadi 
et al., 2012). To test this hypothesis, we could conduct a Rab-extraction assay using Gdi1 to 
assess the proportion of active Ypt7 protein present on organelles isolated from WT or yck3Δ 
cells (Eitzen et al., 2000; Brett et al., 2008; Figures 7C and 16A). In a similar approach, we could 
also incubate isolated organelles with or without purified recombinant Yck3 in the presence or 
absence of ATP and then subject them to extraction by rGdi1. As a positive control, we can 
pretreat isolated organelles with GTPγS to prevent activation and extraction of Ypt7 by rGdi1. If 
my hypothesis is correct, I predict that more Ypt7 will be extracted in reactions incubated with 
rYck3 in an ATP-dependent manner. 
4.5.2 Autophagosome-lysosome fusion 
          The second major pathway that delivers biomaterials to lysosomes via a heterotypic fusion 
event is the autophagic pathway. Although crucial for cell survival, the molecular mechanism 
regulating the fusion of autophagosomes with lysosomes has not been fully established. 
However, like HVF and MVB-lysosome fusion, autophagosome-lysosome fusion requires the 
NSF ortholog Sec18 (Ishihara et al., 2001), the Rab-GTPase Ypt7 (Kirisako et al., 1999), the 
HOPS complex (Liang et al., 2008; Rieder and Emr, 1997), and SNARE proteins (Jiang et al., 
2014). However, most of these studies were based on fluorescence co-localization techniques 
and Western blot analysis (Darsow et al., 1997; Jiang et al., 2014; Diao et al., 2015), which do 
not permit the dissection of the fusion subreactions with molecular precision. Recognizing the 
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impact of cell-free fusion assays on our understanding of homotypic vacuolar lysosome and 
heterotypic MVB-vacuolar lysosome fusion, it is very appealing to fuse the ω-subunit of β-
lactamase followed by the proto oncogene c-Fos to the C-terminus of the autophagosome marker 
protein Atg8 (LC3 ortholog) to target this fusion probe to the autophagosome lumen, then isolate 
these compartments by a flotation gradient that does not damage organelles (e.g. opti-prep) and 
mix them with vacuolar lysosomes carrying the complementary fusion probe CPY50-Jun-α (see 
Figure 11A) in a buffer that permits fusion to quantify this heterotypic fusion event. Based on 
my results in Chapter 3, I predict that a unique trans-SNARE complex would confer specificity 
to this fusion event as Ypt7 and HOPS are shared with HVF and MVB-vacuole fusion. 
 
4.5.3 Nhx1 targets trans-SNARE complex assembly 
          How does NHX1 work? In my targeted screen to identify components of the fusion 
machinery that show altered cellular distribution upon NHX1 deletion, I made two important 
observations: (1) None of the GFP-tagged fusion machinery proteins (e.g., Ypt7, HOPS, 
SNAREs) showed noticeable change in their cellular distribution in WT versus NHX1 knockout 
cells, and (2) Vac1 and Vps45 which are exclusively found on the MVB (Peterson et al. 1999) 
were diffused in the cytoplasm upon NHX1 deletion (data not shown). Vac1 contains a FYVE 
zinc finger domain that binds [PI(3)P], critical for its association with the MVB membrane (Tall 
et al. 1999). It also has been shown that lowering the pH enhances the interaction of the EEA1 
complex and Vps27, both containing similar FYVE domains, with [PI(3)P]-containing 
membranes in vitro and in vivo, while increasing the pH impedes their affinity to [PI(3)P], 
indicating that pH-dependency is a general function of the FYVE finger family (He et al. 2009; 
Kutateladze 2006).  
          Thus, I propose that deleting NHX1 abolishes the capacity of the MVB to counterbalance 
the V-ATPase (Vph1) activity, resulting in an accumulation of protons in the MVB lumen (see 
Figures 15H and 16D). As a consequence, the MVB lumen will become hyper-acidic and that the 
local environment surrounding the MVB becomes alkaline, disrupting Vac1 association with the 
MVB membrane. Vac1 binds Vps45, which is an SM protein orthologous to Vps33 (Hashizume 
et al. 2009; Koumandou et al. 2007), that mediates the interaction between endosomal Qa-
SNARE Pep12 on the MVB and Qb-SNARE Vti1 on Golgi-derived vesicles to drive membrane 
trafficking to the MVB (Tall et al. 1999). Because Vps33 physically interacts with Pep12, and 
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both are required for MVB-vacuole fusion (Figure 12B; Subramanian 2004; Lobingier and Merz 
2012), it would be very interesting to assay for a direct interaction between Vac1 and Vps33 and 
determine whether Vac1 is required for Vps33 mediated trans-SNARE complex templating of 
endosomal Pep12 with vacuolar Nyv1 necessary for MVB-vacuole fusion. I predict that trans-
SNARE pairing between endosomal Pep12 and vacuolar Nyv1 to be defective such that Vac1 
cannot bind Pep12 in the absence of NHX1.  
          If our prediction appears to be true, then Vac1 could be the unknown factor that functions 
downstream of Nhx1 ion exchange activity to orchestrate trans-SNARE complex assembly 
between the MVB and the vacuolar lysosome similar to its function in orchestrating trans-
SNARE assembly between Golgi-derived vesicles and the MVB (Peterson et al., 1999). 
Therefore, pretreating isolated organelles from NHX1 knockout with the weak base chloroquine, 
which accumulates in the MVB lumen and rescues MVB-vacuole content mixing in the absence 
of NHX1 (Figure 15I) also would recover the Vac1-Pep12 interaction and trans-SNARE 
complex assembly required for MVB-vacuole lipid bilayer merger. This strategy could be used 
for the treatment of patients with loss-of-function mutations in NHE6 and NHE9; as such a 
treatment could rescue endocytosis defects causing impaired degradation of neurotransmitter 
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